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ARTEMIS AND METNASE MEDIATED PROCESSING OF 3΄-BLOCKED DNA LESIONS: 
ROLE IN RADIO/CHEMORESISTANCE AND DNA REPAIR 
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A dissertation submitted in partial fulfillment of the requirements for the degree of Doctor of 
Philosophy at Virginia Commonwealth University. 
 
Virginia Commonwealth University, 2012 
 
Advisor: Lawrence F. Povirk, Ph.D. Professor, Department of Pharmacology and Toxicology 
 
DNA double-strand breaks (DSB) with chemically modified end-termini are the most 
significant lesions resulting from radio/chemotherapeutic intervention of cancer and 
non-homologous end-joining (NHEJ) factor Artemis nuclease has been implicated in the repair 
of such breaks. To examine whether the resolution of terminally blocked DNA DSBs is the 
biologically relevant function of Artemis, Artemis deficient fibroblasts were stably 
complemented with wild type or an endonuclease deficient D165N mutant Artemis. 
Physiological levels of wild type (WT) Artemis completely restored DSB repair proficiency and 
resistance to γ-radiation, bleomycin, and neocarzinostatin. Cells expressing the D165N mutants 
remained as chemo/radiosensitive and as repair deficient as parental cells, with persistent 
γ-H2AX and 53BP1 foci that increased in size 6-18 hour post irradiation. These persistent foci 
co-localized with DNA double strand break repair factor Mre11 and also with promyelocytic 
leukemia protein (PML). Further, in vitro studies have revealed that DNA-PK dependent Artemis 
 
xv 
 
endonucleolytic activity may play a role in the repair of commonly found oxidative base damage; 
8-oxoguanine (8-oxoG), a hallmark of complex DSBs.  
However, majority of DNA DSBs are repaired in an Artemis independent manner, and recently 
discovered, DNA end-specific nuclease, Metnase is a candidate enzyme for repair of such 
breaks. To study the role of Metnase in resolution of 3ʹ-blocked termini, several substrates 
mimicking such breaks were constructed. A 3ʹ-phosphoglycolate moiety on longer overhangs (4 
and 6 bases) altered specificity and stimulated Metnase-mediated cleavage of the terminal 
3 nucleotides. However, an 8-oxoG residue at the single-strand/double-strand border did not 
affect specificity or extent of cleavage. Metnase preferentially cleaved ssDNA-overhang of a 
partially duplex substrate, and the cleavage increased with increase in length of 3ʹ-overhangs. A 
D483A mutation in Metnase completely abrogated Metnase cleavage activity towards DNA 
ends. 
These results suggest that Metnase may resolve oxidatively damaged DNA ends to facilitate 
repair while Artemis is required for the resolution of more complex DNA DSBs that persist for 
longer  times  and  are  not  amenable  to  repair  by  other  NHEJ  factors.  
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I. GENERAL INTRODUCTION 
 
According to the National Cancer Institute’s Surveillance Epidemiology and End Results 
(SEER) approximately 1,596,670 people were estimated to be diagnosed with cancer in 2011 and 
571,950 of those diagnosed were predicted to die in United States alone. On January 1, 2008 
approximately 11.9 million people in the United States were alive with a history of cancer. 
About seventy-five percent of these patients may receive radiotherapy sometime during the 
course of their disease (Tofilon, Camphausen 2009).   
Radiation therapy has been used for the treatment of cancer for more than 100 years. The 
first claimed treatment involving  X-rays occurred on January 29, 1896, which was three months 
after the announced discovery of X-rays by Wilhelm Roentgen (Orton 1986), when a medical 
student in Chicago treated advanced breast carcinoma in a patient using X-ray tubes. 
Though radiation therapy has become one of the mainstays for treatment of cancer since, it is 
also a proven human carcinogen. Even today therapy-induced secondary cancers make up an 
astonishing 1/6
th
 of all new diagnosed cancers in the US alone.   
Both the therapeutic and carcinogenic effect of radiation is believed to result mainly from its 
interaction with DNA.  
1.1 Structure of DNA 
 
Until 1953, nucleic acids were not considered very important. At the time, protein rather 
than DNA was considered by most scientists as the carrier of genetic information. Following the 
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discovery of protein structure by Linus Pauling and Robert Corey in the April of 1951 published 
as seven  back to back articles in PNAS (Pauling, Corey 1951a, Pauling, Corey 1951g, Pauling, 
Corey 1951b, Pauling, Corey 1951d, Pauling, Corey 1951f, Pauling, Corey 1951e, Pauling, 
Corey 1951c), the next big question that remained unanswered was the discovery of the structure 
of nucleic acids. 
Subsequently, Pauling and Corey concentrated their efforts on deciphering the structure of 
DNA. However, they had insufficient data to deduce the structure correctly. Using a few blurry 
X-ray patterns published by William Astbury in 1947, Pauling decided that DNA was a three 
chain helix, with the bases facing outward and the phosphates in the core. He published his 
results in 1953 in PNAS. Shortly after, Pauling’s article was published in Feb 1953; it became 
apparent that Pauling’s structure was not correct.  
The correct structure of DNA was solved by Watson and Crick who published their results 
in Nature on April 25, 1953 (Watson, Crick 1953). However, their work was made possible due 
to the contributions of Rosalind Franklin (Franklin, Gosling 2003), who created the world’s best 
X-ray diffraction pictures of DNA and Maurice Wilkins (Wilkins, Stokes & Wilson 1953), who 
was also working at Kings College, London.  
The structure of DNA as described by Watson and Crick has two helical chains coiled 
around the same axis. Both chains follow right handed helical pattern, and are antiparallel. The 
bases are on the inside and the phosphates on the outside. The deoxyribose sugar is roughly 
perpendicular to the attached base. There is a residue on each chain every 3.4 Å, and the 
structure repeated itself after 10 residues or 34 Å. The distance of the phosphorous from fiber 
axis is 10 Å, and as the phosphates are on the outside they have easy access to cations. A purine 
on one chain is hydrogen bonded to a pyrimidine on the other chain. The bases occur in the 
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structure as the keto form with Adenine (Purine) bonding with Thymidine (Pyrimidine) and 
Guanine (Purine) bonding with Cytosine (Pyrimidine). For their accurate description of the 
structure of DNA, James Watson and Francis Crick along with Maurice Wilkins were awarded 
the Nobel Prize in Physiology and Medicine in 1962.  
 
1.2 Types of DNA lesions 
Initially it was assumed that, since heredity is a stable process, the fundamental structure 
of DNA itself was stable and not subject to frequent alterations. However, looking at the double 
helical chemical structure of DNA, it becomes immediately apparent that DNA may continually 
react with oxygen and water, resulting in multiple DNA lesions. Such lesions may be broadly 
classified as endogenous and environmental. Endogenous DNA damage may result from 
intracellular production of reactive oxygen species (ROS), from normal cellular metabolism, 
V(D)J recombination and stalled DNA replication forks. The main types of DNA damage 
resulting from endogenous cellular processes are oxidation of bases (e.g. 8-oxoguanine), 
alkylation of bases (e.g. 7-methylguanine), hydrolysis of bases (deamination, depurination, 
depyrimidination), bulky adduct formation and mismatch of bases (due to errors in replication) 
(De Bont, van Larebeke 2004).   
Exogenous DNA damage can occur due to exposure to ultraviolet light (UV-B light 
causes crosslinking creating pyrimidine dimers, UV-A light creates mostly free radicals), 
industrial chemicals (Polycyclic hydrocarbons like benzo-(a)-pyrene may cause DNA bulky 
adducts) or due to therapeutic exposure to ionizing radiation (oxidation of bases, single-strand 
breaks and double-strand breaks). 
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1.3 Mechanism of DNA double strand break induction by ionizing radiation 
 
DNA is the critical target for radiation and most biological effects of radiation result 
mainly from damage to DNA (Hutchinson 1966). High-LET radiation (Linear Energy Transfer) 
like α-particles or neutrons interact directly with critical biomolecules in cells ionizing atoms of 
the target itself. However, radiation may interact with other molecules in the cell (water) to 
produce free radicals that may damage critical targets within their diffusion distance (Mozumder 
and Magee 1966). The initial radical production following energy deposition is non-homogenous, 
and high local concentrations occur in events called spurs (6-100eV for 1MeV electron) and 
blobs (100-500eV for 1MeV electron) (Schwarz 1969) (Mozumder 1985). The initial size of 
these pockets of energy deposition was estimated to be 17 Å (DNA radius is 10 Å). Since the 
energies deposited in these small volumes are much larger than the energies of chemical bonds 
(4-5eV) (Mozumder 1985), these small pockets inside the cell represent high radical ion 
concentrations. It is also clear that the interstrand distance (10 Å) can be spanned by regions of 
high radical density, making multiple radical attacks on opposite strands possible. These radical 
attacks in close proximity on both strands can lead to locally multiply damaged sites (Complex 
DNA damage) (Ward 1990), that may include DNA double-strand breaks (DSB), along with 
accompanying base damage like 8-oxoguanine and thymidine glycol as well as single strand 
breaks (SSB) (Demple, Harrison 1994b). SSBs and DSBs are produced in different proportions. 
While there are 1000 SSBs estimated for a Gy of radiation, about 40 DSBs occur per cell per Gy 
(Ward 1990). DNA DSBs are thought to be the most important lesion for cell killing.  Hence, it 
is extremely important to understand the various DNA damage responses that have evolved in 
cells to repair this damage, because even a single unrepaired 
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Figure 1-1. Types of DNA damage following irradiation. Radiation directly interacts with 
water, which constitutes 80% of the cell volume, to form hydroxyl radicals (OH
.
) that then 
account for the majority of the damage caused by γ-rays. The hydroxyl radical in aqueous 
solution then diffuses and damages lipid membranes, proteins and DNA. The proximity of the 
free radical generation to DNA, diffusion distance and the energy of the radical are some of the 
factors that are determinant of the type of damage (double-strand breaks, single-strand breaks or 
base damage) generated. 
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DNA DSB can lead to cell death. 
 
1.4 DNA Damage Responses  
DNA DSBs constitute one of the most severe forms of DNA damage. Incorrectly repaired 
DSBs can lead to deletions, inversions, translocations, chromosome fusions and chromosome 
loss, which can result in cell death or transformation, further leading to oncogenesis (Elliott, 
Richardson & Jasin 2005, Jasin 2000, Thompson, Schild 2001, Thompson, Schild 1999). 
However, cells have multiple redundant pathways to appropriately respond to such insult. 
The first step in a cell’s response to any form of DNA damage including DNA DSBs is to 
recognize the presence of damage. The mechanism governing the recognition of DNA DSBs and  
repair pathway choice still remains unresolved. 
According to one hypothesis, phosphorylation of γ-H2AX along with changes in 
chromatin structure activates ATM (Ataxia Telangiectasia Mutated), which is the main DNA 
damage sensor (Abraham 2001, Durocher, Jackson 2001). MRN (Mre11/Rad50/Nbs1) complex 
is also one of the first proteins that recruits and binds to broken DNA ends. It has also been 
shown to promote the recruitment and activation of ATM through an ATM interaction motif 
within the C-terminal of Nbs1 (Uziel et al. 2003, Lee, Paull 2004). Activation of ATM leads to 
its monomerization (Inactive ATM is present as dimers or multimers). Activated ATM further 
phosphorylates H2AX on the C-terminal tail at Ser139, over megabase regions surrounding a 
DSB, within 1 minute of damage and reaches peak levels by 20 minutes (Rogakou et al. 1998) 
(Burma et al. 2001). Many DNA damage response proteins are then recruited to the sites of DNA 
DSBs to form IRIF (Ionizing radiation induced foci). Early IRIF are shown to consist of γ-H2AX, 
53BP1, MRN complex and MDC1, that reach peak levels at the IRIF within 30 min (Rogakou et 
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al. 1998, Schultz et al. 2000) (Stewart et al. 2003). Rad51, Rad52, BRCA1 and BRCA2 do not 
form foci until later times following IR exposure.  ATM along with BRCA1, the mismatch DNA 
repair proteins MSH2, MSH6 and MLH1, BLM and MRN complex are thought to form part of 
BASC (BRCA1-associated genome surveillance complex), which has also been implicated as a 
damage sensing complex (Wang et al. 2000).  
The role of DNA-PK in sensing DNA damage is less clear than ATM and ATR. Some 
studies suggested a role for DNA-PK in mediating checkpoint controls in response to DNA 
DSBs (Woo et al. 1998), while others suggest a role in apoptosis (Wang et al. 2002). DNA-PK 
signaling has also been shown to be important for NHEJ. During NHEJ, KU initially binds to 
DNA ends followed by recruitment of DNA-PKcs, resulting in activation of its kinase activity 
(Lees-Miller, Chen & Anderson 1990, Gottlieb, Jackson 1993). Cheong et al. demonstrated that 
wortmannin mediated inhibition of DNA-PK activity affected the rejoining of DSBs in vivo, but 
did not affect the process in vitro. This may suggest a purely regulatory/damage sensing role for 
DNA-PK in intact cells rather than a direct end joining role. Following recognition of the 
damaged DNA, a choice for repair pathway needs to be made. Over the years, there has been an 
increasing interest in how the cells choose which DNA repair machinery to employ for repairing 
the damage. Recent studies have focused on the molecular mechanisms that regulate this choice. 
The repair pathway that is eventually employed may depend on several different factors that are 
discussed in the following section. 
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1.5 Choice of DNA DSB Repair Pathway 
 
DNA DSBs can adversely affect cell viability and genomic stability. As discussed in the 
previous section, cells have evolved groups of proteins that sense DSBs, arrest cell cycle and 
activate DNA repair pathways. Eukaryotic cells repair DSBs primarily by two mechanisms: 
NHEJ and HRR. The choice of repair pathway may depend on the cell type, cell cycle phase 
(G1/G2/S), site of DNA DSB/accessibility by repair factors (Euchromatin vs heterochromatin) 
and availability of homologous repair template.  
It has been known for some time that a critical factor governing the balance between 
NHEJ and HRR is the cell cycle phase. Cells have been shown to upregulate HRR during S and 
G2 phases of the cell cycle because of the availability of a template. Sister chromatids are the 
preferred template for HRR in mammalian cells. Cohesins (Proteins required for sister chromatid 
cohesion) have been shown to migrate to DSB repair sites and mediate checkpoints (Lightfoot et 
al. 2011). Though HRR is the favored mode of DNA repair in S/G2 phases, NHEJ remains active 
throughout the cell cycle. This may suggest that NHEJ could compete for DSBs even when 
homologous templates are in the vicinity of the break. Biochemical experiments suggested that 
both NHEJ and HRR proteins bind to broken DNA ends, and plasmid DNA transfected into 
mammalian cells could be repaired by either pathway. Therefore, the field moved into 
investigating whether the initial repair factors that are recruited to DSBs could be regulating this 
switch from NHEJ to HRR and vice versa.  
Early studies have shown that RAD51 and RAD52 expression increases during S-phase 
(Chen et al. 1997). Cyclin dependent kinase 1 (CDK1), which is a key regulator of cell cycle 
progression also enhances Mre11 mediated DNA end resection leading to increase in the length 
of 3ʹ single stranded DNA tails that may get bound by RPA and RAD51 to promote strand 
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invasion for HRR (Ira et al. 2004).  Moreover, phosphorylation of S2056 and T2609 clusters on 
DNA-PK which is required for NHEJ is reduced in irradiated S-phase cells. All these processes 
could be part of a regulatory mechanism that downregulates NHEJ and enhances HRR in S/G2 
phases of cell cycle (Chen et al. 2005).  
A defect in NHEJ could also lead to shunting of DSBs through the HRR pathway. Some 
proteins like Mre11, BRCA1, H2AX, PARP1, DNAPK and ATM play roles in both pathways 
(Roth, Wilson 1985, Allen et al. 2002, Pierce et al. 2001). Therefore, a possibility exists that one 
or more of these proteins may be implicated in regulating preference of DNA repair pathway 
employed to repair the damage.  
PARP1 has also been directly implicated in repair pathway choice. It functions with 
Ligase ΙΙΙ in an alternate low fidelity NHEJ pathway, where PARP1 competes with KU for DSB 
ends (Wang et al. 2006). PARP1-defective cells were found to possess reduced HRR repair 
(These cells showed camptothecin hypersensitivity) which was restored by inducing mutations 
that inactivate NHEJ (Saberi et al. 2007). Defects in RAD18 showed similar defect and a double 
PARP1/RAD18  mutant showed synergistic hypersensitivity to camptothecin, implicating both 
proteins in promoting HRR and inhibiting NHEJ (Saberi et al. 2007). Recently, CtIP-BRCA1 
complex was shown to modulate repair pathway choice. Phosphorylation of serine 327 of CtIP as 
cells enter S phase and recruitment of BRCA1 may act to switch repair pathway from NHEJ to 
HRR (Yun, Hiom 2009). Once the pathway choice is made mammalian cells repair DSBs by 
either HRR or NHEJ. 
1.6 Homologous Recombination Repair 
 
Homologous recombination repair (HRR) represents a high fidelity pathway for repair of 
DNA DSBs that depends on the availability of homologous sequences in the form of sister 
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chromatids, homologous chromosomes or DNA repeats for sequence information to replace lost 
nucleotides from the break site. Generally HRR is considered error free and is most active in the 
S/G2 phases of the cell cycle (Takata et al. 1998).  
HRR appears to involve a large group of proteins, including RAD51, RAD52, RAD54, 
RAD55, RAD57, BRCA1, BRCA2, XRCC2, XRCC3 and MRN complex. The first event is 
believed to be a 5ʹ3ʹ resection that leads to formation of ssDNA overhangs that are bound by 
RPA (single stranded DNA binding protein), RAD51, RAD52 and RAD54. RAD51 forms 
nucleoprotein complexes on ssDNA tails coated with RPA and may help in initiating strand 
exchange while RAD52 forms ring structures consisting of seven RAD52 monomers that may 
help RAD51 in forming DNA exchange intermediates. The RAD54 protein has ATPase activity 
and mediates DNA unwinding (Baumann, West 1998, Dronkert et al. 2000). The RAD55 and 
RAD57 exist as heterodimers and interact with RAD51 facilitating strand exchange. BRCA1 and 
BRCA2 (Breast cancer susceptibility proteins) are also thought to be physically associated with 
RAD51 at the DSB repair foci and are linked with DNA repair by virtue of their BRCT domain. 
Embryonic stem cells deficient in BRCA1 show greatly reduced repair of chromosomal DNA 
DSBs by HRR (Moynahan et al. 1999). BRCA2 binds to RAD51 through its carboxy terminus 
and mediates delivery of RAD51 preferentially to ssDNA. Disruption of BRCA2 by targeted 
truncation makes mouse cells susceptible to UV and MMS (Methyl methane sulfonate). 
BRCA1-/- and BRCA2 -/- mouse fibroblasts develop chromosomal aberrations further 
strengthening the role of these proteins in DNA repair. Following the early stages of HRR, 
BRCA1 may also serve as an anchor to co-ordinate the repair events. MRN complex, along with 
other nucleases (CtIP) may resect the DNA to generate ssDNA ends for DNA pairing and strand 
exchange facilitated by RAD51 and RAD51 homologs/paralogs to form Holliday junctions. Now 
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either the Holliday junctions disengage and DNA strands pair or a crossing-over event may result 
in Holliday junction resolution, followed by gap filling. However, MRN complex has only been 
shown to possess a 3ʹ5ʹ and not 5ʹ3ʹ exonuclease activity, hence other nucleases were 
hypothesized to be involved in carrying out the required resection. CtIP is the recently 
discovered nuclease that is suggested to play this role. Both C and N terminal of CtIP has been 
shown to interact with the NBS1 subunit of MRN complex (Chen et al. 2008, Yuan, Chen 2009, 
Sartori et al. 2007). CtIP is phosphorylated by ATM as well as CDK, and ubiquitinated by 
BRCA1 leading to its recruitment to DNA ends. This recruitment is thought to commit the cell to 
end resection and repair by HRR. CtIP along with MRN has been shown to be required for the 5ʹ 
DNA end resection following which the ssDNA is bound by RPA and subsequent steps of HRR 
can occur. 
1.7 Non-homologous end joining 
 
Non-homologous end joining (NHEJ) is regarded as the predominant DNA DSB repair 
pathway in mammalian cells at least in G1/G0 phase of the cell cycle, though there is evidence 
that it is active throughout the cell cycle. NHEJ does not require sequence information from an 
intact copy on homologous chromosomes for repair, hence the term ‘non-homologous’ (Roth, 
Porter & Wilson 1985). The most entrancing aspect of NHEJ is its ability to accept a diversity of 
substrates and convert them to joined products. This demands a great deal of flexibility in 
mechanical interaction of involved proteins to accept a plethora of different substrates that are 
generally produced following exposure to ROS. Radiation and the resulting ROS can interact 
with DNA to produce multiply damaged sites/complex DNA damage with different lengths of 
overhangs, end termini blocked with 4ʹ-oxidation products and several types of base damage 
most commonly 8-oxoguanine and thymidine glycols. These variously modified overhangs are 
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joined in vivo by NHEJ regardless of the sequence, overhang length, DNA end sequence or DNA 
end chemistry.  
1.8 Mechanism of Non-homologous end joining 
 
An oxidatively induced DNA DSB arising in mammalian cells often bears 3ʹ-staggered 
termini with chemically modified ends. Ku heterodimers are thought to be the first proteins that 
bind to DSBs and have a strong equilibrium dissociation constant (approx. 10
-9
 M) for duplex 
DNA ends of varied conformations (Mimori, Hardin 1986). Ku then binds to DNA-PK and the 
KU: DNA-PK complex can serve as a node where nucleases, polymerases and ligases can bind 
(Lieber 2008). Ku can form stable complexes with DNA-PK only in the presence of DNA ends 
(Yaneva, Kowalewski & Lieber 1997), likely because of a change in conformation when bound 
to DNA. This change in conformation may also facilitate interaction of Ku with DNA 
polymerases μ and λ along with XRCC4:DNA ligase IV complex (Nick McElhinny et al. 2000, 
Chen et al. 2000). The Ku: DNA-PK holoenzyme may occupy approx. 30bp from the DNA end 
(Walker, Corpina & Goldberg 2001, Leuther et al. 1999). Formation of the Ku: DNA-PK 
holoenzyme also leads to the activation of its kinase activity. DNA-PK can then phosphorylate 
various DNA repair proteins. Artemis in presence of DNA-PK gains a 3ʹ-endonucleolytic 
activity that has been shown to resolve 3ʹ-PG-terminated DNA DSB ends and various secondary 
structures in vitro. It is this endonucleolytic activity of Artemis that helps promote 
radioresistance and DNA DSB repair proficiency in mammalian cells (Mohapatra et al. 2011). 
Since Artemis: DNA-PK complex is able to endonucleolytically cleave a variety of damaged 
DNA overhangs (Ma, Schwarz & Lieber 2005, Yannone et al. 2008), there is no obvious need 
for other proteins with similar activities, however TDP1, APE1 and Metnase are some 
possibilities. 
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Figure 1-2. Nonhomologous end joining. The Ku 70/80 heterodimer forms a ring structure that 
binds to DNA DSB ends and helps in the recruitment of DNA-PK. This is followed by the 
recruitment of XLF:XRCC4:DNA ligase IV to the DNA ends which in turn leads to the synapsis 
of the two ends. DNA-PK autophosphorylation causes a conformational change causing it to 
move away from the DNA-termini, allowing Artemis and other endonucleases to process the 
ends before gap filling by pol μ and λ and ligation mediated by DNA ligase IV. Adapted from 
(Povirk, Valerie 2003) 
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The apurinic endonuclease APE1 can remove 3ʹ-PGs from blunt and recessed 3ʹ ends, not 
from protruding overhangs (Demple, Harrison 1994a, Haring et al. 1994, Suh, Wilson III & 
Povirk 1997). TDP1 (Tyrosyl DNA phosphodiesterase 1) can remove glycolate residue from 3ʹ 
ends, however additional processing by PNKP is required to remove 3ʹ phosphates left behind by 
TDP1 (Inamdar et al. 2002, Jilani et al. 1999). However, PG removal by these enzymes may be 
suppressed when the DNA ends are sequestered by repair complex and Artemis may be the only 
enzyme that acts in the context of repair complex. Alternatively, these enzymes may work on 
multiple redundant pathways to repair similar 3ʹ-PG terminated DSBs.  
Various evidence support that a complex of XLF:XRCC4:DNA ligase IV helps in 
alignment of partially cohesive ends for gap filling and ligation (Chen et al. 2000, Gu et al. 2007, 
Lee et al. 2003). DNA Polymerases μ and λ can bind to the KU:DNA-PK complexes by their 
BRCT domains located in the N-terminal portion of the polymerases (Ma et al. 2004) and unlike 
replication polymerases, can carry out template-independent synthesis. It is also likely that DNA-
PK may relinquish its position at DNA ends following its autophosphorylation to allow the gap 
filling enzyme complex KU:XRCC4:Ligase IV:Pol μ/λ, access to the extreme ends of DNA.  
The various enzymes that take part in the NHEJ pathway have a great deal of mechanical 
flexibility in their specificity of binding to DNA lesions, which in turn allows them to act on 
wider range of starting DNA end structures.  
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1.9 Structural and biochemical properties of various NHEJ proteins 
 
Ku 
Ku is a heterodimer consisting of a 70 kDa (Ku70) and a 86 kDa (Ku80) subunit based on 
protein gel mobility assays (Walker, Corpina & Goldberg 2001, Valerie, Povirk 2003). It was 
first identified as an autoantigenic protein from a scleroderma patient with initials K.U. The ring 
shape of Ku is consistent with the property of Ku to bind DNA ends and its ability to slide 
internally allowing other DNA repair proteins access to DNA ends (Mimori, Hardin 1986).  
X-ray crystallography studies have shown that Ku occupies approx. 16 bp of double helical DNA 
at DNA ends (Walker, Corpina & Goldberg 2001). The two subunits interact with each other 
through their carboxy-terminal domains. A minimum of 28 amino acids in the center of Ku80 are 
critical for Ku heterodimer complex formation (Wu, Lieber 1996). It also has more affinity for ds 
DNA (dissociation constant of 1-2nM) than ssDNA (diss. const of 300nM) (Tuteja et al. 1994). 
Neither subunit alone can bind to DNA efficiently suggesting that Ku70 and Ku80 functions are 
interdependent. Ku has also been shown to form a bridge between DNA ends that may help in 
aligning the two ends together for carrying out further steps of repair (Ramsden, Gellert 1998). It 
recruits DNA-PK to DNA ends, which then occupies extreme ends of DNA displacing Ku 
approx. 10 bp into the interior (Yoo, Dynan 1999). DNA-PK holoenzyme complex occupies 
approx. 30 bp from the DNA end as suggested by DNase footprinting. In addition to DNA 
alignment and facilitation of DNA-PK recruitment, recently Ku was identified as an effective 
5ʹ-dRP/AP lyase and was found essential for the removal of AP sites near DSBs (Roberts et al. 
2010). The end-joining of such breaks decreased in cells that were complemented with lyase 
deficient Ku mutant. 
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DNA-PK 
DNA-PK belongs to the family of phosphatidylinositol-3 kinase (PI3K) and is a large 
protein with a molecular weight of 469 kDa (Hartley et al. 1995). Its kinase activity is 
specifically activated by binding to duplex DNA ends of various DNA end conformations (Smith, 
Jackson 1999). The equilibrium dissociation constant for DNA-PK:Ku holoenzyme is tighter 
than for DNA-PK alone towards blunt DNA ends (West, Yaneva & Lieber 1998), suggesting that 
Ku facilitates DNA-PK binding to DNA ends. However, DNA-PK catalytic subunit can bind to 
DNA in the absence of Ku and the binding was competitively inhibited by ssDNA or supercoiled 
DNA (Hammarsten, Chu 1998, Hammarsten, DeFazio & Chu 2000). This suggests that DNA-PK 
can be activated by its direct interaction with dsDNA and Ku was needed to stabilize DNA-PK 
binding. Once bound, DNA-PK acquires S/T kinase activity (Hartley et al. 1995), and one of its 
initial target is DNA-PK itself, with more than 15 autophosphorylation sites already identified 
(Meek, Dang & Lees-Miller 2008). Two major autophosphorylation clusters termed ABCDE and 
PQR have been extensively studied and span residues 2609-2647 and 2023-2056 respectively. 
This autophosphorylation of the two end-bound DNA-PK molecules may lead to its dissociation 
from DNA ends to allow further processing (Valerie, Povirk 2003, Karran 2000). Biochemical 
experiments have shown that a minimum of 12 bp DNA was required to activate its kinase 
domain (Leuther et al. 1999). Several studies indicated that overhangs were more robust 
activators of the DNA-PK kinase activity than DNA ends with blunt DNA termini (Hammarsten, 
DeFazio & Chu 2000, Smider et al. 1998, Jovanovic, Dynan 2006).   
DNA-PK preferentially phosphorylates serine and threonine sites followed by a 
glutamine (S-T/Q sites). There is a long list of proteins that possess DNA-PK target sites, 
however the functional relevance of many of these phosphorylation events need to be studied 
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further. Most of the known NHEJ factors XRCC4, KU 70/86, Artemis, DNA-PK and XLF are 
excellent in vitro and in vivo targets of DNA-PK.  DNA-PK-mediated autophosphorylation is 
critical for Artemis endonucleolytic activity. Activated DNA-PK has also been shown to 
stimulate the ligase activity of XRCC4:DNA ligase IV complex (Meek, Dang & Lees-Miller 
2008)   
Previous work from several investigators has defined three major domains in DNA-PKs 
(Llorca, Pearl 2004, Boskovic et al. 2003, Rivera-Calzada et al. 2005). The N terminal repeat 
regions comprise of palm domain that consists of the proximal and the distal claw. An arm 
connects the N-terminal palm domain to the head domain consisting of the FAT, PI3K and the 
FATC domain. Assembly of DNA-PK onto Ku-bound DNA induces a conformational change in 
the protein such that the two globular domains come into contact to form a channel for DNA 
ends to reside. The DNA-PK is thus essential for various stages of NHEJ, especially the 
nucleolytic step and the ligation step. 
 
Mre11/Rad50/Nbs1 (MRN complex) 
 
Mre11, Rad50 and Nbs1 were first identified in yeast when screening for genes involved 
in resistance to DNA damage and meiotic recombination. Ogawa and co-workers demonstrated 
that Mre11, Rad50 and Xrs2 (The Saccharomyces cerevisae homolog of vertebrate-specific Nbs1) 
belong to the same epistasis group and were further shown to associate with each other 
physically (Johzuka, Ogawa 1995, Ogawa et al. 1995).  
Mre11 is a conserved 70-90kDa protein composed of an N-terminal phosphoesterase 
domain, and two distinct C-terminal DNA-binding domains (Williams, Williams & Tainer 2008, 
Jackson 2002). The hMre11 gene is located on chromosome 11q21. The recombinant protein by 
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itself resects DNA ends in 3ʹ-5ʹ direction in a manganese-dependent manner and the 3ʹ resection 
activity increases 3-4 fold in conjunction with Rad50. This process was shown to be ATP-
independent (Paull, Gellert 1998). Mre11 is more efficient with 3ʹ ends of a branched DNA than 
with 3ʹ flaps or 3ʹ overhangs and promotes opening of DNA hairpin loops (Paull, Gellert 1998). 
In vivo, Mre 11 dimer binds to a Rad50 dimer to form a core complex. The Nbs1 or Xrs2 
proteins binds to this core complex via interactions with Mre11, however there is some 
discrepancy over the number of Nbs1 proteins associated with the Mre11:Rad50 core (Lamarche, 
Orazio & Weitzman 2010). 
Nbs1 is a 65-85 kDa protein that consists of an FHA domain and two BRCT domains at 
its N-terminus, in addition to an Mre11 interaction domain at its C-terminus (Lloyd et al. 2009, 
Williams et al. 2009). These domains allow phospho-dependent interactions that are essential for 
recruiting repair proteins to DNA breaks. Nbs1 is also responsible for translocation of MRN 
complex into the nucleus and its mutants lacking the Mre11 binding domain are themselves 
nuclear while Mre11-Rad50 dimer complex is cytoplasmic (Desai-Mehta, Cerosaletti & 
Concannon 2001). Nbs1 stimulates the DNA binding and nuclease activities of the Mre11-Rad50 
dimer complex. The central region of Nbs1 contains several SQ motifs that serve as 
phosphorylation targets of ATM kinase as part of the DNA damage signaling process. The C-
terminus also contains an ATM interaction domain that may function to recruit ATM kinase to 
DNA DSB ends (Falck, Coates & Jackson 2005, You et al. 2005). Thus Nbs1 contributes to 
DNA DSB repair by providing several protein-protein interaction motifs rather than a direct 
enzymatic activity at DSB ends.  
Rad50 is a 150 kDa protein that forms a homodimer and has a sequence and structural 
homology to SMC (Structural Maintainance of Chromosome) family members. The N-terminal 
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Walker A and C-terminal Walker B nucleotide binding moieties associate with each other to 
form ABC-type ATPase domain (Hopfner et al. 2000) which has been implicated in DNA double 
strand unwinding. Rad50 also contains of a 575-amino acid long coiled coil that spans approx. 
500 Å and terminates with a CxxC motif that acts as a zinc hook. This zinc hook helps in 
tethering the two ends of DNA DSB for repair. The zinc-mediated Rad50 dimer is extremely 
flexible and can tether DNA ends about 1200 Å apart. This allows movement of tethered DNA 
ends for homology directed repair (Hopfner et al. 2002). 
MRN complex thus plays multiple roles in DNA DSB repair by both homologous 
recombination and Non-homologous end joining pathways. 
 
XLF/XRCC4/DNA-ligase IV 
 
The XRCC4 gene was originally identified by complementation of radiosensitivity and 
DSB repair deficiency of the CHO derivative XR-1 (Li et al. 1995). It consists of a globular head 
and a long α-helical tail. Crystal structure of XRCC4 has revealed that four XRCC4 monomers 
form a dumb-bell shaped homotetramer with two globular head and four tails that interact with 
each other. Both XLF and DNA ligase IV are present in a complex with XRCC4. (Lee et al. 
2000).  
The crystal structure of XLF (Cernunnos) suggests a similarity to the structure of XRCC4, 
with a globular head and a coiled-coil C-terminus, where multimerization occurs (Andres et al. 
2007). Interaction between XRCC4 and XLF was identified through a yeast two hybrid system 
that led to the discovery of XLF (Ahnesorg, Smith & Jackson 2006). Another study 
demonstrated that residues 1-128 on XLF and residues 1-119 on XRCC4 are the minimal regions 
required for their interaction, suggesting that both proteins interact with their head domains 
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(Deshpande, Wilson 2007). In particular Leu
115 located in the XLF β6-β7 loop is important for 
the XLF-XRCC4 interaction (Andres et al. 2007). Deficiency of XLF in humans leads to 
radiosensitivity with associated microcephaly (Buck et al. 2006) and a lack of V(D)J 
recombination. XLF-deficient cells also fail to rejoin a substantial fraction of radiation induced 
DSBs. In vitro reactions with purified proteins have shown XLF to stimulate ligation by X4L4. 
Our lab has shown that alignment-based gap filling is completely dependent on XLF in whole 
cell extracts suggesting that Cernunnos not only stimulates ligation by ligase IV, but may also be 
important for DNA alignment (Akopiants et al. 2009). Another possibility for XLF dependence 
for gap filling could be a requirement for proper positioning of pol λ or pol μ. However, 
experiments have shown that Ku and X4L4 alone are sufficient to recruit polymerases to DNA 
ends. Mutation of two phosphorylation sites S245A (DNA-PK dependent) and S251A (ATM 
dependent) did not alter either repair efficiency or repair fidelity of XLF. A DNA-PK inhibitor 
(KU57788) inhibited end joining mediated by XLF suggesting that presence of XLF and 
catalytically active DNA-PK is required for end joining while ATM inhibitor KU55933 had no 
effect on XLF-mediated end joining reaction (Akopiants et al. 2009).  
DNA ligase IV was initially co-purified with DNA ligase III in Hela nuclear extracts and 
was later shown to co-immunoprecipitate with XRCC4 (Grawunder et al. 1997). DNA ligase IV 
binds to XRCC4 at a site close to middle of the α-helical tail (Sibanda et al. 2001). Furthermore, 
it exists as a tight hetero-tetrameric complex with XRCC4 and is not detectable in cells lacking it 
(Lee et al. 2000, Bryans, Valenzano & Stamato 1999). DNA ligase IV consists of N-terminal 
core catalytic domain and a carboxy-terminal domain with two tandem copies of BRCT 
(Callebaut,I. 2006) and it is through the BRCT domains that ligase IV interacts with XRCC4 
(Critchlow,S.E. 1997). Contacts between KU and ligase IV, and between DNA-PKcs and 
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XRCC4 mediate binding of XRCC4/ligase IV to DNA-PK at the DNA end termini (Valerie, 
Povirk 2003, Hsu, Yannone & Chen 2001). DNA-PKcs phosphorylates XRCC4 on serine and 
threonine residues in the carboxy terminal of the protein (Leber et al. 1998), however, the 
relevance of this phosphorylation to NHEJ is still not clear. Analysis of the effect of DNA-PKcs 
on ligation by XRCC4/ligase IV complex showed that both proteins bind to the same DNA 
molecule and that such binding promotes intermolecular ligation as opposed to intramolecular 
ligation seen with XRCC4/ligase IV complex alone (Chen et al. 2000). These studies suggested 
that XLF/XRCC4/ligase IV may serve as an alignment factor to bind DNA ends together 
allowing for ligation to proceed following repair by NHEJ.  
 
Promyelocytic leukemia protein 
 
PML nuclear bodies are very interesting sub-nuclear compartments of 0.1 μm-1 μm in 
diameter due to their prominence in the nucleus. The main constituent of PML NBs is the PML 
protein itself, which is a known tumor suppressor and a key organizer of these domains. PML 
protein helps recruit other factors to these domains like SP100, Daxx and CBP etc, whose only 
known common feature is their ability to be sumoylated (Lallemand-Breitenbach, de Thé 2010, 
Yang et al. 2002, Bernardi, Pandolfi 2007). These bodies vary from generally 5-15 per nucleus 
and do not contain RNA or DNA (Boisvert, Hendzel & Bazett-Jones 2000). Although devoid of 
DNA, PML nuclear bodies may be associated with some specific chromosomal loci where they 
are proposed to modulate transcription and chromatin architecture (MHC gene cluster 1) 
(Lallemand-Breitenbach, de Thé 2010).  
PML is phosphorylated by several DNA damage-activated kinases like ATM, ATR and 
Chk2 and has itself been proposed to act as DNA damage sensor (Dellaire et al. 2006). PML-
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NBs have also been implicated in DNA repair due to recruitment and release of several DNA 
sensing/repair factors like BLM helicase, Mre11, WRN, p53 and TOPBP1 in a DNA damage 
dependent manner (Dellaire, Bazett-Jones 2004, Carbone et al. 2002, Bischof et al. 2001).  
Though PML-NBs partially overlap with unrepaired γ-H2AX foci, their localization to 
actual DNA damage sites need to be further investigated and is currently disputed (Mohapatra et 
al. 2011, Lallemand-Breitenbach, de Thé 2010, Boe et al. 2006). PML-/- cells and mice have 
been shown to more resistant to lethal effects of γ-radiation than PML+/+ cells. Cds1/Chk1 
mediated phosphorylation of PML mediates apoptosis (Yang et al. 2002), probably through 
recruitment of Daxx to NBs (Zhong et al. 2000). Our results that PML NBs partially juxtapose 
with late repair foci in Artemis-deficient cells lay credence to the 
fact  that  these  foci  regulate  many  aspects  of  DNA  DSB  repair.
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II. INTRODUCTION TO THESIS 
 
2.1 Nuclease processing of blocked DNA end termini 
 
During NHEJ, the damaged DNA end termini are recognized, bound, aligned and stabilized 
by Ku/DNA-PK complex, followed by processing of DNA to create ligatable ends. Most DNA 
DSBs resulting from exposure to ionizing radiation and radiomimetic chemotherapeutics bear 
chemically modified end termini that must be removed before patching and re-ligation can 
follow. The most commonly found blocked terminus following free radical-induced DSBs are  
3ʹ-phosphates and 3ʹ-phosphoglycolates (Henner et al. 1983) while some ends may bear a 
5ʹ-aldehyde (Dedon, Goldberg 1992, Povirk 1996). It has also been shown that such blocked 
DNA ends may also have accompanying base damage, especially following radiation exposure 
(Nikjoo et al. 1997, Zhou et al. 2008). Such multiply damaged sites are the most difficult to 
repair and are major determinants of survival following radiation exposure or therapeutic 
radiation treatment. The NHEJ machinery has evolved many endonucleases to resect such 
modified termini, and to resolve blocked 3ʹ-phosphoglycolate ends, Artemis, TDP1 and APE1 
have been implicated. However, their role in resolving complex DNA damage is still under 
investigation. This thesis investigates the role of Artemis and newly discovered Metnase 
endonucleolytic function for resolving such damage and promoting DSB repair. 
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2.2 Artemis 
 
Artemis was named after the Hellenic goddess of the hunt who aids in childbirth and is 
considered a protector of children. It was identified as a 77.6 kDa protein (685 amino acids) 
coded from the short arm of chromosome 10, responsible for radiosensitive-severe combined 
immunodeficiency (RS-SCID) or Athabascan SCID (SCIDA) (Moshous et al. 2001). Autosomal 
recessive mutation of this gene is lethal within the first year of life due to occurrences of severe 
opportunistic infections. Several in vitro and in vivo studies have revealed that Artemis nuclease 
is required for the resolution of hairpin coding ends during V(D)J recombination (Li et al. 2005, 
Ma et al. 2002), a critical point in the development of immune system. Defect in Artemis leads to 
a T
-
 B
-
 NK
+
 phenotype, due to an arrest of the B and T cell maturation at early stages. Artemis- 
deficient cells also display increased sensitivity to radiation and radiomimetics suggesting that it 
is also required for DSB repair by NHEJ.  
 
Structural properties of Artemis 
 
Artemis belongs to SNM1 family of proteins and is homologous to yeast SNM1 gene 
products. Since the crystal structure of Artemis has not been determined yet, most of the 
structural properties of the protein have been derived from biochemical analysis over the past 
decade. The N-terminal region of the protein has a metallo-β-lactamase domain spanning amino 
acids 1-155 and a β-CASP (metallo-β-lactamases-associated CPSF ARTEMIS SNM1 PSO 2) 
domain spanning 156-385 amino acids (Callebaut et al. 2002). The β-CASP domain is highly 
conserved among metallo-β-lactamases acting on nucleic acids. Pannicke et al selected four 
conserved aspartic acid residues (D17, 37, 136, 165) and five histidine residues (H33, 35, 38, 
115, 319) in the conserved metallo-β-lactamase/ β-CASP domain of Artemis for further analysis. 
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These aspartic acid and histidine residues are present in the Artemis active site and are thought to 
co-ordinate metal ions for a nucleolytic attack onto the DNA (Pannicke et al. 2004). Experiments 
with Artemis mutated for the above residues revealed that D37 and histidines 33, 35, 38, 115 and 
319 directly co-ordinate metal ions. Thus mutation in these residues reduces or abolishes binding 
of both metal ions and nucleolytic function. Aspartic acid residues 17, 136 and 165 do not 
directly bind to metals but may form salt bridges to the HxHxDH motif backbone and the side 
chain of H38 and 33 to probably stabilize the conformation of the HxHxDH motif for co-
ordination of the metal ions. The D165 residue is interesting and unique because it is not 
available in the crystal structure of available metallo-β-lactamases, however it is important to 
Artemis endonuclease activity since a mutation in this residue completely abrogates Artemis- 
mediated endonucleolytic cleavage (Yannone et al. 2008, Pannicke et al. 2004). The D165 
residue may thus be present in the active site of Artemis to help co-ordination of the metal ions. 
More recently, another histidine residue H254 in the β-CASP domain has been shown to be 
important for the full in vitro and in vivo functions of the protein. A H254A mutant Artemis was 
endonucleolytically inactive and failed to complement the V(D)J recombination defect of 
GUETEL cells (SV40 transformed, htert immortalized skin fibrobalsts from a RS-SCID patient) 
(de Villartay et al. 2009). However, the 5ʹ-exonuclease activity remained unaffected. The H254 
is functionally important because of its location in the β-CASP region outside of the metallo-β-
lactamase domain (All other amino acids important for endonuclease activity of Artemis are 
located in the metallo-β-lactamase domain). Moreover, H254 is located in the most variable 
region of metallo-β-lactamase family of proteins, yet is conserved in Artemis. It is speculated to 
co-ordinate zinc ions in the active site of Artemis, but its exact role at the molecular level needs 
to be further characterized.  
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Biochemical properties of Artemis 
Artemis has been shown to possess ssDNA specific 5ʹ3ʹ exonuclease activity and it 
acquires a 3ʹ5ʹ endonuclease activity when associated with DNA-PK (Yannone et al. 2008, Ma 
et al. 2002). Dr. Lieber’s group synthesized and tested a hairpin substrate for Artemis function. 
They observed the expected exonuclease activity of Artemis at the non-hairpin end of the hairpin 
substrate but no hairpin opening activity of Artemis alone or with addition of Ku was detected. 
However, in presence of DNA-PK the spectrum of Artemis activity shifted more towards the 
endonuclease function (Ma et al. 2002). When longer internally labeled substrates were treated 
with DNA-PK and Artemis, short 3ʹ overhangs (4-5 bases) were efficiently trimmed to 2-3 bases. 
Duplexes with blunt ends or very short overhangs (1-2 bases) were trimmed more slowly than 
longer overhang bearing substrates (Yannone et al. 2008). The trimming of blunt ends by 
Artemis/DNA-PK is executed as trimming of the 5ʹ terminal (removal of approx. 6 bases) to 
generate 3ʹ-overhangs that is then endonucleolytically cleaved as dinucleotides. However, in the 
absence of DNA-PK, an extensive 5ʹ3ʹ resection dependent on the presence of a 5ʹ-phosphate 
was detected. DNA-PK strongly suppresses the exonuclease and upon phosphorylation promotes 
endonucleolytic trimming. This endonucleolytic activity has been shown to remove chemically 
modified 3ʹ and 5ʹ-termini such as 3ʹ-PG and 5ʹ-aldehyde.  
Blocking PG moieties on long 3ʹ overhangs did not influence Artemis endonuclease 
activity; however, 3ʹ-PG moiety on shorter overhangs (closer to the cleavage site) altered 
Artemis nuclease specificity. In reactions with plasmid substrates bearing a 3-base 3ʹ-PG 
overhang, Artemis-mediated single-nucleotide removal was predominant. Moreover, the total 
cleavage for the 3ʹ-PG-terminated end was higher than an analogous 3ʹ-phosphotyrosyl end and a 
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3ʹ-hydroxyl end which was left almost intact (Povirk et al. 2007). Based on the work performed 
in our lab, Artemis-mediated cleavage of 3ʹ-overhangs was found to depend upon, requirement 
for 2 nucleotides (or a nucleotide and a 3ʹ-PG) 3ʹ to the cleavage site or at least 2 unpaired 
nucleotides 5ʹ-to the cleavage site and showed a preference for trimming of 4-5 bases on the 
3ʹ-overhangs from the single/double strand border. There was a pronounced decrease in Artemis- 
mediated trimming for PG substrates having less than 3-base overhangs.  For substrates having  
3ʹ overhangs of less than 3 bases (blunt ends and 2-base overhangs), a 30 min Artemis treatment 
yielded multiple cleavage products totaling less than 10 % of the initial substrate (Povirk et al. 
2007).  
The biochemical data taken together suggest a role for Artemis in resolution of 
oxidatively damaged 3ʹ-PG terminated blocked DNA ends on long 3ʹ overhangs. 3ʹ-PG ends on 
blunt and very short overhangs are also processed, but slowly. Artemis may also lack the 
specificity to remove only the 3ʹ-PG lesions, since it excises a few terminal nucleotides, in turn 
resolving the blocked end. This endonuclease activity of Artemis is stimulated by DNA-PK and 
Ku, two NHEJ proteins. However, the role of Artemis in resolving multiply damaged 
sites/complex DNA lesions with oxidative base damage needs to be biochemically studied and 
has been addressed as part of this thesis. 
 
Regulation of Artemis activity 
Recent publications have tried to address how Artemis activity might be regulated. 
Artemis has been shown to interact with phosphatidylinosytol-3 kinases like DNA-PK and ATM, 
and is basally phosphorylated at S516 and S645 in cultured cells (Ma et al. 2002, Wang et al. 
2005, Zhang et al. 2004, Riballo et al. 2004). ATR mediates hyperphosphorylation of Artemis 
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after UV irradiation (Zhang et al. 2004). Following treatment with radiation or bleomycin, 
phosphorylation of Artemis by ATM increases 10-15 fold at above mentioned positions. Co-
immunoprecipitation studies showed an ATM-dependent interaction of endogenous Artemis with 
Nbs1 (Chen et al. 2005) and the amount of Nbs1 interacting with Artemis increased following 
irradiation. In vitro, ATM-mediated phosphorylation of Artemis at S645 was shown to be 
dependent on the presence of MRN complex (Goodarzi et al. 2006). Nbs1 can form IRIF and 
recruit ATM to sites of DSB (Falck, Coates & Jackson 2005), suggesting that Nbs1 may be 
involved in recruitment and facilitation of ATM-mediated phosphorylation of Artemis at DSB 
ends. This hypothesis is confounded by the fact that Artemis hyperphosphorylation by ATM is 
dispensable for its endonuclease activity and for DSB repair/V(D)J recombination (Goodarzi et 
al. 2006).  
However, in ATM null cells, Artemis can also be phosphorylated redundantly by DNA-
PK (Chen et al. 2005, Goodarzi et al. 2006). Radiation treatment was found to enhance the 
interaction between DNA-PKcs and Artemis (Zhang et al. 2004). Though the same group 
observed a decrease in total Artemis levels on DNA-PK knockdown in cells, DNA-PK- deficient 
MO59J cells do not show any decrease in Artemis levels (Drouet et al. 2006). Treatment of cells 
with a DNA-PK inhibitor NU7026 abrogated the hyper-phosphorylation and cellular retention of 
Artemis following DNA damage. The DNA-PK kinase activity stabilized the interaction of 
Artemis with DNA-PK and DNA ends in presence of KU. Autophosphorylation of DNA-PK at 
T2609-2647 in the presence of KU and DNA promotes Artemis endonuclease activity, possibly 
by causing a conformational change in DNA-PK allowing Artemis access to DNA ends 
(Goodarzi et al. 2006). An alternate hypothesis is that activated DNA-PK could optimally 
organize DNA ends for endonucleolytic resection by Artemis.  
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Artemis, a multifunctional phosphoprotein 
Over the past few years there has been some progress in defining the various C-terminal 
phosphorylation sites on Artemis but the role of this phosphorylation still remains unclear. 
Current findings suggest that phosphorylation by PI3Ks do not regulate Artemis function in 
NHEJ or V(D)J recombination, as a construct containing the Artemis catalytic core is fully 
capable of restoring defects in these pathways due to Artemis deficiency (Poinsignon et al. 2004a, 
Poinsignon et al. 2004b). Thus other groups have indicated a cell cycle regulatory role for 
Artemis. Analysis of Artemis phosphorylation has revealed that the S534 and S538 sites are 
rapidly phosphorylated and also dephosphorylated within 1 hour following IR treatment, while a 
prolonged phosphorylation was observed at S516 and S645 (~24 hrs). These results may indicate 
that phosphorylations at different regions of the protein may regulate separate functions. Studies 
from Dr. Legerski’s laboratory have demonstrated that a S516A and S645A double mutant was 
defective in recovery from G2/M cell cycle checkpoint (Zhang et al. 2004). They knocked down 
Artemis in HEK 293 cells using a siRNA and irradiated these cells with 10 Gy γ-radiation. 
Following irradiation, control siRNA treated cells remained arrested at the G2/M checkpoint 
whereas Artemis-depleted cells did not. However, Artemis-mediated checkpoint arrest did not 
seem to involve well established G2/M checkpoint arrest pathways that are known to function 
downstream of ATM and ATR following DNA damage. Artemis is not required for damage 
induced phosphorylation of Chk1, Chk2 or γ-H2AX. Moreover, its phosphorylation was also not  
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Figure 2-1. Model of Artemis as a multifunctional phosphoprotein. Most of the 
DSBs induced by either radiation or bleomycin are repaired by the classical NHEJ 
pathway; however subsets of DSBs (10-20%) require Artemis nuclease for resolution 
and subsequent repair. Artemis has also been shown to have cell cycle checkpoint 
effects. 
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inhibited by the Chk1 inhibitor UCN-01 suggesting that Artemis does not act downstream of 
Chk1. Mutation of S516 and S645 residues to alanine resulted in defective recovery from the 
checkpoint, while there was no effect of this mutation on DSB repair (Zhang et al. 2004). The 
mutant Artemis was further shown to promote an enhanced interaction between 
unphosphorylated cyclin B and CDK1, which in turn promoted inhibitory phosphorylation of 
CDK1 by the Wee1 kinase. The mutant Artemis also promoted centrosomal retention of cyclin B 
and prevented its subsequent export to the nucleus (Geng et al. 2007). The model thus proposed 
that ATM may regulate recovery from G2/M checkpoint by an early inhibitory phosphorylation 
of Artemis, which may act as a molecular switch to allow cells to recover from checkpoint arrest 
following DNA repair. In a separate work done by the same group, the authors showed that S516 
and S645 was also phosphorylated by ATR in response to UV damage or replication stress 
induced by aphidocolin (Wang et al. 2009). HEK 293 cells expressing S516A/S645A mutant 
Artemis showed significant accumulation of cells in the S-phase of cell cycle 12-18 hrs 
following UV exposure when compared to WT protein expressing cells. In addition, 
S516D/S645D mutant Artemis-expressing cells (phosphorylation competent at these residues), 
resulted in no S-phase checkpoint deficiency. Upon further analysis they found that CDK2 
kinase (principal kinase regulating progression through S-phase), has reduced activity in cells 
expressing S516A/S645A mutant. Moreover, cyclin E levels in these cells were significantly 
higher in these cells following UV irradiation or aphidocolin treatment, whereas there were no 
measurable differences in the cyclin A levels (Wang et al. 2009). Overexpression of cyclin E 
could compete with cyclin A to bind to CDK2 thus affecting S phase cell cycle progression. 
Artemis was also observed to interact with the F-box protein Fbw7, and this interaction may 
regulate cyclin E degradation through the SCF
Fbw7 
E3 ubiquitin ligase complex. Phosphorylation 
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at S516 and S645 was shown to regulate interaction between Artemis and Fbw7. Artemis has 
been shown to interact directly with DDB2 (Damaged DNA binding protein 2) and is a 
component of the Cul4A-DDB1 E3 ligase complex. Several studies have implicated Cul4A 
based E3 ubiquitin ligase complex in the ubiquitination and degradation of p27, an inhibitor of 
CDKs and a cell cycle regulator. Artemis interacts with p27 and both Artemis and DDB2 may be 
required for the ubiquitination and degradation of p27 mediated by the Cul4A-DDB1 complex 
(Yan, Zhang & Legerski 2011). These findings taken together define a new role for Artemis as a 
cell cycle regulator in proliferating tumor cell lines. 
In addition to its cell cycle regulatory function, Artemis has been implicated in telomere 
maintenance. Mouse cells defective in Artemis had increased frequencies of end to end 
chromosome fusions and primary human fibroblasts derived from an RS-SCID patient showed 
accelerated shortening of telomeres, suggesting a role for Artemis in maintaining telomeres 
(Cabuy et al. 2005, Rooney et al. 2003). Analysis of Artemis defective cell lines by immuno-
FISH, using telomeric PNA and γ-H2AX antibody revealed that for older cell lines (PD values 
32/33), Artemis-defective cells showed higher frequencies of spontaneous and radiation induced 
(1Gy/24hr repair) γ-H2AX foci and TIFs (Telomeric dysfunction induced foci) than normal 
“older” cell lines. DNA-PK knockdown (45%) also had greater effect (elevated levels of TIFs) 
on telomeres in Artemis-defective cell lines than normal cells (Yasaei, Slijepcevic 2010). Since 
Artemis has been speculated to help repair DNA DSBs in heterochromatic regions of DSBs and 
telomeres are typical heterochromatic parts of the genome, it could be hypothesized that Artemis 
may be required for repairing DNA damage originating in the telomeric regions of the genome.  
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Artemis depletion in both tumor cell lines and primary fibroblast cells led to upregulation 
and activation of p53 leading to activation of p21. In addition to cell cycle arrest, Artemis 
depletion also led to upregulation of pro-apoptotic gene Bax in U2OS and Hela cells. It co-
immunoprecipitated with p53 suggesting that both these proteins may exist as part of the same 
complex in vivo. Artemis is also regulated by DNA-PK, ATM and ATR. Knockdown of 
DNA-PK in Artemis-depleted cells affected p53 stabilization while a similar knockdown of 
ATM did not (Zhang et al. 2009). These and other findings suggest that Artemis depletion results 
in spontaneous phosphorylation and stabilization of p53 in a DNA-PK dependent manner 
without requirement of DNA ends or KU heterodimers. Thus Artemis may also act as an 
oncogene in the sense that an overexpression of Artemis may suppress p53 activity, thereby 
promoting tumorigenesis. However the role of Artemis in apoptosis is not limited to regulation 
of p53 activity and it was also reported to recruit onto damaged chromatin during apoptotic DNA 
fragmentation (Britton et al. 2009). When human fibroblast cells were treated with either 
calicheamicin (DNA DSB causing agent) or staurosporine, Artemis bound to apoptotic 
chromatin along with DNA-PK in a time and drug dose dependent manner. Artemis-deficient 
GUETEL cells showed a delay in DNA laddering compared to Artemis-proficient counterparts 
possibly due to a defect in high molecular weight DNA fragmentation step of apoptotic 
chromatin cleavage (A hallmark of apoptosis is that DNA fragmentation occurs as high 
molecular weight fragments, followed by extensive internucleosomal cleavage). More recently it 
was suggested that Artemis may be involved in endonucleolytic cleavage at internucleosomal 
sites near an HO-endonuclease cut site releasing a ladder of 200 bp fragments (Kanikarla-Marie, 
Ronald & De Benedetti 2011). This activity of Artemis was found to be enhanced by 
wortmannin treatment (PI3K inhibitor), which otherwise should have inhibited instead of 
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enhanced Artemis endonucleolytic function (due to inhibition of DNA-PK). However, this work 
still suggests that Artemis endonucleolytic function may cleave DNA at the internucleosomal 
sites to resolve blocked DNA ends. 
 
Causative Artemis mutations in SCID patients 
Athabascan SCID (SCIDA) or RS-SCID is a autosomal recessive inherited disease (gene 
frequency 2.1%) that is very rare in the general population, however the T
-
B
-
NK
+
 
immunophenotype has a very high incidence in (1:2000 live births) in Navajo and Apache Native 
Americans believed to have originated from Athabascan speaking linguistic group. The SCIDA 
condition is characterized by early onset of severe opportunistic infections and severe oral and 
genital ulcers. Affected children generally die from these infections within six months without 
bone marrow transplant.  
Of the reported DCLRE1C (Artemis) alleles (96) in various families (43) reported in one 
study, the most frequent mutations found were gross deletions (43.8%), while small deletions 
(13.5%), small insertions(1%), missense point mutations (19%), nonsense point mutations (8%) 
and point mutations of splice sites (12%) were also identified (Pannicke et al. 2010). In another 
study where 58 mutated DCLRE1C alleles were described, the most frequent mutation was again 
gross deletions (65%). The frequent exons that are deleted are exons 1-3 or exons 1-4 which are 
N-terminal exons, while in few cases exons more towards C-terminal (exons 7-8, 10-12) were 
also deleted (Pannicke et al. 2010). Most of the Artemis mutants described so far are functionally 
null mutants. Small deletions in exon 14 allow residual hairpin cleavage activity in vivo. The 
C-terminal domain contains residues that are phosphorylated by DNA-PK, and is thought to 
regulate Artemis endonucleolytic function. These mutants thus have reduced activity even 
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though they possess intact N-terminal endonuclease domain. However, truncation of C-terminal 
residues may also lead to protein variants that are either not expressed or are not stable. A 
hypomorphic mutation (AUG to ACG) in the start codon of DCLRE1C gene, was shown to 
cause omen syndrome, possibly due to inefficient translation (Mancebo et al. 2011). Two hotspot 
regions of missense point mutations that completely eliminate Artemis functions are in exons 1-2 
and exons 5-6, that hold residues essential for Artemis endonucleolytic cleavage. However, a 
genomic exon 3 deletion and a 2-nucleotide insertion in exon 14 resulting in frameshift and early 
termination was also identified in four Japanese patients (Most of the SCID patients identified 
earlier were Europeans or Athabascan speaking Native Americans) (Kobayashi et al. 2003). Thus 
most mutations identified in Artemis gene are complex or nonsense mutation. 
 
2.3 Metnase 
Metnase (SETMAR) was identified as a SET and transposase fusion protein that was 
shown to promote in vivo end joining activity and mediate foreign DNA integration. It contains 
two functional domains: a SET [Su(var)3-9, Enhancer-of-zeste, Trithorax] domain that is 
associated with histone methyltransferase activity at  lysine 3, 4 and 36, and a DDE motif that is 
essential for its DNA cleavage action (Lee et al. 2005b, Roman et al. 2007). Since its initial 
discovery in 2005, Metnase has been implicated in influencing lentiviral integration, mediating 
chromosome decatenation, promoting restart and repair of stalled and collapsed replication forks 
and in repair of DNA DSBs by NHEJ. 
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Structure and biochemical properties of Metnase 
The crystal structure of Metnase predicted it to contain at least one helix-turn-helix motif 
and a catalytic domain. The catalytic domain of Metnase transposase appears to form a dimer. In 
all the crystal lattices obtained, there were two transposase domains that formed a dimer within 
the asymmetric unit of the crystal, as characterized by gel filtration chromatography (Goodwin et 
al. 2010). The dimerization of Metnase seemed to be required for the TIR sequence binding 
activity and its DNA cleavage function. A F460 residue was proposed to be important for 
dimerization, and an F460K mutant showed reduced TIR (terminal inverted repeat) binding and 
DNA cleavage.  
The Metnase gene extends over 13.8 kb located at 3p26 and has three exons. Two of the 
exons form SET, pre-SET and post-SET domains while the third exon codes for the Mariner 
transposase sequence that includes an HTF motif which mediates TIR binding. Metnase catalytic 
domain has a DDN motif instead of the DDD/E motif commonly found in transposases 
(Goodwin et al. 2010, Lee et al. 2005a). The SET domain is most related to SuvHar91 histone 
methyl transferase, with 36% homology.  
 
Metnase promotes foreign DNA integration 
Metnase encodes a transposase domain similar to catalytic domains of retroviral 
integrases and hence was postulated to promote viral DNA integration. Metnase enhanced 
Moloney Leukemia virus DNA integration by fourfold and plasmid DNA integration by sixfold, 
while Metnase knockdown reduced both viral and plasmid DNA integration (Lee et al. 2005a). 
Further along these lines, overexpression of Metnase influenced genomic integration of intact 
HIV cDNA from HIV infection of human cells, whereas reducing the levels  
37 
 
 
 
Figure 2-2.  Metnase mediated DNA end processing following radiation exposure. Exons 1 
and 2 encode for the various SET domains and exon 3 codes for the transposase domain. The 
nuclease activity of Metnase resides in the transposase domain (DDE like motif). Metnase 
interacts with Pso4 and this interaction may be required for Metnase localization onto DSB ends 
following DNA damage. Metnase has also been shown to interact with DNA ligase IV which 
catalyzes the final ligation step in NHEJ. Though Metnase may form a part of the repair complex 
on DNA ends it is still unclear whether its histone methylase activity or its end processing 
function is  important for DSB repair. (Adapted from Shaheen et al, 2010) 
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of Metnase decreased the amount of HIV cDNA copies integrated into human genome 
(Williamson et al. 2008a). However, it had no effect on total cellular viral RNA, cDNA or 
double-LTR circles after infection. Thus, Metnase may be a target for treatment of HIV infection.  
 
Histone methylase activity of Metnase 
Metnase possesses a SET domain and hence was tested for histone methylase activity 
using a SAM donor. Metnase transferred a radiolabelled [
3
H]-methyl group from SAM to 
recombinant histone H3 as determined by autoradiography. Further analysis by Western blotting  
revealed that Metnase stimulated specific dimethylation of histone H3 at lysine 36 (H3K36) and 
lysine 4 (H3K4) in a concentration-dependent manner. However, this histone methylation 
activity of Metnase was lesser at H3K4 than at H3K36 (Lee et al. 2005a). Western analysis also 
revealed lesser Metnase mediated methylation of Histone H3 at K9, K27 and K79 or H4K20 and 
H4K79. This Histone methylation function of Metnase may play a major role in regulation of 
transcription, replication, DNA integration and DNA repair due to its chromatin modifying effect. 
 
DNA cleavage function of Metnase 
Since Metnase was a SET-transposase fusion protein with putative roles in DNA repair, 
and had a DDE like motif, its nuclease activity was further investigated. Metnase was found to 
possess a single strand nicking and a double strand endonuclease activity that converted a 
supercoiled plasmid into nicked and linearized form. Since Metnase possesses a TIR-specific 
DNA binding activity it was speculated that it may have a sequence-specific DNA cleavage 
activity, however direct sequencing of cleavage products revealed that the cleavage occurred at 
no defined sequence (Roman et al. 2007). The HTH motif that was essential for its TIR binding 
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activity was not essential for its DNA cleavage activity, while the transposase domain was found 
to be critical for this function. A D483 residue within the DDE-like motif within the transposase 
domain is essential for DNA cleavage activity. A D483A mutant showed little or undetectable 
DNA cleavage function even with substrate (DNA) incubations at higher protein concentrations 
(Roman et al. 2007). These results suggest that DDE like motif within the transposase domain is 
critical for the DNA cleavage activity of Metnase.   
More recently Metnase’s endonuclease activity has been more carefully characterized 
using DNA substrates mimicking endogenous DNA DSBs. It was found that Metnase 
preferentially cleaves 50 mer ssDNA more readily than a blunt ended dsDNA with the same 
sequence. To find a more physiological relevance to Metnase ssDNA cleavage function, its 
activity towards a partial duplex substrate was examined. It showed preferential cleavage of the 
ssDNA region of a 5ʹ-overhang and a 3ʹ overhang was cleaved at both single stranded and double 
stranded regions (Beck et al. 2011). This ssDNA cleavage activity of Metnase was also 
preferentially directed towards partial DNA duplexes with flaps and pseudo Y structures. When 
the protein was incubated with hairpin DNA or loop DNA, it did not show endonucleolytic 
activity at the ssDNA region (Beck et al. 2011). It was also found that this endonuclease function 
of Metnase is essential for promoting NHEJ in cell extracts (Beck et al. 2011, Shaheen et al. 
2010). A linearized pBS DNA was incubated with cell extracts containing increasing amounts of 
the protein and the circular duplex DNA generated from end joining was transformed into E.coli 
for colony formation on ampicillin resistant plates. Cell free extracts obtained from Metnase- 
overexpressing HEK 293 cells stimulated end joining, when compared to Metnase-depleted cell 
extracts. Addition of purified wt Metnase restored end joining activity while addition of D483A 
mutant did not stimulate end joining. End joining in Metnase-containing extracts  required ATP 
40 
 
and Mg
2+
 and was inhibited by wortmannin (PI3K inhibitor) (Beck et al. 2011), also affecting 
E.coli colony formation following transformation. These data suggest a role for Metnase in end 
joining following DNA damage. 
 
Metnase in chromosomal decatenation and replication fork restart 
DNA replication results in intertwined sister chromatids that must be decatenated to 
ensure proper segregation and to prevent chromatid breaks during anaphase. Metnase has been 
shown to interact with TopoIIα, the principal decatenating enzyme, which works by creating 
transient DNA DSB (Williamson et al. 2008c). Nuclear extracts containing Metnase promoted 
TopoIIα mediated decatenation of highly interlocked DNA to relaxed circular forms more 
rapidly than those lacking Metnase. Overexpression of Metnase was found to promote 
progression through metaphase decatenation checkpoint and survival after exposure to VP16, a 
TopoIIα inhibitor (Wray et al. 2009a, Williamson et al. 2008b). Knocking down Metnase 
significantly sensitized breast cancer cells to Adriamycin and AML cells to etoposide (Wray et al. 
2009b). Thus Metnase could be used as a target to increase sensitivity of TopoIIα inhibitors. 
Metnase also promotes resistance to agents that cause replication stress by enhancing 
restart of stalled or collapsed replication forks. Metnase knockdown greatly enhanced sensitivity 
of cells to UV rays and camptothecin due to a marked defect in restart of stalled replication forks 
(De Haro et al. 2010). Log-phase HEK 293 cells were stably transfected with shRNA targeting 
Metnase and a control RNA, incubated with IdU and treated with hydroxyurea (HU), then 
incubated with CldU. IdU was labeled red and CldU green and stretched DNA fibers were 
quantified by confocal microscopy. Adjacent red-green signals showed continuing replication 
forks, while gaps indicated stalled forks. There was a marked decrease in the number of stopped 
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and continuing replication forks in Metnase depleted cells following treatment with HU (De 
Haro et al. 2010).  Metnase was also shown to interact with PCNA, RAD9 and 9-1-1 complex 
that have roles in intra-S-phase checkpoint and restart of stalled replication forks.  Together these 
results establish that Metnase may play a key role in cell survival following exposure to agents 
causing replication stress by promoting restart of stalled forks. 
 
Metnase in DNA repair 
Given its histone methylating and DNA cleavage function, the role of Metnase in DNA 
repair was postulated. Overexpression of Metnase did not alter repair of DNA DSB by HRR, but 
it was found to enhance NHEJ. Conversely, Metnase knockdown reduced NHEJ by 12-20 fold, 
while mutations in essential residues within SET or transposase domains ablated 
NHEJ-enhancing Metnase activity (Lee et al. 2005a). It was found to co-immunoprecipitate with 
NHEJ factor DNA ligase IV and Pso4 (Hromas et al. 2008, Beck et al. 2008). DNA ligase IV 
mediates the final ligation step in NHEJ and Pso4 is a multifunctional protein that has been 
implicated in RNA splicing and DNA repair. Both Metnase and Pso4 co-localize with Nbs1 at 
DSBs and knockdown of Pso4 abrogated Metnase localization at DSB foci (Beck et al. 2008). 
Thus interaction of Metnase and Pso4 may be essential for Metnase activity in DSB repair by 
NHEJ. Since Pso4 has been implicated in repair of DNA cross links, it is also probable that 
Metnase endonucleolytic activity may contribute to processing of such these lesions (Zhang et al. 
2005). The SET histone methylase domain of Metnase directly mediated dimethylation of 
H3K36 near induced DSB that was shown to promote association of NHEJ repair proteins 
promoting DNA repair (Fnu et al. 2011). Whether the endonuclease function of Metnase also 
contributes to DNA repair still needs to be investigated. 
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Regulation of Metnase activity 
Investigations into the regulation of Metnase activity has revealed that the protein is 
phosphorylated in vivo following DNA damage. Metnase possesses two ATM/ATR consensus 
sites, one Chk1/2 and p21 consensus sequence (Sequence surrounding S495) as well as a PKC 
site where it can be potentially phosphorylated. However, two-dimensional gel electrophoresis 
followed by phosphopeptide screening identified only one phosphopeptide that perfectly 
matched the S495-containing domain. A S495A Metnase showed no phosphorylation in vivo 
when expressed in HEK293 cell lines confirming that there may be only one phosphorylation site 
on the protein (Hromas et al. 2012). This phosphorylation site is in the DDE-like transposase 
nuclease domain and three-dimensional modeling suggests that phosphorylation could affect the 
mobility of this otherwise flexible region thus affecting the nuclease function of the catalytic 
triad. Metnase is primarily phosphorylated by Chk1 (8 fold greater than Chk2) and 
dephosphorylated by phosphatase PP2A. HEK 293T cells expressing the S495A mutant were 
unable to induce H3K36 dimethylation when compared with WT Metnase expressing cells by 
western blot analysis. Interestingly, the S495A mutant showed increased restart of stalled 
replication forks but decreased enhancement of DNA repair (Hromas et al. 2012). Thus the 
authors of this work speculated that Chk1-mediated phosphorylation of Metnase at S295 may 
regulate its DNA repair and stalled replication fork restart activities.  
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2.4 Specific Aims 
Resolution of oxidatively damaged chemically modified end-termini is a critical step in 
repair of DNA-DSBs induced by radiation or radiomimetic chemotherapeutics. We have sought 
to study the role of two candidate enzymes Artemis and Metnase in endonucleolytic removal of 
such terminal blocking groups. Specifically we proposed 
1. To determine the role of Artemis endonucleolytic activity in promoting 
radio/chemoresistance.  
Biochemical studies have shown that Artemis has a metallo-β-lactamase and a β-
CASP domain that promotes slow trimming of several bases from blunt DNA ends or 
overhangs and resolves chemically modified 3ʹ-phosphoglycolate ends. At the same time 
Artemis has been implicated in regulation of G2/M and S-phase cell cycle checkpoints 
following DNA damage. In this thesis we have sought to establish the biologically 
relevant role of Artemis by creating human fibroblast cell lines that express either D165N 
mutant or wild type Artemis in Artemis-deficient cells obtained from a SCID patient and 
corresponding normal cell lines. As reported below, survival and DSB repair assays were 
performed using these cells, following exposure to ionizing radiation and radiomimetic 
drugs. Co-immunostaining experiments revealed NHEJ factors that may play a role in the 
repair of DSBs in an Artemis dependent pathway. Additional in vitro studies were also 
performed to further characterize the chemically modified DSB ends that require 
Artemis-mediated end processing. 
 
 
44 
 
2. To investigate the effect of DNA end modifications on Metnase-mediated end 
processing. 
Metnase is a recently identified transposase which acts as a DNA DSB repair 
factor that seems to promote in vivo end joining. Metnase has a methyltransferase domain 
and an endonuclease domain that has been shown to cleave DNA near DSB ends. 
Metnase knockdown confers about 2-fold radiosensitivity and decreases fidelity of repair. 
On the other hand, Metnase overexpression has been shown to increase radiosurvival and 
also increases precise NHEJ. It interacts with DNA ligase IV and increases both 
efficiency and accuracy of DNA DSB repair. All these data suggest a possible role of 
Metnase in resolution of terminally blocked DNA DSBs that has been investigated as part 
of this thesis. Specifically, plasmid-length substrates with variously modified DNA ends 
were designed that provided an in vitro system for investigation of end processing of 
these DNA lesions by Metnase endonucleolytic activity. Additional studies were also 
performed to characterize the interaction of Metnase with other NHEJ factors (Ku and 
DNA-PK) affecting end joining. 
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III. MATERIALS AND METHODS 
 
3.1 Cell lines and complementation  
Normal 48BR and patient-derived Artemis-deficient CJ179 hTERT-immortalized human 
fibroblasts originally from Dr. Penny Jeggo, were obtained from Dr. Lynn Harrison, Louisiana 
State University, and were cultured in minimum essential medium (MEM-α) supplemented with 
10% FBS and antibiotics (GIBCO). Cells were constantly maintained at 37°C in 5% CO2 and a 
humidified atmosphere. Normal Epstein-Barr virus-transformed human lymphoblastoid cells 
(patient 1646) were from Dr. James Lupski, Baylor College of Medicine.   
These obtained cell lines were complemented in Dr. Steven M. Yannone’s laboratory. 
Lentiviral constructs were prepared in the 693-2 lentiviral backbone harboring the hygromycin 
resistance gene (Campeau,E et al. 2009) carrying either wild-type or D165N mutant Artemis 
cDNA fused to a c-myc epitope tag on the carboxyl terminus. Artemis wild type, D165N and 
empty lentivector DNAs were transfected along with packaging plasmids, pLP1, pLP2 and pLP-
VSVG into 293FT cells with Lipofectamine 2000 (Invitrogen). Medium containing packaged 
lentivirus was collected 48 hr post transfection, centrifuged 5 min at 1200 rpm in a clinical 
centrifuge at room temperature. The supernatant was filtered through 0.45 µm filters (Novagen), 
then ultracentrifuged at 20,000 RPM for 2.5 hr at 4°C in a SW28 rotor (Beckman). Resulting 
viral pellets were resuspended with 200 µL of Hanks balanced salt solution and stored in 10 µL 
aliquots at -80°C.  The 48BR and CJ179 cell lines were seeded at approximately 75% confluence 
in 25 cm
2
 dishes and incubated for 24 hr, then infected with 5 µL of concentrated lentivirus with
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4 µg/mL polybrene in 1 mL medium without serum for 8 hr, then fed with fresh medium and 
incubated for 48 hr. Cells were then selected in medium containing 100 µg/mL hygromycin for 7 
days. Cells were expanded under selection to produce cryogenic stocks and 2.5 x 10
6
 cell 
aliquots harvested and stored at -80°C as cell pellets for Western analysis. 
 
3.2 Selection of Clones 
From each derivative cell line, approximately 20 clones were isolated. 100 cells from 
each cell line were plated on a 15 cm tissue culture dish and incubated for 8-10 days. The 
separate colonies were identified under the microscope and marked. Sterile rings were put over 
the colonies which were trypsinized and grown separately in 25 ml tissue culture flasks. Total 
RNA was extracted from each clone using Qiagen RNeasy minikit and converted to cDNA using 
high capacity RNA to cDNA kit (Applied Biosystems) following the protocols provided by the 
manufacturer. Amplification of cDNA was performed on an ABI 7900HT Real time q-PCR 
instrument using SYBR green (Applied biosystems). Relative Artemis levels were determined 
after normalizing to β-actin levels using SDS 2.2.2 software. The primers used were 
5′-ACAGAGCCTCGCCTTTGCCG-3′, 5′-CACCATCACGCCCTGGTGCC-3′ for β-actin and 
5′-AGTACGGAGCCAAAGTATAAACCACT-3′, 5′-TCCGGGTATGGAACTTTGTGC-3′ for 
Artemis cDNA amplification (Synthesized by IDT). Highest and lowest Artemis expressing 
clones among those screened were identified and the protein levels were confirmed by 
IP/western as described below. The selected clones were further used in survival/repair assays. 
 
3.3 Immuno-precipitation and Western blots 
Direct western blotting of cell lysates was attempted with a variety of antibodies to 
Artemis but was found to be insufficiently sensitive and specific for Artemis detection; therefore, 
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an immunoprecipitation step was added. For each cell line approximately 2.5 million cells were 
harvested and sonicated on ice with three 30-second pulses in 750 µL of TBST (25 mM Tris-
HCL pH 7.4, 130 mM NaCl, 3 mM KCl, 0.1% (v/v) Tween 20) supplemented with 1 μM 
leupeptin, 1 μM pepstatin A, and 1 μM aprotinin protease inhibitors (IP-buffer). Lysates were 
cleared by centrifugation at 14,000 x g for 15 minutes at 4°C and supernatant incubated with 
equilibrated protein A/G beads (Protein A/G UltraLink Resin, Thermo Scientific, prod#53132) 
for 1 hr, then the extract was transferred to a new tube. Equilibration of the beads was performed 
by first collecting the beads by centrifugation at 5000rpm for 30 sec, followed by removal of the 
supernatant and washing 2 times with TBST (5000rpm, 30sec). The beads were then re-
suspended in IP-buffer to make up the original volume. Extracts were incubated with 1 µL of 
SCIDA1024 rabbit antiserum (Wang et al. 2005) for 1 hr at 4°C, then 20 µL of equilibrated A/G 
beads were added and tumbled overnight at 4°C. The A/G beads were pelleted in a microfuge at 
5000 rpm for 30 sec at 4°C and washed three times with 500 µL IP-buffer. 50 µL Laemmli 
buffer (2% SDS, 10% glycerol, 5% 2-mercaptoethanol, 0.004% bromphenol blue, 0.125 M Tris 
HCl pH 6.8) was added to the washed beads and heated for 10 minutes at 98°C and centrifuged 
at 14,000 x g for 15 minutes. Approximately 1 million cell equivalents of protein (20 µL) was 
loaded onto 8% SDS-PAGE gels and resolved at 150 volts and transferred to a nitrocellulose 
membrane with 100V for 90 minutes in methanol transfer buffer (25mM Tris, 192 mM glycine, 
10% methanol), then incubated in TBST, 10% (w/v) powdered milk (blocking buffer), 1 hr at 
22°C, with rocking. Membranes were probed with chicken IgY anti-human Artemis antibody 
(Abcam, ab14289) at a 1:2000 dilution in 8 mL blocking buffer overnight at 4°C with rocking, 
then washed in TBST 10 minutes x 3, and incubated in peroxidase-conjugated donkey anti-
chicken IgY (H+L) (Gallus Immunotech Inc.,) at 1:5000 dilution in 8mL blocking buffer rocking 
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for 1 hr at 22ºC then washed in TBST 10 minutes x 3 and developed with ECL plus (GE 
Healthcare).  
 
3.4 Cell Survival Assays 
Confluent cells were further maintained in 0.5% serum for 5 days. The cells were then 
irradiated (MDS Nordion Gammacell 40 research irradiator (ON, Canada), with a 
137
Cs source 
delivering a dose rate of 1.05 Gy/min) or treated with either 0.5, 1 or 2 μg/ml bleomycin (stock 
concentration 2.5mg/ml) or 3, 6 or 12 nM neocarzinostatin (NCS) (stock concentration 1.2 μM) 
for 4 hr. Following treatment, cells were washed with PBS and 500-20000 cells were seeded into 
10 cm dishes in fresh medium. Cells were then incubated for 12 days before they were fixed with 
methanol (100%) and stained with 1% crystal violet, rinsed with water and air-dried. Visible 
colonies were counted manually.  
 
3.5 Immunofluorescence 
Cells were grown to confluence on tissue culture treated 4-well chamber slides (Nunc lab 
tek, prod#154526) and further maintained at 0.5% serum for 24 hr. Cells were then either 
irradiated (2 or 4 Gy) or treated with NCS (6 nM) for 1 hr. After treatment, cells were fixed by 
incubating with 1 ml of 3% paraformaldehyde per well at room temperature (RT) for 15 min and 
permeabilized with 0.5% triton X-100/PBS for 10 min/RT. The slides were then washed two 
times with 1 ml PBS/well followed by blocking with 1 ml casein buffer (Bio-Rad, prod#161-
0783) for 3 hours/RT. Primary antibody was appropriately diluted in casein buffer, 0.3 ml was 
added per well and was allowed to incubate overnight at 4ºC with rocking. When doing double 
immunostaining, 0.3 ml of the second primary antibody was added at the same time as the first 
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antibody. Primary antibodies used for immunostaining were anti--H2AX (Upstate), anti-53BP1 
(gift of Dr. David Gewirtz, Virginia Commonwealth University, originally from Dr. Thanos 
Halazonetis, University of Geneva) at 1:500 dilution, anti-PML (PG-M3, Santacruz biotech) at 
1:200 dilution, anti--H2AX rabbit polyclonal (Novus biologicals) at 1:400 dilution and 
anti-hMre11 rabbit polyclonal (Novus biologicals) 1:200 dilution. The primary antibody was 
then removed and the wells were washed 4 times with 1ml PBS for 15 min followed by 
incubation with secondary antibody for 3 hours at RT. All secondary antibodies used were 
obtained from Invitrogen molecular probes and used at 1:500 dilution in casein blocker. The 
secondary antibodies were Alexa fluor 488 goat anti-mouse (γ-H2AX, 53BP1), Alexa fluor 568 
goat anti-mouse (PML), Alexa fluor 488 goat anti-rabbit (γ-H2AX), Alexa fluor 568 goat 
anti-rabbit (Mre11). After 4 × 15 min washes, the antibodies were fixed in place by treating with 
1 ml 3% paraformaldehyde for 10 min. Paraformaldehyde was removed by 2 × 1 ml PBS washes. 
Slides were then mounted with Vectashield mounting medium containing DAPI (4′, 
6-diamidino-2-phenylindole). Images were captured using Olympus fluoview 500 confocal 
microscope, using a 430-nm diode laser with a 605-nm band pass filter (DAPI), a 510-nm laser 
with a 530-nm band pass filter (Alexa fluor 488) and a 660-nm laser with 605-nm band pass 
filter (Alexa fluor 568). Foci from 100 cells were scored for each time point in 2-3 independent 
experiments for each cell line. Focus diameter for the five largest foci in each cell was measured 
in one direction parallel to the equatorial plane of the image field.  
 
3.6 Fraction of activity released (FAR) DSB repair assay 
Pulsed-field gel electrophoresis (PFGE) was used to quantify DSB repair as described 
previously (Fouladi et al. 2000) with minor variations. Briefly, subconfluent cells were cultured 
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on a 150-cm dish and labeled for 24 hr with 0.2 µCi/mL [methyl-
3
H] thymidine (20 Ci/mmole, 
Perkin-Elmer). Confluence-arrested cells were serum-starved (0.5%) for 24 hr prior to irradiation. 
After irradiation samples were incubated for noted repair times and then trypsinized and 
resuspended in L buffer (0.1 M EDTA, 0.01 M Tris-Cl, 0.02 M NaCl) at a concentration of 2 x 
10
7 
cells/mL. 250 µL of this suspension was mixed with 250 µL of 2% low-melting agarose 
(Nusieve GTG) in a 15-mL conical tube maintained at 45°C. About 60 µL of cell agarose 
mixture was transferred to a sample CHEF disposable plug mold (Bio-Rad) and allowed to 
solidify at 4°C. The plugs were removed and incubated in the digestion mixture (0.1 M EDTA, 
0.01 M Tris-Cl, 0.02 M NaCl, 1% w/v Sarkosyl, 0.1 mg/mL proteinase K). The plugs were 
incubated for 24 hr at 50°C with a change of digestion mixture after 3 hr. They were then washed 
with TE (Tris-EDTA) over a period of 3 hr. The plugs were further incubated with 40 µg/mL 
PMSF for 30 min at 50°C followed by 3 washes over a period of 3 hr. The plugs were inserted 
into the wells of a 1% agarose gel (Bioline, DNA type grade) and separated in 0.5x TBE for 65 
hr at 1.5 V/cm with switch times varying between 60 to 3600 seconds. The temperature was 
maintained at 14°C throughout the run. Each lane of the plug was cut into 5 equal slices and each 
slice was put into a separate scintillation vial. The slices were melted by autoclaving in liquid 
cycle for 20 min. 15-20 ml of scintillation fluid (Biosafe II) was added and the fraction of 
radioactivity released (FAR) from the plugs and remaining in the plugs was measured by liquid 
scintillation. FAR is given as the ratio of total counts in the lanes (damaged DNA) to the total 
counts in the lanes and the plugs (total DNA loaded onto the wells) expressed as a percentage. 
 
3.7 Flow cytometric analysis of cell cycle 
Cells were grown to confluence and further serum starved (0.5% serum) for 24 hours. 
Control cells were neither serum starved nor confluent. Cells were then trypsinized, pelleted and 
51 
 
the pellets were washed with PBS. The cell pellet was resuspended in 2 ml of 70% ethanol at -
20ºC and kept at -20ºC for at least 3-4 hrs. Cells were then pelleted and washed two times with 
PBS to remove all ethanol which may interfere with propidium iodide staining. The cell pellet 
was resuspended in 200 μl of PBS. To this cell suspension, 5μl of RNase (10 mg/ml) and 10 μl 
of propidium iodide (1mg/ml) were added followed by incubation at 37ºC for 30 min. The cells 
were then pelleted and resuspended in 0.5ml PBS. The data were acquired using BD 
FACScaliber flow cytometer and analyzed using the Modfit LT software. 
 
3.8 Oligonucleotide purification 
Oligonucleotides of various lengths were purchased from Integrated DNA technologies 
Inc. and resuspended in molecular biology grade water (Sigma) to a concentration ranging from 
250 μM to 500 μM. 400-500 pmoles of the oligonucleotide was 32P labeled and was subjected to 
purification by 20% denaturing polyacrylamide gel electrophoresis. When purifying unlabeled 
oligo, 10-20 nmoles were loaded onto the gel in SGLS (98% Formamide, 2% EDTA, 
bromophenol blue) gel loading buffer. 
 
3.9 Polyacrylamide gel electrophoresis 
Polyacrylamide gels with acrylamide:bisacrylamide ratio of 20:1 and urea added to a 
final concentration of 8 M were used for electrophoretic separations. The gel dimensions were 
33.2cm X 38.5cm X 0.08cm. Urea was dissolved into the mixture at low heat and allowed to 
cool down to room temperature before adding 0.075% (w/v) ammonium persulfate and 0.03% 
(v/v) TEMED (Nʹ, Nʹ, Nʹ, Nʹ-tetramethylethylene diamine). The gel was allowed to set for 
approximately 1 hour, following which the samples were loaded into the wells of the gel and 
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electrophoresed at constant power of 40-60 watts for 4-6 hours in 1X TBE buffer. For the 
32
P 
labeled as well as unlabeled samples, short wave UV light (254 nm) was used to visualize the 
bands that appear as greyish blue shadows on white paper in the dark. Phosphorylated 
oligonucleotides (Oligos) which run faster than corresponding unphosphorylated starting oligos 
were cut from the gel and eluted into 800 μl of 1 mM EDTA. To this, 800 μl of 0.2M 
triethylamine was added, the mixture was filtered using a 0.45 μm filter and subjected to high 
pressure liquid chromatography. 
 
3.10 High Pressure Liquid Chromatography 
The oligonucleotides to be used in various assays were further purified by reverse phase 
high pressure liquid chromatography using a C18 column. Buffer A comprised of 5% acetonitrile 
and 0.1 M triethylaamine while buffer B comprised of 50% acetonitrile and 0.1 M triethylamine. 
Both buffers were adjusted to pH 7 using acetic acid or triethylamine. The column was 
prewashed with buffers A and B for 10 minutes before beginning the run. A linear gradient was 
used for purifying the oligonucleotides which increased from 5% buffer B to 30% buffer B over 
a 60 min period at a flow rate of 1 ml/min. The peaks were detected with a UV detector in case 
of unlabeled and a Geiger counter attached to the elution line for 
32
P labeled oligos. Collected 
volumes were then vaccum dried and dissolved in 1x TE (10 mM Tris-HCL, 0.1mM EDTA/pH 8) 
buffer.  
 
3.11 Trimming of pRZ56 
Trimming of pRZ56 (pBR322 with a polylinker cloned into the tetracyclin-resistance 
region) was done to generate a plasmid substrate with a ligatable end. First, 76 μg of pRZ56 was 
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linearized in 300 μl of 1X buffer 3 (New England biolabs) using 100 units of MluI (pRZ56 has 
single MluI site). Following incubation at 37ºC for 2 hours, 0.5 μl of was loaded onto a 0.8% 
agarose gel and electrophoresed for 1 hr, stained with EtBr (Ethidium bromide) and visualized 
under UV. If all the plasmid was cut, then linearized plasmid was precipitated by addition of 1/9 
volume of 3 M NaOAc and 2.5 volume of 100% EtOH, at room temperature, centrifuged at 
14000 rpm on a table top ultracentrifuge (Eppendorf) and washed with 70% ethanol to remove 
excess salts. It was briefly dried in a Speed Vac (Savant) and resuspended in 100 μl of 1X TE 
buffer and stored in -20ºC freezer. Ten micrograms of MluI-digested plasmid was used each time 
for trimming reaction. Trimming was carried out in 35 μl reaction containing 5 units of T4 DNA 
polymerase (NEB), 1mM dTTP and a buffer made up of 33 mM Tris acetate pH 8/ 66 mM 
potassium acetate/ 500 μM DTT/ 100 μg/ml BSA at 11ºC for 2 hours. The reaction was stopped 
by addition of 1.4 μl of 0.5 M EDTA to the reaction which was immediately extracted with 40 μl 
of phenol. After centrifugation at 10,000 rpm for 10 min, the bottom layer was discarded. The 
sample was again centrifuged for 1 min and the aqueous (top) layer was transferred to an 
ethanol-washed tube, avoiding residue at the bottom. Then, 40 μl of chloroform was added to the 
aqueous layer to remove the excess phenol, centrifuged for 5 min at 10,000 rpm and the bottom 
layer discarded. The reaction was then brought to 3 M Ammonium acetate (Add 16 μl of 7.5 M 
AmAc) and precipitated with 2.5 volumes of 100% EtOH. The pellet was resuspended in 45 μl 
of molecular biology grade water and again precipitated with NaAc as described above. Finally 
the pellet was washed with 170 μl of 70% EtOH and following air drying, was redissolved in 25 
μl 1X TE. 
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Various oligonucleotide modifications used in this thesis for substrate generation 
CGAGGAACGC(oxoG)ACG  (8-oxoG); CGAGGAACGCGACG-3ʹPG  (14-PG) 
CGAGGAACGCGAACG-3ʹPG  (15-PG); CGAGGAACGCGAAAACG-3ʹPG  (17-PG) 
CGAGGAACGCGAAAAAAAAAAAA(LongA); CGAGGAACGCGTTTTTT(ShortT) 
CGAGGAACGCGAAAAAA(ShortA), 3ʹ-PG is 3ʹ-phosphoglycolate ends 
Figure 3-1. Method for generation of DNA substrates for in vitro nuclease assays. pRZ56 
was cut with MluI and subjected to exonuleolytic digestion by T4 DNA polymerase in presence 
of dTTP alone. This generated an overhang to which previously labeled, variously end-modified 
substrates can be ligated. The internally labeled substrates were subjected to various nuclease 
and enzyme assays and the products were analyzed on a 20% polyacrylamide gel.  
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3.12 Construction of substrates with 3ʹ-PG terminated DSBs 
Exonucleolytic digestion of pRZ56 by T4 DNA polymerase in presence of dTTP creates an 
11 - base overhang to which oligos of desired length and end modifications were ligated to  
generate various chemically modified and corresponding normal ended substrates mimicking 
DSBs in cells. To generate a 3-base 3ʹ-overhang substrate, a 3ʹ-PG 14-mer (14-PG) was ligated 
into the 11-base gap that was created by the controlled digestion earlier.  For the ligation 5 μg 
(1.5 pmole) of of pRZ56 was added to 5 pmoles of the oligo in 1X One-Phor-All (10 mM tris 
acetate, 10mM Magnesium acetate, 50 mM potassium acetate, Pharmacia biotech, pH 7.4) was 
added to 40 μl of the reaction which was carried out in the presence of 60 units of T4 DNA 
ligase. Sodium chloride was added to 150 mM and ATP to 2 mM. In later studies the ligations 
were performed in 1X DNA ligase buffer (New England Biolabs). Overnight incubation was 
carried out at 16ºC followed by 15 min incubation at 65ºC to inactivate the ligase. The ligation 
product was then loaded onto a 0.8% agarose gel which was run in 1X TBE buffer with 0.5 
μg/ml EtBr. The gel was run at 100 V for 2 hours, visualized under UV, the band corresponding 
to the plasmid DNA was excised and subjected to electroelution. 
 
3.13 Electroelution of the modified substrate 
A pretreated dialysis tubing of about 10 inch was cut and tied at one end. The tube was 
then filled with a buffer containing 20 mM Tris, pH 8 and 1 mM EDTA (Elution buffer), the gel 
was placed in the tubing and the other end knotted carefully to remove any air bubbles. The 
tubing was placed in a electroelution apparatus filled with the same buffer and eluted overnight 
at 30 V with the buffer circulating between both the reservoirs. Following completion of the 
elution, the potential (Leads) were reversed for 1 minute to release the DNA stuck to the tubing 
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wall into the buffer. The dialysis bag was carefully cut open and the buffer containing DNA 
substrate was removed into 15 ml centrifuge tubes. The solution was filtered through a 0.45 μm 
filter to remove any debris and was concentrated by micro-concentration to about 250 μl using 
centricon-100 (Amicon). The concentrate was collected by pipetting into a 1.5 ml 
microcentrifuge tube and precipitated using 1/9 volume of NaOAc and 2.5 volume of 100% 
EtOH as described previously. The precipitate was washed with 70% EtOH and following drying 
was reconstituted in 50 μl 1X TE. 
 
3.14 Construction of 8-oxoguanine-containing substrates 
The protocol described above for preparation of 3ʹ-PG containing substrates was 
modified for preparation of substrates bearing 8-oxoguanine (8-oxoG) to prevent oxidation and 
degradation of the 8-oxoG residue during the purification process. The 8-oxoG residue- 
containing 14 mer with a sequence CGAGGAACGC(8-oxoG)ACG was obtained from the 
Midland Certified Reagent Company, Inc. It was dissolved in 200 μl of 10 mM HEPES 
(Hydroxyethyl piperazineethanesulfonic acid) buffer / 1 mM EDTA buffer, pH 8 at a final 
concentration of 1.17 mM oligo. 20 pmoles of the 8-oxoG oligo was labeled with [γ-32P] ATP (5 
μl of 0.151 mCi/μl) using T4 PNK in a 12.5 μl reaction for 1 hour at 37ºC. The reaction was 
extracted with 12.5 μl of Phenol/chloroform as described above. To 4 pmoles of the labeled 8-
oxoG oligo, 5 μg of trimmed pRZ56 plasmid was added followed by precipitation with 1/9 
volume of NaOAC and 2.8 volume of EtOH as previously described and briefly dried in the 
speed vac. The dried pellet was resuspended in either 1X One-Phor-All buffer (supplemented 
with ATP) or 1X T4 DNA ligase buffer to a total volume of 70 μl and was ligated with T4 DNA  
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Figure 3-2. Method for generation of thymidine glycol containing substrate for Artemis 
nuclease reactions. A new method was devised to generate DNA substrates that allows 
manipulation of both strands to mimic DNA DSBs with modified ends in vivo. PUC19 was first 
double digested with BsaI and ScaI to generate noncomplementary 5ʹ-overhangs and blunt ends. 
The 406 bp fragment released following ScaI digestion was removed by gel purification. To this, 
previously labeled duplex oligonucleotide having the sequence shown was ligated and the 
ligation product was further purified as described in the text. The ligation of the duplex 
oligonucleotide with the ligatable end generated a BsrDI site that was used to release the end 
termini for analysis in biochemical assays. 
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ligase as described for 3ʹ-PG containing substrates. The plasmid was precipitated with 7.5 M 
AmAc (53.5 μl), water (30 μl) and 2.5 volume EtOH (575 μl) (leaving most of the oligo in 
solution), washed and resuspended in 50 μl water. The ligated DNA substrate was then purified 
by using Qiaquick spin columns using PCR purification protocol (Qiagen) and eluted in 30 – 50 
μl of elution buffer and stored at -80ºC. The recovery of the ligated product varied from 0.5 μg – 
1.2 μg. 
 
3.15 Construction of Thymidine glycol containing substrate 
PUC19 was transformed into E.coli (alpha-gold from Bioline) and purified using Qiagen 
Plasmid Midi Kit according to the manufacturer’s protocol and analysed on a 0.8% agarose gel 
to ascertain purity. Concentration was measured on a UV spectrophotometer at 260 nm 
wavelength. Twenty microgram of pUC19 was double digested with 60 units of BsaI and ScaI 
(NEB) in a total volume of 130 μl in buffers provided by the manufacturer. The digestion was 
continued for two hours and 0.5 μl aliquot was analyzed by agarose gel electrophoresis as 
described. In case of incomplete digestion, the reaction was continued for another two hours.  
Thymidine glycol oligo with a sequence 5ʹ-ACCGCGAGACTCACGCTCA(ThyGly)ACG-3ʹ 
was obtained from Midland Certified Reagents and dissolved in 1X TE to a final concentration 
of 250 μM. About 750 pmoles of the thymidine glycol containing oligo was then labeled with 
γ-32P-ATP, electrophoresed to separate it from unphosphorylated oligo and HPLC purified. 
Twenty five pmoles of it was then annealed to HPLC-purified (Method described above) partial 
complementary oligo with sequence 5ʹ-ATGAGCGTGAGTCTCG-3ʹ (IDT) by first heating to 
80ºC followed by slow cooling to 16ºC. The BsaI/ScaI double digested pUC19 (4 μg) was then 
ligated to the annealed oligo (4 pmoles) and purified as described for the 3ʹ-PG substrates. 
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Corresponding normal substrate bearing thymidine instead of the modified thymidine glycol was 
prepared similarly. 
 
3.16 Artemis nuclease assays 
Full length Artemis protein was purified from SF9 insect cells infected with recombinant 
baculovirus generated by subcloning Artemis cDNA into pFASTBAC-HT (Invitrogen). Ku70/80 
was purified from insect cells coinfected with a mixture of recombinant baculovirus harboring 
the human Ku70 and Ku80 genes, and DNA-PK was purified from Hela cells as described 
(Povirk et al. 2006). These purified proteins were obtained from Dr. Steven M. Yannone. Each 
nuclease reaction was typically 10 μl, containing 25 mM Tris-HCL, pH8, 25 mM NaCl, 10 mM 
MgCl2, 1 mM DTT, 0.25 mM ATP and 50 μg/ml BSA . To this reaction mixture 10 ng of the 
labeled DNA substrate (8-oxoG/ThyGly) was added and mixed by pipetting. Ku (25 nM) and 
DNA-PK (65 nM) was then added to the reaction followed immediately by Artemis (90 nM).  
The reaction was then mixed by pipetting (Avoid vortexing) and placed in a 37ºC bath for 10, 30, 
60 or 120 min. The control reactions (where Artemis was excluded) were incubated for 60 min. 
All the reactions were stopped by addition of 20 μl of 10 mM EDTA, 0.45 M NaOAc and 100 
μg/ml tRNA, followed immediately by Phenol/chloroform extraction and ethanol precipitation. 
The pellet was washed with 70% ethanol and dried. DNA was then cut with AvaI at 37ºC for 4 
hrs in 40 μl of the buffer supplied by the vendor.  Following digestion, 1/9 volume of NaOAc 
was added to each reaction which was then ethanol precipitated and was further washed with 70% 
ethanol. Vaccum dried pellet was dissolved in 10 μl of formamide containing 20 mM EDTA and 
analyzed by 20% PAGE. Quantification was done by using ImageQuant 5.1 densitometry 
software.  
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3.17 Metnase nuclease reactions 
The human FLAG-Metnase purified from HEK 293 cells as described (Roman et al. 2007) 
was obtained from Dr. Suk-Hee Lee. Reaction mixtures (10 μl) containing 25 mM Tris-HCL, 
pH8, 25 mM KCl, 10 mM Mg(Ac)2, 5 mM DTT, 0.25 mM ATP and 50 μg/ml BSA were 
prepared. To this reaction mixture 10 ng of variously modified DNA substrates were added. The 
substrates used were 12-PG (1-base 3ʹ-overhang), 14-PG (3-base 3ʹ-overhang), 15-PG (4-base 3ʹ-
overhang), 17-PG (6-base 3ʹ-overhang) and 8-oxoG (3-base 3ʹ-overhang, 8oxoG modification at 
the last paired base). Oligomeric single stranded substrates with 3ʹ-phosphotyrosine and 3ʹ-biotin 
were also used in the reactions as indicated. This was followed by immediate addition of 20, 50 
and 100 nM Metnase to the reaction which was mixed by pipetting and incubated at 37ºC for 2 
hours. Reactions performed following addition of 50 nM Metnase were incubated for 4 hours at 
37ºC. All reactions with either plasmid or oligomeric substrates were stopped by addition of 20 
μl of 10 mM EDTA, 0.45M NaOAc and 100 μg/ml tRNA, followed immediately by 
Phenol/chloroform extraction and ethanol precipitation. In some cases the pellet was resuspended 
in 0.25 mM CoCl2 and 1X Terminal transferase buffer and the samples were treated with 12 
units of terminal transferase in presence of 250 μM ddTTP. Plasmid DNA substrates were then 
cut with either AvaI (30 units, 37ºC for 4 hrs) or TaqαI (30 units, 65 ºC for 4 hrs) in 40 μl of the 
buffer supplied by the vendor, ethanol precipitated, dissolved in 10 μl of formamide containing 
20 mM EDTA and analyzed by 20% PAGE. In case of oligomeric substrates the plasmid 
digestion steps were omitted. 
 
3.18 DNA footprint analysis 
To assess the accessibility of DNA ends, an internally labeled substrate (10 ng) with a 12- 
base 3ʹ-overhang was incubated with 25 nM Ku and 65 nM DNA-PK in buffer containing 25mM 
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Tris-HCL, pH8, 25 mM KCl, 10 mM Mg(Ac)2, 5 mM DTT and 50 μg/ml BSA for 20 min. Then, 
S1 nuclease (Invitrogen, 980U/μl) was diluted to 10 U/μl in S1 nuclease dilution buffer provided 
by the manufacturer and 0.3 U of the enzyme was added to 10 μl reaction and incubated at 25ºC 
for 5 mins. The reaction was stopped by adding 20 μl of 10mM EDTA, 0.45M NaOAc and 100 
μg/ml tRNA, followed immediately by phenol/chloroform extraction and ethanol precipitation. 
The reaction was analyzed on 20% PAGE.  
 
3.19 Statistics 
 Error bars represent standard error of mean (SEM) for at least three independent 
experiments or standard deviation (SD) for two experiments. In certain cases, unpaired two tailed 
t-tests were performed using Sigmaplot and the data was reported as significant for P values 
<0.05.   
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IV. RESULTS 
 
4.1 Generation of wild type and D165N mutant Artemis expressing cell lines. 
 Radiosensitive severe combined immunodeficiency (RS-SCID) is an autosomal 
recessively inherited genetic disorder that can result from several different causative mutations in 
DCLRE1C gene leading to functionally null Artemis mutants (Pannicke et al. 2010, Kobayashi 
et al. 2003). Several cell lines have been established from such patients and have been used 
extensively in the literature for studying Artemis functions in V(D)J recombination and DNA 
repair (Riballo et al. 2004, Beucher et al. 2009).  
 Patient-derived CJ179 cells (human fibrobalsts) and corresponding normal 48BR cells 
were obtained from Dr. Penny Jeggo and complemented with either wild type (WT) or D165N 
mutant Artemis using lentiviral vectors by Dr. Steven M. Yannone. First, Artemis expression 
levels were evaluated by Western blots of Artemis immunoprecipitated from extracts of the 
complemented and mock-complemented lines (Fig. 4-1). The levels of lentiviral-mediated 
Artemis expression are similar for the two alleles and expression was much greater than that of 
endogenous Artemis in normal cells, which was below the level of detection by western blot. 
However, the presence of an Artemis transcript in normal 48BR cells was verified by real time 
qPCR (Fig. 4-2) followed by agarose gel electrophoresis that showed a product of the expected 
size which was not seen in the Artemis null CJ179 cells (Fig 4-3).
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Figure 4-1. Expression levels of wild-type and D165N mutant Artemis in 
complemented Artemis-deficient CJ179 cells (CJ Arte+, CJ Endo-), and in 48BR 
normal fibroblasts (48BR Arte+, 48BR Endo-). CJ Vect and 48BR Vect are the 
respective empty-vector-infected cell lines. Artemis was immunoprecipitated using rabbit 
polyclonal anti-hArtemis antibody and immunoblotted using chicken polyclonal IgY anti-
hArtemis (Abcam). Endogenous Artemis in 48BR cells is below the level of detection. 
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Figure 4-2. Amplification plot for detection of Artemis transcript. Total RNA was isolated 
from the mentioned cell lines and subjected to cDNA synthesis. Exon spanning primers were 
used to amplify Artemis or β-Actin cDNA. PCR was conducted in an Applied Biosystems 
9700HT system with a thermal profile consisting of 2 min at 50ºC and 10 min at 95ºC, followed 
by 40 cycles of 15 sec at 95ºC and 1 min at 60ºC.
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Figure 4-3. Normal human fibroblasts (48BR) express low levels of Artemis 
transcript. Artemis cDNA from Normal (48BR Vect) and Hela cells were amplified 
using real time q-PCR as described for 40 cycles. 10 μl from a 25 μl reaction was run on 
3% agarose gel with hyperladder 4 (Bioline) as reference. A specific amplification 
product 137 bp long was detected for both Hela and 48BR Vect cells but not in CJ179 
Vect cells. 
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Figure 4-4 (A). Representative FACS plots of Artemis-deficient human fibroblasts 
showing G1 arrest. Various cell lines (CJ179) were confluence arrested and serum 
starved (0.5% serum for 5 days) to synchronize them in G1 phase of cell cycle. Flow 
cytometric analysis to confirm cell cycle arrest was performed following propidium iodide 
staining. Data were analysed using Modfit LT software. 90-95% cells were arrested in G1 
phase of cell cycle for all cell lines. 
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Figure 4-4 (B). Representative FACS plots of normal human fibroblasts showing G1 
arrest. Various cell lines (48BR) were confluence arrested and serum starved (0.5% 
serum for 5 days) to synchronize them in G1 phase of cell cycle. Flow cytometric analysis 
to confirm cell cycle arrest was performed following Propidium iodide staining. Data 
were analysed using Modfit LT software. 90-95% cells were arrested in G1 phase of cell 
cycle for all cell lines. 
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  Figure 4-5. Radio/chemosensitivity of Artemis deficient and D165N Artemis 
mutant fibroblasts. Clonogenic survival assays were performed on confluence- arrested 
serum-starved cells treated with bleomycin (A), neocarzinostatin (B) and radiation (C). 
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4.2 D165N mutant Artemis fails to rescue chemo/radiosensitivity. 
Previous in vitro studies have shown that in the presence of DNA-PK, Artemis has 
endonucleolytic activity toward both the 3′ and 5′ termini of DNA ends (Yannone et al. 2008, Ma 
et al. 2002). This endonucleolytic activity may facilitate the slow processing of 3′-PG-terminated 
blunt ends by Artemis/DNA-PK (Povirk et al. 2007). To investigate the biological relevance of 
Artemis endonucleolytic activity, confluence-arrested, serum-starved (0.5% serum, 5 days), 
wild-type and D165N mutant Artemis expressing patient-derived CJ179 cells, as well as normal 
48BR cells were exposed to radiation, bleomycin, and neocarzinostatin (NCS). These agents are 
known to induce free radical-mediated DSBs of diverse structure, many of which bear 3′-PG 
termini (Henner et al. 1983, Povirk 1996, Dedon, Goldberg 1990). Due to confluence and serum 
starvation, 90- 95% of the cells used in survival assays showed G1 arrest, thus increasing their 
dependence on NHEJ (Fig 4-4 A, B). In all cases the Artemis-deficient CJ179 fibroblasts showed 
significant hypersensitivity to -irradiation, bleomycin, and NCS (Fig. 4-5), as reported 
previously for other, unrelated Artemis-deficient cell lines (Povirk et al. 2007). Complementation 
with wild-type Artemis but not D165N mutant Artemis rescued this sensitivity. Furthermore, this 
overexpression of wild-type Artemis increased the chemo/radioresistance of normal 48BR cells, 
as compared to that of 48BR cells carrying the empty vector. Taken together, these results 
suggest a direct role of Artemis endonucleolytic activity in resolution of DNA DSBs following 
irradiation or radiomimetic drug treatment.  
 
4.3 Endonucleolytic activity of Artemis is essential for DNA DSB rejoining in cells. 
To directly evaluate the role of Artemis’ endonuclease activity in DSB repair, γ-H2AX 
and 53BP1 foci were quantified as a measure of residual DNA DSBs in Artemis-deficient or  
70 
 
 
  
Figure 4-6. Resolution of γ-H2AX foci in Artemis deficient and D165N mutant 
Artemis cell lines. Immunostaining was performed for phosphorylated γ-H2AX 
following exposure to 2 Gy γ-radiation for the wild-type/D165N mutant Artemis 
expressing cell lines and the repair was followed at indicated times. Representative 
images for data quantified in Fig 4-7A are shown.  
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Figure 4-7. Dependence of cellular DSB rejoining on Artemis endonucleolytic 
activity. (A) γ-H2AX foci were scored in confluence-arrested serum-starved cells 
following 2 Gy γ-irradiation, and the results plotted as number of foci/cell. (B) 53BP1 
foci were scored following 4 Gy γ-irradiation. (C) γ-H2AX foci were scored as in (A) 
following treatment with 6 nM NCS for 1 h. Error bars represent the SEM from three 
independent experiments except for (B), which shows data from two experiments. 
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Figure 4-8. Co-localization of  γ-H2AX and 53BP1 following exposure to 2 Gy  
γ-radiation. Green fluorescence: 53BP1 (Monoclonal anti-53BP1 antibody, Dr. 
Gewirtz’s lab). Red fluorescence:  γ-H2AX (Polyclonal anti- γ-H2AX antibody, Novus 
biologicals). About 70% of γ-H2AX foci merge with 53BP1 foci. This indicates that 
there is 30% less induction/detection of 53BP1 foci than γ-H2AX foci in cells. 
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Figure 4-9. Fraction activity release assay showing DSB repair defect in Artemis 
deficient and D165N mutant Artemis cell lines. (A) PFGE was performed on DNA from 
confluence-arrested serum-starved normal (48BR) or Artemis-deficient (CJ179) cells that 
were complemented with wild-type or D165N mutant Artemis. Cells were irradiated and then 
incubated for the indicated times (in hours) to allow repair before analysis by PFGE. (B) FAR 
values were plotted after subtraction of the FAR value for unirradiated cells. PFGE 
experiments with NCS were precluded by the large amount of drug required. 
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proficient cell lines following irradiation or NCS treatment. γ-H2AX is a well-established and 
sensitive marker that becomes phosphorylated at a conserved C-terminal SQ site within minutes 
of exposure to ionizing radiation (Rogakou et al. 1998) and radiomimetic drugs. Phosphorylated 
H2AX is believed to recruit other repair and cell cycle control factors such as MRN complex and 
53BP1 to the sites of DNA DSBs to facilitate repair. 
These assays were performed using non-replicating G0/G1 cells to avoid spontaneous 
focus formation at stalled replication forks. The formation and loss of γ-H2AX and 53BP1 foci 
was similar in all cell lines at 30 min and 2 hr post irradiation. However, at 6-18 hr, a significant 
fraction of foci were seen to persist in Artemis-deficient CJ179 fibroblasts, while nearly all of the 
foci resolved in normal 48BR cells (Fig. 4-6, 4-7). A stable complementation with wild-type 
Artemis was able to correct this defect to normal levels while the D165N mutant Artemis 
completely failed to rescue the DSB repair defect of CJ179 cells, suggesting that this process 
requires Artemis endonucleolytic activity. Essentially identical complementation results were 
obtained in cells treated with NCS (Fig. 4-7C). Although the kinetics of γ-H2AX and 53BP1 foci 
were nearly identical, a higher dose of radiation was required to induce a comparable number of 
53BP1 foci. Staining with a mouse monoclonal antibody to γ-H2AX confirmed that some  
γ-H2AX foci did not contain detectable 53BP1, as has been previously reported (Van Vugt et al 
2010) (Fig. 4-8). 
The above results were confirmed by a PFGE assay that measures DSBs directly but 
requires use of higher doses of radiation (40 Gy, Fig. 4-9). Again, 10-20% of the DSBs remained 
unrejoined in Artemis-deficient and D165N mutant-complemented CJ179 cells, indicating that 
repair of this subset of DNA DSBs require Artemis endonucleolytic activity even at these higher 
doses. 
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4.4 Low-level Artemis expression is sufficient to restore radiosurvival  
A possible concern for these studies, as well as earlier studies using transient expression 
from transfected plasmids (Beucher et al. 2009), is that the levels of Artemis transgene 
expression are much higher than endogenous levels in normal fibroblasts, thus bringing into 
question the physiological significance of such expression. Thus, to assess the possible effect of 
Artemis expression levels on survival and repair, clones having the highest/lowest level of 
Artemis expression among those screened were isolated from 48BR and CJ179 cells transduced 
with vectors encoding WT or D165N Artemis. 
Artemis expression levels were first determined by real time q-PCR and confirmed by 
IP/western analysis. All transgene-expressing clones produced detectable levels of Artemis 
protein, which correlated with the levels of Artemis mRNA.  While the Artemis levels in all 
clones were still higher than in 48BR and other normal fibroblasts, they were comparable to and 
in some cases lower than the endogenous level in normal lymphoblastoid cells (Fig 4-10A, B).   
Moreover, the CJ179 clone expressing the lowest level of WT Artemis was as radioresistant and 
as repair proficient as the highest-expressing clone (showing sevenfold higher expression by 
 q-PCR), and both were more radioresistant than normal 48BR-Vect cells (Fig 4-11B, C). In 
contrast, even high levels of Artemis D165N expression (~8-fold higher than the level in CJ 
Arte+clone 1 by q-PCR; Figure 4-10A) conferred no detectable radioresistance (Figure 4-11B).  
Overall, these results suggest that a modest amount of WT Artemis is sufficient to correct 
the repair defect in Artemis-deficient cells and increase radioresistance, and that the restoration  
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Figure 4-10. Wild type/D165N Artemis expression levels in various isolated clones. 
(A) Artemis cDNA was amplified using real time q-PCR and the relative quantities of 
Artemis expression for indicated clones (cln) using normal lymphoblastoid cells as 
calibrator sample and β-actin as endogenous control are plotted. Error bars indicate SEM 
for 3 independent experiments. All 20 isolated CJ Endo
-
 clones had similar levels of 
expression. (B) Artemis protein level for selected clones was verified by IP/Western blot. 
JRL2 are normal lymphoblastoid cells. 
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Figure 4-11. Effect of wild-type/D165N Artemis expression levels on radiosurvival 
and repair. Clonogenic survival assays were performed on confluence-arrested serum-
starved clones following exposure to radiation. The data points for CJ Vect and 48BR 
Vect are same for (A) and (B). Error bars represent SEM for three independent 
experiments. (C) γ-H2AX foci were scored in confluence-arrested serum-starved 
high/low wild-type Artemis-expressing CJ179 cells. Error bars represent standard 
deviation for two independent experiments. 
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of radioresistance is dependent on Artemis-mediated endonuclease activity and is not an artifact 
of overexpression.  
 
4.5 Persistent radiation-induced foci in Artemis-deficient cells grow larger with time and 
juxtapose with PML-nuclear bodies. 
In addition to a larger number of persistent foci, cells lacking functional Artemis showed 
a significant time-dependent increase in the average diameter of the residual foci, from 
approximately 0.8 μm at 30 min to 1.4 μm at 12-18 hr (Fig. 4-12A, B, C). This increase was seen 
for both 53BP1 and γ-H2AX foci, and for both Artemis-deficient and Artemis D165N-
complemented cells. These results provide further evidence that the hypersensitivities in these 
cells are due to defective repair processes.  Moreover, these results suggest that the unrepaired 
DSBs promote persistent ATM activation and continued accumulation of repair factors like 
Mre11 (Fig. 4-13A, B and C) in the vicinity of the break site. 
 Promyelocytic leukemia protein (PML) is a tumor suppressor that along with Daxx, SP 
100 and CBP has been identified as the main constituent protein within subnuclear compartments 
also referred to as nuclear bodies (NBs) (Carbone et al. 2002, Weis et al. 1994). PML is 
phosphorylated by ATM  (Lallemand-Breitenbach, de Thé 2010) and PML-NBs have also been 
shown to co-localize with Mre11 and p53 at the sites of radiation induced foci (Carbone et al. 
2002) at later time points.  
To investigate whether PML NBs and associated proteins may be recruited to the residual 
DNA DSBs, PML and γ-H2AX interaction was analyzed in cells by double immunostaining and 
confocal microscopy. As shown in Fig. 4-14, a subset of PML NBs were found to be juxtaposed 
to the residual DNA DSBs in Artemis-deficient cell lines at later time points of 12 -18hr.  These  
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Figure 4-12. (A) Growth of persistent radiation-induced foci in Artemis-deficient 
cell lines. Confocal microscopy of Artemis-deficient and D165N mutant-complemented 
CJ179 fibroblasts, showing increase in the size of γ-H2AX foci that persist 12–18 h post-
irradiation. Arrows are pointing towards large foci. 
A 
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Figure 4-12. Growth of persistent radiation-induced foci in Artemis-deficient cell 
lines. (B) Average size of 53BP1 (dose of 4 Gy) or (C) γ-H2AX (dose of 2 Gy) foci. 
Focus diameter on fluoromicrographs was measured in one direction parallel to the 
equatorial plane of the image field. The error bars represent SEM for 35 foci. 
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Figure 4-13. (A) Mre11 and γ-H2AX co-localization following exposure to 2 Gy 
 γ-radiation in CJ Arte+ cells. Double Mre11 : γ-H2AX staining was performed after 
paraformaldehyde fixation. Confocal analysis of representative cell, CJ Arte+ are shown. 
Green fluorescence: γ-H2AX (monoclonal anti γ-H2AX, Millipore); red fluorescence: 
Mre11 (Polyclonal anti-hMre11 Novus biologicals). 
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Figure 4-13. (B) Mre11 and γ-H2AX co-localization following exposure to 2 Gy 
 γ-radiation in CJ Vect cells. Double Mre11:γ-H2AX staining was performed after 
paraformaldehyde fixation. Confocal analysis of representative cell, CJ Vect are shown. 
Green fluorescence: γ-H2AX (monoclonal anti γ-H2AX, Millipore); red fluorescence: 
Mre11 (Polyclonal anti-hMre11 Novus biologicals). 
 
83 
 
  
Figure 4-13. (C) Mre11 and γ-H2AX co-localization following exposure to 2 Gy 
 γ-radiation in CJ Endo- cells. Double Mre11:γ-H2AX staining was performed after 
paraformaldehyde fixation. Confocal analysis of representative cell, CJ Endo- are shown. 
Green fluorescence: γ-H2AX (monoclonal anti γ-H2AX, Millipore); red fluorescence: 
Mre11 (Polyclonal anti-hMre11 Novus biologicals). 
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Figure 4-14. PML and γ-H2AX partial co-localization and juxtapositioning after 2 
Gy γ-radiation exposure. Double PML/γ-H2AX staining was performed after 
paraformaldehyde fixation. Confocal analysis of representative cells is shown. Green 
fluorescence: γ-H2AX (polyclonal anti γ-H2AX, Novus biologicals); red fluorescence: 
PML (monoclonal anti-PML, Santa Cruz, PGM-3). IR Ctrl=no irradiation. 
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results indicate that such positioning occurs even at relatively low levels of initial DNA damage, 
as long as there are a significant number of residual foci.  
 
4.6 Overexpression of D165N mutant Artemis renders normal cells repair-deficient. 
If, as proposed, the primary role of Artemis in chemo/radioresistance is endonucleolytic 
trimming of DSB ends, then overexpression of mutant Artemis might be expected to displace the 
normal enzyme and prevent such trimming. A D37N-413aa C-terminal truncated Artemis 
overexpression has recently been shown to increase radiosensitivity and induce repair defect in 
tumor cell lines. However, since the mutant protein is both phosphorylation-deficient (due to 
deletion of C-terminal regulatory region) and endonuclease deficient (D37N) it is difficult to 
conclude which activity of the protein leads to this dominant negative effect (Liu et al. 2011). 
At 2 Gy, or at equally toxic concentrations of bleomycin or NCS, no such dominant-
negative effect was seen in our experiments, as D165N-overexpressing 48BR cells were as 
chemo/radioresistant as empty-vector controls (Fig. 4-16A, B and C), and were fully competent 
in resolution of repair foci (2 Gy, Fig. 4-15A).  However, in FAR assays, overexpression of 
D165N mutant Artemis conferred upon normal fibroblasts a slight repair defect at high doses of 
γ-radiation (40 Gy, Fig. 4-15B), indicating that when the repair system is saturated with DSBs 
(40 Gy exposure is predicted to result in 1600 DSBs compared to 80 DSBs at 2 Gy), the 
probability of the end termini being occupied by D165N mutant Artemis is more than that of the 
endogenous protein. Conversely, overexpression of wild-type Artemis rendered normal cells 
more resistant to γ-radiation (Fig. 4-16A) and chemotherapeutic drugs bleomycin (Fig. 4-16B)  
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Figure 4-15. Overexpression of D165N mutant Artemis confers high-dose DSB-
repair deficiency. (A) γ-H2AX focus assay was performed after 2 Gy γ-irradiation. (B) 
PFGE analysis of normal fibroblasts overexpressing wild-type or D165N mutant Artemis 
after exposure to 40 Gy γ-rays. The panel displays FAR versus repair time (for 48BR Vect 
versus 48BR Arte+ P>0.3 at all times; for Vect versus Endo- P=0.04 at 12 h and P=0.16 at 
18 h, by t-test). 
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Figure 4-16. Overexpression of D165N Artemis has no effect on 
radio/chemosensitivity of normal 48BR fibroblasts (A) Clonogenic survival was 
determined following treatment with radiation (for Vect versus Arte+ P=0.04 at 4 Gy and 
P=0.07 at 6 Gy; for Vect versus Endo- P>0.3 at all doses). Vect cells are empty-vector 
controls. The data for 48BR Vect and 48BR Arte+ are same as shown in Figures 4-5, and 
are shown here separately for the sake of clarity and comparison with 48BR Endo-. (B, C). 
Clonogenic survival was determined following treatment with bleomycin, or 
neocarzinostatin. Although survival of 48BR Endo‾ cells was slightly lower than that of 
Vect cells following bleomycin treatment, the difference was not statistically significant. 
For bleomycin treatment, p = 0.56, 48BR Vect vs 48BR Endo‾ (1μg/ml, t test), p = 0.49, 
48BR Vect vs 48BR Endo‾ (2μg/ml, t test). For NCS treatment, p = 0.62, 48BR Vect vs 
48BR Endo‾ (3nM, t test), p = 0.93, 48BR Vect vs 48BR Endo‾ (6nM, t test). 
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and neocarzinostatin (Fig. 4-16C) suggesting that an excess of wild type Artemis in cells adds to 
the survival advantage following genotoxic insult. But such an overexpression of WT Artemis 
but did not produce a detectable change in repair, with all measurable DSBs being rejoined 
within 12 hr according to both focus-formation (Fig. 4-15A) and FAR assays (Fig. 4-15B). 
 
4.7 8-oxoguanine residue stimulates and thymidine glycol inhibits KU- and DNA-PK-
mediated Artemis activity. 
 The most lethal DNA DSBs are those that have a high structural complexity and thus are 
resolved with slow repair kinetics (Riballo et al. 2004). High-LET radiation has been suggested 
to induce such complex DNA DSBs, which also comprise a subset of DSBs induced by low-LET 
radiation. These complex DSBs are defined as multiply damaged sites consisting of a DSB with 
varied end morphology and flanking base damage (Asaithamby, Chen 2011). The most 
commonly found base damage associated with a DSB is 8-oxoguanine and thymidine glycol, due 
to their lower oxidation potential. Such oxidized bases are usually repaired by base excision 
repair, however it was recently shown that an 8-oxoguanine residue in close proximity  
to a DSB is a poor substrate for the base excision repair mechanism (Dobbs et al. 2008). 
Moreover, a base damage immediately upstream of a DNA DSB had a severe inhibitory effect on 
non-homologous end joining (Datta et al. 2011), indicating that these lesions might be 
preferentially repaired by the alternate ATM-and Artemis-dependent NHEJ pathway that is 
implicated in the slow repair of more complex DNA DSBs. Two different internally labeled 
substrates were used to determine whether the endonucleolytic activity of Artemis was affected 
by the presence of an 8-oxoguanine or a thymidine glycol moiety. The internally labeled 
plasmid-length substrates were designed to contain 8-oxoguanine or thymidine glycol as 
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Figure 4-17. 8-oxoguanine residue stimulates DNA-PK dependent Artemis 
endonucleolytic activity. (A) An internally labeled plasmid substrate bearing an 8-oxoG 
residue as the last paired base before a 3-base 3ʹ-overhang and the corresponding normal 
substrate were treated with Artemis (90 nM), DNA-PK (65 nM) and Ku (25 nM) as 
indicated. Following digestion of treated plasmid with AvaI for 2 hrs, the released end 
was analyzed by 20% PAGE under denaturing conditions. The numbers to the right 
indicate the number of nucleotides resected from the 3ʹ-end. The overall kinetics of 
cleavage were measured as a function of time (10-120min) for the complete reaction. For 
all other reaction, the time of incubation was 60 min. 
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Figure 4-17. 8-oxoguanine residue stimulates DNA-PK dependent Artemis 
endonucleolytic activity. Artemis activity towards resection of 2-nt (B), 3-nt (C), 4-nt 
(D) and 5-nt (E) is quantified for the 8-oxoguanine and corresponding normal substrate. 
Error bars represent SEM of three independent experiments. 
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Figure 4-18. Thymidine glycol blocks Artemis-mediated end-trimming. (A) An 
internally labeled plasmid substrate on pUC19 backbone bearing a thymidine glycol 
residue as the last paired base before a 3-base 3ʹ-overhang and the corresponding normal 
substrate were treated with Artemis (90 nM), DNA-PK (65 nM) and Ku (25 nM) as 
indicated. Following digestion of treated plasmid with BsrDI at 65ºC for 2 hrs, the 
released end was analyzed by 20% PAGE under denaturing conditions. The overall 
kinetics of cleavage was measured as a function of time (10-120min) for the complete 
reaction. For all other reactions, the time of incubation was 60 min. 
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B 
Figure 4-18. Thymine glycol blocks Artemis-mediated end-trimming. (B) Kinetics of 
Artemis endonucleolytic activity towards a thymidine glycol-containing substrate in 
presence of Ku and DNA-PK is plotted. The abundance of detected cleavage products was 
measured using ImageQuant 5.1 densitometry software and is reported as a function of 
time. The total cleavage for thymidine glycol containing substrate was lower than 
corresponding normal substrate. 
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the last paired base in a duplex DNA before a 3 base 3ʹ-overhang that is amenable to cleavage by 
Artemis endonuclease activity. The substrates were incubated with recombinant soluble Artemis 
in presence or absence of Ku and DNA-PK for 10 – 120 min, to assess the dependence of 
Artemis reaction on availability of DNA-PK component proteins. As expected, resection of the 
modified and the corresponding normal substrate by Artemis was completely dependent on 
availability of DNA-PK and Ku in presence of ATP (Fig. 4-17A, compare lanes 6 with 11 and 
lanes 18 with 22).  
For the 8-oxoG substrate, the abundance of detectable cleavage products were higher 
than corresponding normal substrate, indicating stimulation of Artemis activity by the presence 
of the modified base close to end termini. On closer examination, we found that there was little if 
any single nucleotide trimming, with predominant removal of 2 bases from the 3ʹ-end to generate 
a 12-mer, 2-nucleotide cleavage product, that reached maximum abundance at 30 min post 
incubation. The abundance of this specific product was particularly enhanced 2-3 fold in the  
modified substrate relative to an analogous product generated from the normal guanine 
containing substrate (Fig 4-17 B), for which there was minimal overall detected trimming 
activity and little trimming specificity (Fig. 4-17A, compare lanes 6-8 and 17-19). Moreover, 
addition of Ku to the reaction stimulated Artemis:DNA-PK mediated endonucleolytic reaction 
without altering the product distribution, in contradiction to previous results that this reaction 
was independent of Ku (Ma et al. 2002) (Fig. 4-17A, compare lanes 6 with 10, and lanes 17 with 
21). Though the stimulated Artemis activity was not observed for the resection of the 8-oxoG 
residue itself, once the modified base was removed, the activity returned to levels comparable to 
that seen with cleavage of the corresponding normal substrate (Fig 4-17A, B, C, D and E).  
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 Thymidine glycol, owing to its nonplanar structure, has been shown to severely block 
replicative and translesional DNA polymerases (Aller et al. 2007) (Zhou et al. 2008). In contrast 
to the 8-oxoG substrate that altered specificity of Artemi-mediated end trimming and stimulated 
cleavage, the presence of thymidine glycol severely blocked Artemis activity (Fig. 4-18A). 
Substrate incubations with Artemis, Ku and DNA-PK showed approximately 2 fold lower 
cleavage activity (determined by quantification of total cleavage products by densitometry) than 
the corresponding unmodified normal thymidine containing DNA, even at extended incubation 
times of 2 hours (Fig 4-18B). These results suggest that Artemis 3ʹ5ʹ endonucleolytic activity 
may resolve complex DNA ends with a flanking 8-oxoguanine, but not with a thymidine glycol, 
which may require additional factors for processing. 
 
4.8 Metnase endonucleolytically resects ssDNA overhangs of a duplex DNA substrate. 
 Metnase has been shown to possess ssDNA cleavage activity (Roman et al. 2007). To 
investigate the biological relevance of this activity, plasmid-length substrates were constructed 
by ligating 5ʹ-labeled 23 mer or a 17 mer oligonucleotide to a 3ʹ-resected plasmid generating 12-
base adenine (Long A), 6-base adenine (Short A) or 6-base thymidine (Short T), 3ʹ-overhangs 
(Fig 4-19C). These substrates with varying 3ʹ-overhang length and end sequence were subjected 
to Metnase reaction for various times (2 hr and 4 hr) as indicated, and then released from the 
plasmid by Taq1 digestion and analyzed by 20% PAGE. 
  Metnase was found to cleave on both ss- and dsDNA regions of the duplex DNA 
substrates, but the detected cleavage activity was preferential towards the ssDNA regions. Long 
12 base 3ʹ-overhangs were efficiently trimmed to generate shorter product spectrum 
predominantly corresponding to 2-8 nt 3ʹ-overhangs (23 mer gave a product distribution ranging  
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Figure 4-19. Stimulation of Metnase mediated resection by increase in length of 
ssDNA overhangs. All samples were treated with 50 nM of Metnase as indicated. (A) a  
3ʹ-resected plasmid with an 11-base 5ʹ-overhang was prepared as described, to which  
5ʹ-labeled 23-mer or 17-mer was ligated to generate 12-base or 6-base 3ʹ-overhang. 
Following 2hr or 4hr Metnase treatment, the labeled substrates were digested with TaqI, 
resolved by 20% PAGE, exposed 24 hrs to a phosphoimager screen and scanned on a 
Typhoon scanner. The numbers indicate size of resected products. (B) Total abundance of 
cleavage products is plotted as a percentage of the un-resected substrate (23-mer or 17-
mer band) after subtraction of the control lanes. Error bars indicate SEM for 2 
independent  experiments (C) Sequence of substrates is shown. Arrows indicate major 
cleavage positions interpreted from gel shown in (A). The star shows the position of the 
32
P label. Long A vs Short A (50 nM, 4hr, t test), p = 0.31 
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Figure 4-20. Metnase 3ʹ-end cleavage specificity is altered by a change in sequence of 
overhangs. (A) Substrates were treated with 50 nM Metnase for indicated time in hours. 
The released 17-mer upon TaqI cleavage resolves differently on 20% PAGE due to 
sequence differences. Numbers indicate size of major products. (B)  Total abundance of 
cleavage products in indicated lanes is plotted as a percentage of the un-resected substrate 
(17-mer band) after subtraction of the control lanes. Error bars indicate SEM for 2 
independent experiments (C) Partial sequence of the substrates is shown. Arrows indicate 
major cleavage positions interpreted from gel shown in (A). The star shows the position 
of the 
32
P label. Long A vs Short A (50 nM, 2hr, t test), p = 0.18. Long A vs Short A (50 
nM, 4hr, t test), p = 0.20 
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from 13-mer to 19-mer) (Fig. 4-19A) This product pattern also suggests that approx. 2-3 
nucleotides from the 3ʹ-ends and ss/ds DNA junction are excluded as sites of cleavage by 
Metnase. Though a similar product distribution was observed when the unligated 23 mer used to 
construct the plasmid length duplex long A substrate was subjected to Metnase reaction, the 
intensity of cleavage products was diminished indicating that Metnase nuclease activity could be 
confined to ssDNA overhangs of partial duplex DNA (Fig 4-19A). Analysis of total cleavage 
following Metnase nuclease reaction revealed that the long A substrate was cleaved ~2 fold more 
than the short A substrate indicating that the longer 3ʹ-overhangs may be the preferred 
biologically relevant substrate for Metnase (Fig 4-19B). 
Metnase cleavage specificity was also altered with the change in sequence of the  
3ʹ- overhangs from 6-base Adenine (Short A) to 6-base thymidine (Short T). For substrates with 
6-nt adenine overhang (17-mer), 4-nt cleavage from the 3ʹ-terminal to generate a 2-base 
overhang product (13-mer) was predominant, while a 6-base Thymidine 3ʹ-overhang was cleaved 
to also generate a 3-nt cleavage product (14-mer) in addition to the product spectrum generated 
by the Short A substrate (Fig 4-20A). A hotspot of cleavage was  also interestingly generated in 
the duplex DNA region of the short T substrate unlike that observed with either the short A or 
the long A substrates (9-mer, 2-base 5ʹ to the blunt end). The total cleavage of the substrate by 
Metnase was also higher when all 6 adenine bases were replaced by thymine (Fig 4-20B).  
These results suggest that Metnase end-trimming activity depends upon both length and 
sequence of the ssDNA overhang. Thus, Metnase endonuclease may resolve physiologically 
relevant long ssDNA overhangs for facilitating end joining but this function is sensitive to 
changes in DNA sequence. 
 
98 
 
4.9 3ʹ-phosphoglycolate termini on longer DNA overhangs altered specificity and 
stimulated Metnase-mediated cleavage. 
DNA DSBs induced by radiation or some radiomimetic drugs bear 3ʹ-PG termini that may inhibit 
repair by blocking polymerases and ligases. These oxidatively modified DNA ends need to be 
resected before DNA repair can proceed, and several enzymes like Tdp1, Ape1 and Artemis have 
been shown to process such ends in the context of NHEJ repair. Though Metnase can 
endonucleolytically cleave oligonucleotides and 3ʹ-ssDNA overhangs of a duplex DNA substrate, 
its activity towards modified DNA termini is unknown.  
To generate substrates mimicking DSBs arising due to oxidative damage, a 3ʹ-resected 
plasmid with an 11-base 5ʹ-overhang was prepared as described, to which 5ʹ-labeled oligomers of 
various lengths (12, 14, 15 and 17 mer) with 3ʹ-PG termini (12-PG, 14-PG, 15-PG and 17-PG) 
were ligated to give 1, 3, 4 and 6-base overhang with phosphoglycolate ends. Processing of 3ʹ-
overhanging termini was assessed on 20% PAGE following digestion of the treated plasmid with 
AvaI or TaqI to release the labeled oligomer from the 3ʹ-end. Metnase treatment of the various 
3ʹ-PG substrates revealed that it may be a candidate protein to resolve such damaged ends for 
efficient repair.  
When a 3ʹ-PG-terminated 1-base (12-PG) or 3-base (14-PG) overhanging substrate was 
treated with increasing concentrations of Metnase, the predominant cleavage occurred in the 
region of duplex DNA. Both substrates were preferentially cleaved internally from the 3ʹ-
terminus to release a 5ʹ-labeled 9-mer as the prominent product upon Taq1 cleavage (Fig 4-21A, 
lanes 7 and 8, Fig 4-21C, lanes 7 and 8). However, for the 1-base overhang 3ʹ-PG substrate, 
shorter products originating from cleavage in the duplex region were also evident that were not 
seen for the 3-base overhang 3ʹ-PG substrate.   
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Figure 4-21. Effect of 3ʹ-phosphoglycolate termini and substrate length on Metnase 
endonuclease activity. (A) a 12- or 15-mer 3ʹ-PG or 3ʹ-OH was ligated to the 3ʹ-resected 
end of a plasmid to generate substrate with a 1-base or 4-base 3ʹ-overhang. The substrates 
were treated with indicated amount of Metnase for 2 hr. The sequences for the substrates 
used are shown on the top panel. The numbers (2, 3, 4, 5) indicate number of nucleotides 
removed from the 3ʹ-end and are also shown on the substrate sequences on the top panel. 
(B) The graph shows abundance of products resulting from cleavage of 2, 3, 4 or 5 
nucleotides from the 3ʹ-end for 1-base overhang (top panel) or a 4-base overhang (bottom 
panel) following 100 nM Metnase treatment. The abundance of total cleavage products 
following 100 nM Metnase treatment is also shown.  
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Figure 4-21. Effect of 3ʹ-phosphoglycolate termini and substrate length on Metnase 
endonuclease activity. (C) A modified 14-mer was used to construct internally labeled 
plasmid substrate with 3ʹ-PG end or an 8-oxoG positioned before a 3-base 3ʹ overhang. 
The substrates were treated with the indicated concentrations of Metnase for 2 hr. (D) 
The 2, 3, 4, 5 nucleotide and total cleavage products resulting from Metnase nuclease 
reaction were quantified using ImageQuant 5.1. Error bars represent SEM for three 
independent experiments. 
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Figure 4-21. Effect of 3ʹ-phosphoglycolate termini and substrate length on Metnase 
endonuclease activity. (E) A modified 17-mer was used to construct internally labeled 
plasmid substrates with 3ʹ-PG end on a longer 6-base 3ʹ-overhang. The substrates were 
treated with indicated concentrations of Metnase for 2 hr. (F) The 2, 3, 4, 5 nucleotide and 
total cleavage products resulting from Metnase nuclease reaction were quantified using 
ImageQuant 5.1. Error bars represent SEM for three independent experiments. 
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Figure 4-21. Effect of 3ʹ-phosphoglycolate termini and substrate length on Metnase 
endonuclease activity. (G) The abundance of total cleavage products following treatment 
of 3ʹ-PG/3ʹ-OH substrates with varying overhang lengths as indicated is plotted after 
normalization to the control lanes following quantification for the gels shown in Fig 4-
21A,C,E. Metnase-mediated-end resection increases proportionally with the increase in 
length of ssDNA overhangs.  
G 
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The corresponding 1-nucleotide overhang 3ʹ-OH substrate showed a similar but lower intensity 
cleavage pattern as the PG substrate (Fig 4-21A, compare lanes 3 and 4 with lanes 7 and 8). For 
the 3-base overhang unmodified substrate, the product distribution differed from that of the 
corresponding PG substrate and indicated multiple cleavage products in addition to the 
predominantly released 9-mer, indicating that the PG end may affect Metnase cleavage 
specificity (Fig 4-21C, compare lanes 3,4 with lanes 7,8). Interestingly, when DNA substrates 
with longer 3ʹ-overhangs (15-mer 4-base and 17 mer 6-base) were treated with Metnase, both 
stimulation of cleavage and alteration of specificity was detected. The 4-nt overhang substrate 
was cleaved by Metnase to generate a product pattern corresponding to preferred resection at the 
ssDNA region (2 and 3 nucleotide from the 3ʹ-end) and also in the duplex DNA (Fig 4-21A lanes 
9-16). Furthermore, a 3ʹ-PG moiety on a 4-base overhang stimulated Metnase endonucleolytic 
activity for 2-5 nt resection from the 3ʹ-terminal, with an overall 2 fold greater abundance of the 
total cleaved products than corresponding unmodified DNA Fig 4-21B, lower panel). With an 
even longer 3ʹ-PG overhang containing substrate, Metnase cleavage specificity altered to 
predominant resection of terminal 3 and 4 nucleotides, with no detectable cleavage in the duplex 
region. A D483A mutation in Metnase completely abrogated Metnase cleavage activity towards 
DNA ends (Fig 4-21E). The abundance of total cleavage products increased proportionally to 
increase in the length of 3ʹ-overhangs, confirming our earlier finding that Metnase activity is 
stimulated by longer ssDNA regions (Fig 4-21 F). 
Overall, these results indicate that 3ʹ-PG modified termini can stimulate Metnase activity 
and alter specificity of cleavage especially on longer 3ʹ-overhang regions, with a 4-base 
overhang of a partial duplex DNA as being the minimum requirement for efficient cleavage in 
ssDNA region. 
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Figure 4-22. Thymidine glycol blocks Metnase-mediated end processing. An 
internally labeled plasmid substrate on pUC19 backbone bearing a thymidine glycol 
residue as the last paired base before a 3-base 3ʹ-overhang and the corresponding normal 
substrate were treated with Metnase (20, 50 and 100 nM) as indicated. Following 
digestion of treated plasmid with BsrDI at 65ºC for 2 hrs, the released 23-mer end was 
analyzed by 20% PAGE under denaturing conditions (left panel). Total abundance of all 
detectable cleaved products following 100 nM Metnase treatment was quantified using 
ImageQuant and results following normalization with respective untreated controls are 
plotted. Error bars represent SEM for two independent experiments (right panel). 
Thymidine glycol vs Normal (100 nM, t test), p = 0.16. 
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4.10 Thymine glycol inhibits Metnase endonucleolytic activity. 
 As discussed previously, oxidative base damage is a hallmark of complex DNA DSBs 
and may block NHEJ repair. These damaged bases are generally repaired by the base excision  
repair mechanism, however, if the base damage arises in the context of a DSB, then it is possible 
that NHEJ nucleases may recognize and resect the damaged base to facilitate completion of 
repair. We have shown that Artemis activity is stimulated by the presence of 8-oxoguanine and 
inhibited by thymine glycol. Since Metnase may form a part in NHEJ repair machinery, we 
subjected the physiologically relevant 8-oxoguanine and thymidine glycol substrates (described 
previously) to 20, 50 and 100 nM Metnase. Metnase activity was not stimulated and its cleavage 
pattern remained unaffected by the presence of oxidized guanine at the ssDNA/dsDNA border 
before a 3-base 3ʹ-overhang, which was cleaved with equal efficiency as a normal guanine 
substrate (Fig 4-21C, compare lanes 3, 4 with lanes 11,12, Fig 4-21D). However, a nonplanar 
thymidine glycol blocked Metnase mediated resection of the ssDNA overhangs (Fig 4-22). 
Interestingly, no cleavage in the duplex DNA region was observed for the thymidine glycol 
substrate, suggesting that Metnase may load from the DNA ends and that once it encounters the 
modified residue it may be blocked from cleaving the substrate further. Since an 8-oxoguanine 
residue failed to alter, and thymidine glycol inhibited Metnase nuclease activity, complex DNA 
DSBs may not be biologically relevant susbtrates for Metnase-mediated resection and require 
other NHEJ factors like Artemis for resolution. 
 
4.11 Metnase endonucleolytic activity is independent of Ku and DNA-PK. 
 Recruitment of Ku heterodimers and DNA-PK to the DSB ends is considered to be 
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Figure 4-23. Metnase endonuclease activity is independent of DNA-PK and Ku 
availability. (A) The internally labeled long A substrate generated by ligating the 23 mer 
oligonucleotide to 3ʹ-resected plasmid was incubated for 20 min with DNA-PK (65 nM) 
and Ku (25 nM) followed by S1-Nuclease ( 0.3U, 25 ºC, 5 min). S1-nuclease reactions 
were performed in the absence of ATP. The same substrate was incubated with Metnase 
(50 nM), DNA-PK (65 nM) and Ku (25 nM) for 4 hrs at 37 ºC. S1-nulcease was chosen 
for footprinting because of its specificity towards ssDNA overhangs. 
1 2 3 4 5 6 7 8 1 2 3 5 4  
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B 
Figure 4-23. Metnase endonuclease activity is independent of DNA-PK and Ku 
availability. (B) The footprint experiment shown in (A) is quantified. Cleavage of 
indicated nucleotides by Metnase or S1-Nuclease in presence of Ku and DNA-PK 
(lanes 1 and 4) is plotted as a percentage relative to the cleavage in presence of 
Metnase and S1-nuclease alone (lanes 3 and 6). Error bars indicate SEM for two 
independent experiments. 
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essential for repair by NHEJ pathway. Ku 70/80 forms a bridge between DNA ends helping  
alignment and also facilitates DNA-PK binding to the DNA ends. Once bound, DNA-PK 
acquires a S/T kinase activity and both DNA-PK autophosphorylation and DNA-PK-mediated 
phosphorylation of NHEJ factors has been shown to affect repair by NHEJ. Moreover, Ku and 
DNA-PK are essential for stimulation of Artemis endonucleolytic activity (Yannone et al. 2008). 
Thus, to determine whether NHEJ proteins Ku and DNA-PK stimulate or otherwise affect 
Metnase cleavage function on long ssDNA overhangs, a 12-base 3ʹ-overhang plasmid substrate 
was incubated with Metnase (50 nM) both in the presence and in the absence of Ku (25 nM) and 
DNA-PK (65 nM). Ku alone did not alter Metnase endonuclease activity towards DNA ends, 
however Ku along with DNA-PK was found to partially protect the ssDNA overhang from 
Metnase mediated resection (Fig 4-23A). Since the protection was not complete, we performed 
an S1 nuclease footprint assay (instead of DNase1, since S1 nuclease preferentially cleaves 
ssDNA) to determine the extent of Ku and DNA-PK binding to the long 3ʹ-overhang region. 
Substrate incubation with Ku and DNA-PK prior to S1 nuclease treatment, resulted in approx. 50% 
protection of the ssDNA overhang which interestingly was more than the protection afforded 
against cleavage by Metnase (Fig 4-23B). Ku alone did not affect S-1 nuclease activity (Fig. 4-
23A) suggesting that Ku when not bound to DNA-PK may slide to the interior of the duplex 
DNA region, thus exposing the ssDNA region for Metnase mediated resection (hence no 
differences from Metnase reaction alone). As indicated by S1-nuclease footprint assay, in 
presence of DNA-PK, more protein may be retained on DNA ends as a complex, thus protecting 
the ends from Metnase activity. 
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V. DISCUSSION 
 
Direct rejoining of DSBs generated by ionizing radiation or certain radiomimetic 
chemotherapeutics is precluded by the presence of fragmented sugars and damaged or missing 
nucleotide bases near DNA-termini. Free radical-mediated oxidation at the C-4ʹ position of the 
deoxyribose in DNA results in sugar fragmentation and strand cleavage, releasing a base 
propenal and leaving a two carbon fragment –PO4CH2COOH (PG) linked to 3ʹ-end of the break 
(Chen et al. 2007). The three DNA-damaging agents used in this thesis work, i.e., radiation, NCS 
and bleomycin, generate different types of 3′-PG-terminated DNA DSBs. Bleomycin treatment 
gives rise to DSBs having either blunt ends or single-base 5′ overhangs, with 5′-phosphate and 
3′-PG termini at both ends of the break. NCS-induced DSBs have at one end a 5′-phosphate and 
a 3′-phosphate on a 2-base 3′-overhang. The opposite end has a 5′-aldehyde and either a 3′-PG 
(~20%) or a 3′-phosphate (~80%) on a one-base 3′-overhang (Povirk 1996, Dedon, Goldberg 
1990). About half of radiation-induced strand breaks bear 3ʹ-PG termini in different contexts and 
many of these are presumably on 3ʹ-overhangs of DSBs. These end groups can block DNA 
polymerases and DNA-ligases to inhibit repair (Noguti, Kada 1975) and unrepaired DSBs can 
lead to mutations and cell death. Thus, in the repair of such blocked DNA lesions, a step of 
paramount importance is removal of the 3ʹ-PG termini, which must precede gap filling and re-
ligation of the DSB. Several enzymes have been biochemically shown to resolve 3ʹ-PG ends, on 
DSBs. Apurinic/apyrimidinic endonuclease1 (APE1) can remove PGs 
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on blunt and 3ʹ-recessed ends, however PGs on short 3ʹ-overhangs are not removed by APE1 
(Suh, Wilson III & Povirk 1997). TDP1 can also process 3ʹ-PG termini but has substrate 
specificity opposite to that of APE1. Though it can resect 3ʹ-PG ends on overhangs, the 
processing of PG termini by TDP1 is inefficient compared to a phosphotyrosyl substrate. 
Moreover, it leaves a 3ʹ-phosphate end that needs to be removed by PNKP so that the DNA end 
can be ligated. 
Artemis was originally identified as the gene localized in chromosome 10 that codes for a 
V(D)J recombination/DNA repair factor belonging to metallo-β-lactamase family of proteins.  
Mutations in Artemis gene result in RS-SCID due to a defect in the hairpin opening step of 
V(D)J recombination leading to T
-
B
-
NK
+
 phenotype. Artemis has also been implicated in 
resolving PG ends on short 3ʹ-overhangs as well as blunt DNA ends, but slowly. Artemis can 
also interact with and be stimulated by other NHEJ factors like DNA-PK and Ku. Experiments 
using defined substrates and purified enzymes have shown that in the presence of DNA-PK, 
Artemis gains an endonucleolytic activity toward DNA ends that is capable of resolving DSBs 
bearing terminal blocking groups such as 3ʹ-PGs (Povirk et al. 2007). Artemis deficiency has 
pleiotropic effects in human cells following exposure to DNA damaging agents, including 
defects in regulation of cell cycle checkpoints (Wang et al. 2009, Geng et al. 2007) and in 
apoptotic DNA fragmentation (Britton et al. 2009). Other studies suggest that Artemis is epistatic 
with ATM in promoting radiosurvival and DSB repair, even in growth-arrested cells that should 
not be subject to cell cycle effects (Riballo et al. 2004). This thesis work investigates whether the 
endonucleolytic activity of Artemis is its biologically relevant function for promoting cell 
survival following exposure to ionizing radiation and radiomimetic drugs. Since the majority of 
induced DSBs are repaired even in Artemis-deficient cells, there must be other nucleases or 
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phosphodiesterases that can resolve blocked ends in different contexts. The biochemical role of 
Metnase, a candidate nuclease for processing of blocked DNA DSBs during NHEJ, has also been 
studied as part of this work. 
To investigate whether the endonucleolytic activity of Artemis functions in 
chemo/radioresistance, patient-derived CJ179 cells defective for Artemis were complemented 
with lentiviral vectors expressing wild-type or D165N Artemis. The D165N mutation eliminates 
Artemis-mediated endonucleolytic processing of 3ʹ-PG DSB ends in vitro (Yannone et al. 2008, 
Povirk et al. 2007). To establish the role of Artemis nuclease activity in DNA repair and cellular 
survival after DNA damage, clonogenic and DSB-repair assays were carried out with these cells, 
following treatment with radiation or radiomimetic drugs. Earlier studies (Riballo et al. 2004, 
Beucher et al. 2009) investigating complementation of Artemis defect by exogenous protein 
expression were carried out with transiently expressing cell lines due to difficulties in expressing 
Artemis in cells (Beucher et al. 2009). In contrast to these studies, our collaborator, Dr. Steven M. 
Yannone was successful in stably complementing Artemis-deficient fibroblasts with WT or 
D165N mutant Artemis, allowing us to explore the effect of such expression on the critical 
endpoint of survival following radiation or genotoxic chemical treatment. Survival assays with 
stably complemented cell lines show that only WT endonuclease-proficient Artemis is able to 
restore radio/chemoresistance and that an endonuclease-deficient Artemis fails to do so (Fig. 4-5). 
These data indicate that a lack of endonuclease activity and thus of end-processing is the 
principal cause of radio/chemosensitivity of Artemis-deficient fibroblasts. Though an effect of 
D165N mutation on recruitment to damaged DNA ends cannot be completely ruled out, the 
mutant protein has been shown to be phosphorylated by DNA-PK and retains its 5ʹ3ʹ 
exonuclease activity, suggesting that the mutant protein may properly attain tertiary structure to 
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bind DNA ends and retain functionality. Recently, it was shown that most (but not all) of the 
exonuclease activity can be separated from the endonuclease activity. Recombinant His6-tagged 
Artemis expressed in a Baculovirus insect cell expression system and purified on a Ni-agarose 
affinity column still retained both activities. The two activities were partially fractionated on an 
ion exchange hydroxyapatite column (Pawelczak, Turchi 2010). However, other studies showed 
that extensively purified Artemis protein retained exonuclease activity (Gu et al. 2010), and that 
antibodies raised against Artemis protein gel-purified from Escherichia coli inactivate the 
exonuclease, suggesting that this exonuclease activity is intrinsic (Yannone et al. 2008).  
Artemis has also been speculated to have a cell cycle regulatory role following DNA 
damage. It has been shown to affect cell cycle recovery from G2/M and S-phase cell cycle 
checkpoints. The finding that endonuclease-deficient Artemis, even when overexpressed, has no 
effect at all on chemo/radiosurvival (Fig.4-5), combined with evidence that Artemis-deficient 
fibroblasts retain functional G1 and G2 checkpoints (Wang et al. 2005, Krempler et al. 2007), 
would also appear to exclude a checkpoint defect as a major contributor to the 
chemo/radiosensitivity of Artemis-deficient fibroblasts. Although checkpoint deficiencies have 
been reported for tumor cells in which Artemis expression has been knocked down with siRNA 
(Wang et al. 2009, Geng et al. 2007), there is no evidence that these deficiencies account for 
radiosensitivity. 
 PFGE as well as focus-formation assays in noncycling contact-arrested fibroblasts 
(Figure 4-6, 4-7, 4-9) show that wild-type but not endonuclease-deficient Artemis completely 
restores DSB-repair proficiency, in agreement with recent observations in G2 cells where 
Artemis was expressed transiently (Beucher et al. 2009). Previous studies have also suggested 
that Artemis deficient cells fail to rejoin a subset of DNA DSBs, but the exact nature of these 
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breaks remains undefined. Since the endonucleolytic activities of Artemis/DNA-PK do not 
require a specific structure at either the 5ʹ or the 3ʹ ends and can bypass terminal moieties 
(Yannone et al. 2008), these activities could serve to remove chemically modified termini such 
as 3ʹ-PGs and 5ʹ-aldehydes that are generated following treatment with radiation, bleomycin or 
NCS. It is highly unlikely that the exonucleolytic activity of Artemis plays a role in resolving 
such blocked 3ʹ-ends since it acts on 5ʹ-termini and requires a 5ʹ-phosphate. Artemis 
exonucleolytic activity is also suppressed by the presence of DNA-PK, which is expected to be 
bound to DNA-ends during DSB repair in G1. Taken together, these results strongly suggest that 
the primary function of Artemis in DSB repair is the endonucleolytic processing of DNA ends. 
However, in both Artemis deficient and Artemis mutant cell lines, the majority of 
radiation and NCS-induced DSBs (~80%) are repaired within 2 hrs, raising the question as to 
why only a subset of DNA DSBs require endonucleolytic trimming by Artemis for repair, while 
the majority do not. At least for NCS-induced DSBs, the repair-resistant, Artemis-requiring 
fraction cannot be a subset of complex DSBs with accompanying base damage, as neither NCS 
nor bleomycin produces such lesions (Povirk 1996, Dedon, Goldberg 1990). It is also unlikely 
that there is a one-to-one correspondence between 3ʹ-PG DSBs and DSBs requiring Artemis for 
repair, as in that case Artemis-deficient cells should be much more sensitive to bleomycin, which 
forms DSBs that have almost exclusively 3ʹ-PG termini at both ends, than to any of the other 
agents. Another possibility is that the DSBs that absolutely require Artemis may be those arising 
in heterochromatin. Heterochromatic DSBs are thought to be particularly difficult to repair 
because the condensed DNA may preclude certain factors of the DNA repair machinery access to 
DNA ends. Moreover, the heterochromatic DNA constitutes about 20% of the genome which 
correlates with the amount of DSBs that are repaired with slow repair kinetics and are dependent 
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on ATM for repair (~20%). ATM has been shown to promote local decondensation of 
heterochromatin by several groups (White et al. 2012, Goodarzi et al. 2008, Fernandez-Capetillo, 
Nussenzweig 2008) and since Artemis is epistatic with ATM in DSB repair (Fernandez-Capetillo, 
Nussenzweig 2008), it is by inference thought to play a role in repair of heterochromatic DSBs. 
If the unrepaired DSBs are those in heterochromatin, as has been proposed for DSBs that require 
ATM for repair, then there must be alternative enzyme(s) [e.g. TDP1; (Inamdar et al. 2002, Zhou 
et al. 2009)] that are biochemically competent to resolve the damaged ends, but are specifically 
excluded from heterochromatic DSBs. Alternatively, the repair focus-associated protein 
complexes that are recruited to unrepaired DSBs may effectively shield the breaks from most 
enzymatic processing, so that any breaks which fail to repair within 1–2 h (including those in 
heterochromatin) can only be processed by Artemis, due to its close association with DNA-PK 
(Ma et al. 2002, Goodarzi et al. 2006). A recent study of repair joints from a site-specific HO 
endonuclease-induced DSB in mouse mammary cells has raised yet another alternative: that in 
heterochromatin Artemis may excise a whole DSB-containing nucleosome, exposing 
internucleosomal DNA at both ends of the break that can then be more easily joined (Kanikarla-
Marie, Ronald & De Benedetti 2011). A final possibility is that a fraction of the initial DSBs 
may be processed into derivative structures that only Artemis can resolve, for example, hairpins 
resulting from single-strand resection at inverted repeat sequences, as suggested previously 
(Povirk et al. 2007). 
 A time-dependent increase in the size of both γ-H2AX and 53BP1 foci was observed 6-
18 hr post-irradiation for Artemis deficient and D165N Artemis mutant cell lines. A similar 
increase in size of residual foci has been previously reported for cells exposed to high linear 
energy transfer radiation (Ibañez et al. 2009), which induces complex DSBs that are relatively 
115 
 
resistant to repair and persist for longer times. One study that followed foci along α-particle 
tracks in three dimensions, showed that these foci often coalesce into a few larger foci (Aten et al. 
2004). Exposure to high salt immediately after γ-irradiation can also promote increased focus 
size, an effect attributed to inhibition of repair, due to chromatin compaction (Reitsema et al. 
2004). Thus, in several contexts, persistent unrejoined DSBs appear to promote further H2AX 
phosphorylation and aggregation of repair factors, suggesting continued ATM/DNA-PK 
activation (Bakkenist, Kastan 2003) and a gradual spreading of decondensation over larger areas 
of chromatin (Kinner et al. 2008). The determinants that control H2AX distributions are still 
unknown, but it is believed to be bidirectional and may not be entirely uniform on both sides of 
the break (Iacovoni et al. 2010). Thus, increase in focus size indicates persistent DSBs in cells 
deficient in functional Artemis protein, suggesting that a subset of DNA DSBs absolutely require 
processing by Artemis for their resolution. 
 The persistent DNA DSBs represented by large γ-H2AX foci were further analyzed by 
co-immunostaining in an effort to identify other NHEJ factors that may have accumulated at 
these loci and may presumably play a role in the Artemis-dependent NHEJ pathway for repair of 
breaks that show slow repair kinetics. Both 53BP1 and Mre11 were found to co-localize with 
regions of phosphorylated γ-H2AX (Fig. 4-8, 4-13). Recently 53BP1 was shown to be an 
essential factor for promoting heterochromatic DSB repair. ATM promotes DSB repair in 
heterochromatin by phosphorylating KAP1 (KRAB associated protein 1). Cells that did not form 
53BP1 foci (human RIDDLE syndrome cells) also failed to form p-KAP1 foci (Noon et al. 2010). 
Thus, 53BP1 may also be essential for Artemis-dependent heterochromatic DSB repair and for 
amplification of Mre11 accumulation at late repairing foci (Figure 4-13). MRN complex plays an 
important function in facilitating activation of ATM kinase, which also requires direct interaction 
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between BRCT domains of 53BP1 and Mre11 (Lee et al. 2010). Mre11 and associated proteins 
have a 5ʹ3ʹ processing activity that may convert 3ʹ-PG containing blunt ends or short 3ʹ-
overhangs to longer 3ʹ-overhangs that is a more favorable Artemis substrate. The simultaneous 
increase in size of Mre11 foci along with γ-H2AX and 53BP1 suggests that Mre11 is also 
epistatic with Artemis for repair of DSBs.  
 Moreover, these persistent breaks were seen to juxtapose with PML-NBs (Figure 4-14). 
PML is a known tumor suppressor (Lallemand-Breitenbach, de Thé 2010, Yang et al. 2002) and 
is a key constituent of PML-NBs along with Daxx, SP100 and CBP. PML protein itself is 
thought to be the main organizer of these diverse groups of proteins whose commonly identified 
feature is their ability to be sumoylated. SUMO (Small Ubiquitin like Modifier) is a post-
translational modification that is thought to be the essential for PML-NB assembly. PML protein 
itself forms the outer shell of the NBs and the other constituent proteins are usually in the core. 
PML-NBs are usually present in the interchromosomal space under normal conditions 
(Lallemand-Breitenbach, de Thé 2010, Guiochon-Mantel et al. 1995). 
PML
-/-
 cells and mice have been shown to be resistant to lethal effects of γ-radiation. 
Cds1/Chk2-mediated phosphorylation of PML triggers apoptosis (Yang et al. 2002) probably 
through recruitment of Daxx to nuclear bodies (Zhong et al. 2000). PML is phosphorylated by 
several DNA damage activated kinases such as ATM and ATR (Lallemand-Breitenbach, de Thé 
2010) and associates with hMre11 and p53 at 12–24 hr following irradiation (Carbone et al. 
2002). PML-NBs have recently been shown to support DNA DSB repair by homologous 
recombination. PML knockdown by siRNA resulted in a defect in PML-NB formation that 
resulted in 20 fold decrease in HRR. It is speculated that PML-NBs may not affect the early steps 
of HRR like DSB recognition but may inhibit later steps of DNA repair (Yeung et al. 2011). Our 
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results that PML NBs partially juxtapose with late repair foci in Artemis-deficient cells suggest 
that these foci represent highly persistent unrepaired DSBs that continue to recruit additional 
DNA-repair machinery for their resolution. Repair-focus expansion may also reflect a search for 
additional DNA end(s) that can be resolved into a ligatable substrate. At least for UV-induced 
DNA damage, the nuclear bodies were shown to recruit single-stranded DNA molecules in 
response to the damage (Boe et al. 2006). Moreover, confocal real-time imaging of YFP-tagged 
PML did not show either splitting of PML-NBs as reported by other groups (Carbone et al. 2002) 
or formation of de-novo NBs (Boe et al. 2006). These results suggest that PML-NBs may be 
permanent nuclear structures and the ssDNA focus formation was hypothesized to form within 
the pre-existing PML-NBs. Thus PML-NBs may have an intrinsic ability to recruit damaged 
DNA and organize repair and processing events to resolve the damage. Partial co-localization of 
PML NBs in our results (Fig. 4-14) at later time points and in the absence of endonucleolytically 
active Artemis suggests that the damaged chromosomal DNA may be subjected to extensive 
exonucleolytic resection on one strand leading to generation of areas of ssDNA that may be 
sequestered by the PML-NBs. 
However, the involvement of PML-NBs in NHEJ repair is still under dispute (Yeung et al. 
2011), hence another possibility could be that these recalcitrant DSBs that are not repaired by 
NHEJ machinery due to lack of functional Artemis at DNA ends may be directed towards HRR 
at later time points, and the juxtapositioning of PML-NBs at unresolved DNA ends may signify 
this change. Recently, a mutation in the BRCT domain (M1775R) of BRCA1, an essential HRR 
gene, was also found to induce unusual thread-like PML-NBs and clustered RPA foci rather than 
the expected partially colocalized RPA:PML foci seen with WT BRCA1 (Dever et al. 2011). 
Hence, PML-NBs may also be sites for processing of HRR complexes. Moreover, if the repair 
118 
 
efforts by the cell fail, then the constituent proapoptotic proteins of PML bodies may drive cells 
toward cell-death. 
 Our results also show that an overexpression of wild-type Artemis in normal cells adds to 
the survival advantage of these cells (Figure 4-16), however, no effects on repair (PFGE or foci) 
were detected (Fig. 4-15). Since no added repair advantage was detected in these cells by PFGE 
or focus formation assays, it is possible that in presence of excess of Artemis, some breaks which 
can be repaired by multiple redundant pathways may be channeled through an Artemis-
dependent pathway. This NHEJ sub-pathway may be less error-prone than the alternative(s), and 
the resulting higher fidelity of repair might lead to increased survival without necessarily 
affecting measurements of DSB rejoining. However, once a critical level of Artemis expression 
is reached in cells, additional protein does not confer any increased survival advantage (Fig 4-11). 
This result suggests that in the Artemis transgene-expressing cells, the concentration of Artemis 
at DSBs is no longer a limiting factor in repair. Though it is unknown how may molecules of 
Artemis may recruit to DNA ends and whether there is a one-to-one correlation between Artemis 
and DNA-PK required to process a given DSB in cell, it appears that low levels of Artemis 
expression are sufficient to resolve even large amounts of breaks with modified ends such as 
those produced in our PFGE experiments. This may also indicate that the interaction of Artemis 
with DNA ends is dynamic. Once a given DSB is processed for gap filling and re-ligation, 
Artemis may leave the DNA ends and recruit onto another terminally blocked DSB singly or in 
complex with DNA-PK to process it. Thus, low amounts of the protein are all that is required by 
the cells to resolve complex DSBs.  
 Conversely, overexpression of D165N mutant Artemis in normal cells made them slightly 
repair-deficient as judged by PFGE (Figure 4-15B), suggesting that the mutant Artemis can 
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effectively compete with endogenous protein for DNA binding. The defect in repair appears to 
be expressed only when the repair system is saturated by very high levels of DNA damage. 
Although there was a slight trend toward greater radiosensitivity when very high levels of mutant 
Artemis were expressed in normal cells, it was not statistically significant (Figure 4-11A). 
Nevertheless, the dominant-negative effect on repair as well as the increase in radioresistance 
with overexpression of Artemis is most consistent with Artemis functioning directly in the repair 
process. 
 However, repair of most DSBs do not require the presence of a functional Artemis at 
DNA ends, and there is no direct correlation between sensitivity in Artemis-deficient cells and 
amount of DSBs induced with 3ʹ-PG ends, because Artemis-deficient cells are not dramatically 
more sensitive to bleomycin (a drug that induces DSBs bearing 3ʹ-PGs at most DNA ends), 
suggesting that there are other factors that can resolve DSBs with modified 3ʹ-PG end. Metnase 
is one such recently discovered enzyme that may play a role in repairing such damage. 
 Metnase was discovered as a SET and transposase fusion protein that owing to its dual 
histone methylase and nuclease activities, was implicated in DNA repair (Lee et al. 2005a). Later 
it was found to form foci at DSBs along with other NHEJ repair factors like Nbs1, which forms a 
part of MRN complex. Metnase recruitment to the DSB sites requires its physical interaction 
with hPso4 (Beck et al. 2008) and both SET and transposase domains have been shown to be 
necessary for stimulation of NHEJ repair (Lee et al. 2005a). Metnase-mediated dimethylation of 
H3K36 at DSB sites promotes association of NBS1 and Ku to DNA (Fnu et al. 2011). At the 
same time experiments with oligonucleotide substrates have shown Metnase to possess a DNA 
cleavage activity; however its role in processing damaged DNA ends remains to be investigated. 
In this thesis we have also sought to clarify the role of Metnase endonuclease activity, in vitro, 
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on physiologically relevant DNA substrates with modified 3ʹ-PG ends or nucleobase damage 
such as those generated following exposure to ionizing radiation or radiomimetic agents. 
 When longer (5.5kb) internally labeled plasmid substrates were treated with soluble flag-
tagged Metnase, additional processing activities not seen in earlier studies with oligonucleotides 
were revealed. Metnase showed prominent cleavage at the ssDNA regions of a duplex substrate 
and the intensity of cleavage increased ~2 fold with doubling of overhang length on 3ʹ-ends (Fig. 
4-19). This suggests that longer 3ʹ-overhangs may be ideal Metnase substrates in vivo. Moreover, 
an alteration in cleavage specificity was observed with change in overhang sequence from 6-base 
adenine (short A substrate) to 6-base thymidine (short T substrate) (Fig. 4-20). In case of the 
short T substrate, Metnase cleaved with higher intensity one base closer to the 3ʹ-terminus than 
the short A substrate and also generated a hot-spot of cleavage at the double-stranded region of 
DNA. Moreover in all cases (Fig 4-19, 4-20), 2-3 nucleotides from the extreme end were 
excluded from Metnase-mediated cleavage. If Metnase loads onto  DNA overhangs from 
extreme ends then these discrepancies could be explained by differences in positioning of the 
Metnase active site (D483, D575 and N610) over different substrates (Goodwin et al. 2010). 
Based on crystal structure, Metnase was also proposed to act on DNA ends as a dimer (Goodwin 
et al. 2010) and the interaction energies of the dimer could be different for purines than 
pyrimidines. This along with deoxyribose base-stacking differences could result in more Metnase 
binding to dsDNA region than ssDNA overhang composed of thymidines and hence the cleavage 
difference (Goodwin et al. 2010, Kool 2001). However, the effect of base stacking differences 
and active site interactions has been more extensively studied for DNA replication than DNA 
cleavage.  
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When the 3ʹ-OH was replaced by 3ʹ-PG (deoxyribose C-4ʹ oxidation product), the cleavage was 
still dependent upon overhang length and in some cases presence of the modified end itself (Fig. 
4-21A-G). For 3ʹ-blocking PG moieties on short 3ʹ-overhangs closer to duplex DNA region (≤ 3 
bases) the predominant resection was in the dsDNA region compared to a 3ʹ-OH substrate that 
was cleaved to generate a product pattern consistent with cleavage in both ssDNA and dsDNA 
regions. For 3ʹ-PG moieties on 3ʹ-overhangs ≥ 4-base, resection was predominantly in the 
ssDNA region. A 3ʹ-PG-containing 4-base overhang was cleaved with greater intensity than a 
corresponding 3ʹ-OH containing substrate. Metnase cleaved only on the ssDNA region of a 6-
base overhang with 3ʹ-PG ends. These results may suggest that a minimum of 4-base overhang 
region may be required to load Metnase to DNA ends. Moreover, an oxidatively modified DNA 
end like the 3ʹ-PG moiety stimulates Metnase mediated resection and alters specificity, 
indicating that these damaged ends may be physiologically relevant substrates for Metnase 
processing following radiation or radiomimetic drug exposure. Metnase-mediated resection of 3ʹ-
PG ends increased by more than 5 fold with increase in overhang length from 1-base to 6-base 
(Fig. 4-21G). Long 3ʹ-overhangs with blocked termini are especially difficult to repair and can 
preclude NHEJ unless resolved. Artemis has been shown to trim such longer overhangs into 
ligatable ends, however most DNA DSBs do not require Artemis for repair. Such breaks may be 
amenable to resection by Metnase before gap filling and ligation in an alternative NHEJ pathway 
independent of Artemis. Alternatively, the longer 3ʹ-overhangs may be trimmed to 3-4 bases by 
Metnase before further processing by Artemis:DNA-PK complex. 
Most of the radiation-induced DNA damage sites rarely consist only of DSBs with 3ʹ-PG 
ends, and are often accompanied with base damage in close proximity to the DSB with modified 
termini (Asaithamby, Chen 2011). More commonly, damaged nucleobases are resolved by the 
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base excision repair pathway, however if the nucleobase damage is in the vicinity of a break, it is 
more likely to be removed by NHEJ endonucleases (Dobbs et al. 2008). Since such breaks are 
critical determinants of cell survival, two different plasmid length substrates were constructed 
with either an 8-oxoguanine or a thymidine glycol residue positioned 5ʹ to a 3-base 3ʹ-overhang. 
Neither stimulation nor alteration of Metnase activity was observed for the 8-oxoguanine 
substrate which showed comparable product pattern as a normal guanine containing DNA (Fig. 
4-21C, D). Interestingly, the same substrate stimulated Artemis-mediated resection of 2 terminal 
nucleotides from the 3ʹ-end but required the presence of both Ku and DNA-PK for maximal 
endonuclease activity (Fig. 4-17). Since there was no increased Artemis activity for removal of 
the 8-oxoguanine residue itself, Artemis mediated processing may precede 8-oxoguanine 
removal from DNA ends by other repair factors, or the lesion itself may be bypassed by the 
repair machinery.  Conversely, thymidine glycol severely blocked both Metnase and 
Artemis:DNA-PK:Ku endonuclease activity (Fig. 4-18 and Fig. 4-22). The normal thymidine- 
containing substrate showed a product distribution indicating endonucleolytic nucleotide 
removal from the DNA ends, while for the thymidine glycol substrate there was a substantial 
decrease in resection. Since thymidine glycol is non-planar, it may offer a more severe block 
than the 8-oxoguanine residue (Zhou et al. 2008) and thus require other NHEJ factors for 
resolution. 
 Ku and DNA-PK are considered to be the first proteins that are recruited to DSBs in the 
canonical NHEJ pathway; hence we investigated whether Metnase nuclease activity is affected 
by the presence of these proteins. On a 12-base 3ʹ-overhang, Metnase activity was unaffected by 
Ku alone but was reduced to ~75-80% when DNA-PK was added to the reaction. Though, 
DNase footprint assays revealed that Ku:DNA-PK holoenzyme can occupy 30 bp from the end 
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of dsDNA (Povirk & Valerie 2003), the affinity of this enzyme for binding to long ssDNA 
overhangs is unknown. Our S1-Nuclease footprint analysis revealed partial protection of DNA 
ends by the presence of Ku:DNA-PK holoenzyme, while Ku alone had no protective effect (Fig. 
4-23). This suggests that Ku when present alone may slide to the interior of the break, and is 
partially retained at the ends when present in a complex with DNA-PK. Thus, unlike Artemis, 
Metnase activity was not stimulated by DNA-PK and Ku, however the protection of the ssDNA 
overhang towards Metnase-mediated resection was lower when compared to that of S1-nuclease. 
Thus Metnase may be involved in alternative Ku:DNA-PK independent backup NHEJ pathways 
for repair of DNA DSBs (Wang et al. 2003). Metnase-mediated end processing may precede Ku 
and DNA-PK recruitment at DNA DSBs. Once Ku and DNA-PK are recruited to DNA ends, 
further processing may occur in an Artemis-dependent pathway. 
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VI. CONCLUDING HYPOTHESIS AND FUTURE PERSPECTIVES 
 
Considering the known literature and our own results, it is also tempting to speculate on a 
model NHEJ repair mechanism involving processing of the ends by Metnase and Artemis. 
Following induction of blocked DNA DSBs by ionizing radiation or radiomimetics, Metnase 
may be recruited to the DNA damage sites in presence of hPso4 (Beck et al. 2008). Damage-
induced Chk1-mediated phosphorylation at S495 residue has been shown to aid in recruitment of 
the Metnase to DNA (Hromas et al. 2012). Our results show that Metnase nuclease domain 
mediated end-processing can resect both 3ʹ-hydroxyl and 3ʹ-PG containing DNA ends (Fig 4-19 
4-20, 4-21). Phosphoglycolate moieties on long 3ʹ-overhangs are particularly favorable Metnase 
substrates in vitro. If the generated DNA ends are compatible, then further end-processing may 
not be necessary and the re-joining can occur by the alternate NHEJ pathway. Moreover, 
Metnase SET domain mediated dimethylation close to the damage site has been shown to 
enhance association of Ku 70/80 heterodimer and MRN complex to DNA ends (Fnu et al. 2011). 
Mis-matched DNA ends require XRCC4 and XLF recruitment for alignment followed by gap 
filling by DNA polymerases λ and μ and ligation in presence of DNA ligase IV for re-joining. 
Experiments involving incubation of substrates with Metnase in presence of NHEJ factors Ku 
and DNA-PK suggest that although Metnase can resect ssDNA overhangs in the presence of 
these proteins at DNA ends, maximal resection occurs when the overhangs are not protected (Fig 
4-23). Thus, Metnase could be an early-response NHEJ factor and with most
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Figure 6-1. Proposed model of Metnase and Artemis dependent NHEJ pathway. 
DNA DSBs originating from radiation exposure presumably bear 3ʹ-PG blocked 3ʹ-
overhangs. DNA damage induced Chk1 mediated phosphorylation of Metnase at S495 
can facilitate Metnase:hPso4 complex recruitment to DNA ends. If Metnase can resolve 
these modified DNA termini into compatible ligatable ends that do not require further 
processing, they can be repaired through Alternate-NHEJ pathway. Metnase mediated 
dimethylation at H3K36 can facilitate recruitment of Ku:DNA-PK and MRN complex 
followed by repair via canonical NHEJ pathway. However, DSBs originating in the 
heterochromatin or complex DSBs associated with nucleobase damage require Artemis-
mediated endonucleolytic processing for re-joining and show slow overall repair kinetics. 
The slow-repairing subset of DSBs form large γ-H2AX foci, especially if functional 
Artemis is not present and juxtapose with PML-NBs at later time points. If the DSBs still 
remain unrepaired then the pro-apoptotic machinery in PML-NBs may drive cells towards 
cell death. 
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of the Metnase-mediated processing possibly occuring before recruitment of Ku and DNA-PK to 
DNA-ends and on longer overhangs that may not be efficiently bound by these proteins. The 
longer overhangs may be trimmed to shorter more easily ligatable ends facilitating further 
processing through the canonical end-joining pathway.  
 While this work has shown that Metnase endonuclease activity can trim blocked 3ʹ-PG 
DSB ends, whether this activity can facilitate end joining needs to be investigated. A D483 
residue in the DDE motif of the protein is known to be essential for the Metnase endonuclease 
activity and a D483A mutant Metnase has no detectable cleavage function (Fig. 4-21E). Recently 
solved crystal structure of Metnase also suggests that dimerization of the protein may be required 
for optimal DNA binding and cleavage activities (Goodwin et al. 2010). A phenylalanine 460 
residue was considered essential for dimerization and the F460K mutation was shown to 
preclude formation of the Metnase dimer and inhibited ssDNA cleavage activity using oligomers. 
In vitro end-joining assays with cell extracts complemented with either D483A (endonuclease 
deficient) or F460K (dimerization deficient) mutant Metnase and WT Metnase may further 
clarify if cleavage of blocked DNA ends by Metnase can facilitate NHEJ. Though the present 
evidence suggests that a Metnase monomer may not be able to bind DNA and stimulate end-
joining, addition of Metnase interacting proteins like hPso4 to the end-joining reactions may 
demonstrate if the monomeric protein can be recruited to DNA ends and retain activity. Further, 
generation of D483A mutant (endonuclease deficient) and WT Metnase expressing cell lines 
may clarify whether the endonuclease activity of the protein is an important determinant of cell 
survival following genotoxic insult. However, due to the unavailability of Metnase null or 
knockout cell lines, these experiments may be inconclusive. Moreover, DSBs associated with 
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nucleobase damage are not ideal Metnase substrates (Fig. 4-21C and 4-22) suggesting that end-
processing by other NHEJ factors  may be required to resolve complex DNA DSBs. 
 Results in this thesis also suggest that a fraction of DSBs with chemically modified 
termini require Artemis endonuclease activity for repair in G1 (Fig 4-7). This subset of breaks 
could either be DSBs arising in the heterochromatin that is exclusively accessible to Artemis or 
could be regions of complex DNA damage that may indispensably require Artemis for resolution 
(Riballo et al. 2004, Beucher et al. 2009, Goodarzi et al. 2008). If the 10-20% DSBs that fail to 
rejoin are heterochromatic then euchromatinization of DNA using a histone deacetylase inhibitor 
should reduce heterochromatic DNA in cells and lead to efficient repair even in the absence of 
Artemis. Double-immunostaining experiments using anti-Tri-Me K9 Histone H3 and γ-H2AX 
antibody could reveal the percentage of residual foci co-localizing to the regions of 
heterochromatic DNA. Alternatively, the residual breaks could be separated using pulsed field 
gel electrophoresis, Southern blotted and probed with α-satellite DNA probe to identify the 
fraction of heterochromatic DNA remaining un-rejoined. If the subset of breaks that are 
unrepaired at later times are clustered DNA damage with 3ʹ-PGs and 8-oxoguanine in close 
proximity, as is suggested in this dissertation work, then treating Artemis deficient cells with I
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an auger electron emitter that produces such breaks should increase the number of residual foci. 
In any case, evidence from both in vivo and in vitro work performed here indicate that this 
Artemis dependent pathway for resection of damaged DNA also requires Ku and DNA-PK with 
recruitment of MRN complex, 53BP1 and at later time points PML-NBs. The complete failure of 
endonuclease-deficient Artemis to improve survival suggests that lack of end-processing by this 
endonuclease can fully account for the chemo/radiosensitivity conferred by Artemis deficiency. 
In case the DSBs are not repaired for extended times then constituent pro-apoptotic proteins of 
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PML-NBs may lead cells into apoptosis. It is still unknown whether Metnase can compensate for 
Artemis deficiency in resolving residual DSBs though current evidence suggests that such a 
possibility may not exist due to differences in substrate requirements and differing partner-
protein interactions. However, expression of WT Metnase in CJ179 (Artemis null cell lines) cells 
followed by exposure to ionizing radiation may clarify whether Metnase can replace Artemis in 
the NHEJ sub-pathway for repair of DSBs showing a slow-repair kinetics. 
Clinically, radiation along with concomitant chemotherapy is the mainstay for therapeutic 
intervention of many types of cancer and the most clinically significant lesions resulting from 
such therapy are DNA DSBs that often bear chemically modified end-termini, most commonly a 
3ʹ-PG moiety. The ability of cancer cells to recognize and remove such cytotoxic DNA damage 
by employing DNA repair pathways like NHEJ plays a key role in resistance to 
radio/chemotherapy (Helleday et al. 2007, Helleday et al. 2008). Thus inhibitors of DNA repair 
may improve the therapeutic efficacy when used in combination with radiation or other DNA 
damaging agents. An ATM inhibitor developed by KUDOS pharmaceuticals (KU55933) is 
already being tested for radiosensitizing glioblastomas. Several DNA-PK inhibitors have also 
been developed (NU7441, KU57788) 
But DNA repair pathways are highly complex, mutually collaborative, and 
interconnected. A given DNA lesion can be processed through multiple redundant repair 
pathways (multiple NHEJ pathways exist, see Fig. 6-1) and a single DNA repair protein may 
resolve different kinds of DNA lesions (Artemis can process 3ʹ-PG ends and 8-oxoguanine 
residues, APE1 functions in BER and alt-NHEJ). Removal of the 3ʹ-blockade is an essential step 
in DSB repair by NHEJ that could be manipulated as a potential target for improving therapeutic 
index of the currently available radiotherapeutic regimen (Dexheimer et al. 2008). The exclusive 
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requirement of Artemis for repair of ~20% DNA DSB (presumably heterochromatic or complex 
DNA damage) following radiation exposure leading to 2-3 fold increase in radiosensitivity on 
Artemis deficiency makes it an ideal target for development of inhibitors which could be used as 
radiosensitizers. However the crystal structure of Artemis is yet unknown precluding targeted 
development of inhibitors for the protein. This thesis demonstrates complete loss of Artemis 
endonucleolytic activity on mutation of a single asparatic acid residue at 165 position to 
asparagine (D165N). Expression of the D165N protein fails to rescue the repair defect and 
restore survival in Artemis deficient cells exposed to ionizing radiation or radiomimetic 
chemotherapeutics. Since the D165N residue is not present in the available crystal structures of 
other metallo-β-lactamase family of proteins, but is indispensable for Artemis endonuclease 
function, it may be a good target for development of Artemis inhibitors. However, Artemis is 
essential for V(D)J recombination and antibody diversity. This constitutive Artemis function will 
need to be considered before any therapeutic drug development can occur. But if Artemis 
inhibition were restricted to a short time period before and after irradiation, effects on overall 
immunity would be minimal. Moreover, it is unknown if the cells can eventually compensate for 
the loss of protein by overexpressing other candidate nucleases like Metnase. Thus, more work 
for a better understanding of the various functions of NHEJ proteins and inter-relationships 
between various NHEJ pathways is essential before further clinical development for achievement 
of the desired therapeutic outcome. 
130 
 
 
 
REFERENCES 
Abraham, R.T. 2001, "Cell cycle checkpoint signaling through the ATM and ATR kinases", 
Genes & Development, vol. 15, no. 17, pp. 2177-2196.  
Ahnesorg, P., Smith, P. & Jackson, S.P. 2006, "XLF interacts with the XRCC4-DNA ligase IV 
complex to promote DNA nonhomologous end-joining", Cell, vol. 124, pp. 301-313.  
Akopiants, K., Zhou, R.Z., Mohapatra, S., Valerie, K., Lees-Miller, S.P., Lee, K.J., Chen, D.J., 
Revy, P., de Villartay, J.P. & Povirk, L.F. 2009, "Requirement for XLF/Cernunnos in 
alignment-based gap filling by DNA polymerases lambda and mu for nonhomologous end 
joining in human whole-cell extracts", Nucleic Acids Research, vol. 37, no. 12, pp. 4055-
4062.  
Allen, C., Kurimasa, A., Brenneman, M.A., Chen, D.J. & Nickoloff, J.A. 2002, "DNA-dependent 
protein kinase suppresses double-strand break-induced and spontaneous homologous 
recombination", Proceedings of the National Academy of Sciences of the United States of 
America, vol. 99, no. 6, pp. 3758-3763.  
Aller, P., Rould, M.A., Hogg, M., Wallace, S.S. & Doublie, S. 2007, "A structural rationale for 
stalling of a replicative DNA polymerase at the most common oxidative thymine lesion, 
thymine glycol", Proceedings of the National Academy of Sciences of the United States of 
America, vol. 104, pp. 814-818.  
Andres, S.N., Modesti, M., Tsai, C.J., Chu, G. & Junop, M.S. 2007, "Crystal structure of human 
XLF: a twist in nonhomologous DNA end- joining", Molecular Cell, vol. 28, pp. 1093-
1101.  
Asaithamby, A. & Chen, D.J. 2011, "Mechanism of cluster DNA damage repair in response to 
high-atomic number and energy particles radiation", Mutation Research, vol. 711, no. 1-2, 
pp. 87-99.  
Aten, J.A., Stap, J., Krawczyk, P.M., van Oven, C.H., Hoebe, R.A., Essers, J. & Kanaar, R. 
2004, "Dynamics of DNA double-strand breaks revealed by clustering of damaged 
chromosome domains", Science (New York, N.Y.), vol. 303, no. 5654, pp. 92-95.  
Bakkenist, C.J. & Kastan, M.B. 2003, "DNA damage activates ATM through intermolecular 
autophosphorylation and dimer dissociation", Nature, vol. 421, pp. 499-506.  
131 
 
Baumann, P. & West, S.C. 1998, "Role of the human RAD51 protein in homologous 
recombination and double- stranded-break repair", Trends in Biochemical Sciences, vol. 23, 
pp. 247-251.  
Beck, B.D., Lee, S.S., Williamson, E., Hromas, R.A. & Lee, S.H. 2011, "Biochemical 
characterization of metnase's endonuclease activity and its role in NHEJ repair", 
Biochemistry, vol. 50, no. 20, pp. 4360-4370.  
Beck, B.D., Park, S.J., Lee, Y.J., Roman, Y., Hromas, R.A. & Lee, S.H. 2008, "Human Pso4 Is a 
Metnase (SETMAR)-binding Partner That Regulates Metnase Function in DNA Repair", 
Journal of Biological Chemistry, vol. 283, pp. 9023-9030.  
Bernardi, R. & Pandolfi, P.P. 2007, "Structure, dynamics and functions of promyelocytic 
leukaemia nuclear bodies", Nature Reviews.Molecular Cell Biology, vol. 8, no. 12, pp. 
1006-1016.  
Beucher, A., Birraux, J., Tchouandong, L., Barton, O., Shibata, A., Conrad, S., Goodarzi, A.A., 
Krempler, A., Jeggo, P.A. & Lobrich, M. 2009, "ATM and Artemis promote homologous 
recombination of radiation-induced DNA double-strand breaks in G2", The EMBO Journal, 
vol. 28, no. 21, pp. 3413-3427.  
Bischof, O., Kim, S.H., Irving, J., Beresten, S., Ellis, N.A. & Campisi, J. 2001, "Regulation and 
localization of the Bloom syndrome protein in response to DNA damage", The Journal of 
Cell Biology, vol. 153, no. 2, pp. 367-380.  
Boe, S.O., Haave, M., Jul-Larsen, A., Grudic, A., Bjerkvig, R. & Lonning, P.E. 2006, 
"Promyelocytic leukemia nuclear bodies are predetermined processing sites for damaged 
DNA", Journal of Cell Science, vol. 119, no. Pt 16, pp. 3284-3295.  
Boisvert, F.M., Hendzel, M.J. & Bazett-Jones, D.P. 2000, "Promyelocytic leukemia (PML) 
nuclear bodies are protein structures that do not accumulate RNA", The Journal of Cell 
Biology, vol. 148, no. 2, pp. 283-292.  
Boskovic, J., Rivera-Calzada, A., Maman, J.D., Chacon, P., Willison, K.R., Pearl, L.H. & Llorca, 
O. 2003, "Visualization of DNA-induced conformational changes in the DNA repair kinase 
DNA-PKcs", The EMBO Journal, vol. 22, no. 21, pp. 5875-5882.  
Britton, S., Frit, P., Biard, D., Salles, B. & Calsou, P. 2009, "ARTEMIS nuclease facilitates 
apoptotic chromatin cleavage", Cancer Research, vol. 69, no. 20, pp. 8120-8126.  
Bryans, M., Valenzano, M.C. & Stamato, T.D. 1999, "Absence of DNA ligase IV protein in XR-
1 cells: evidence for stabilization by XRCC4", Mutation Research, vol. 433, pp. 53-58.  
Buck, D., Malivert, L., de Chasseval, R., Barraud, A., Fondaneche, M.C., Sanal, O., Plebani, A., 
Stephan, J.L., Hufnagel, M., Le Deist, F., Fischer, A., Durandy, A., de Villartay, J.P. & 
132 
 
Revy, P. 2006, "Cernunnos, a novel nonhomologous end-joining factor, is mutated in human 
immunodeficiency with microcephaly", Cell, vol. 124, pp. 287-299.  
Burma, S., Chen, B.P., Murphy, M., Kurimasa, A. & Chen, D.J. 2001, "ATM Phosphorylates 
Histone H2AX in Response to DNA Double-strand Breaks", Journal of Biological 
Chemistry, vol. 276, no. 45, pp. 42462-42467.  
Cabuy, E., Newton, C., Joksic, G., Woodbine, L., Koller, B., Jeggo, P.A. & Slijepcevic, P. 2005, 
"Accelerated telomere shortening and telomere abnormalities in radiosensitive cell lines", 
Radiation Research, vol. 164, no. 1, pp. 53-62.  
Callebaut, I., Moshous, D., Mornon, J.P. & de Villartay, J.P. 2002, "Metallo-beta-lactamase fold 
within nucleic acids processing enzymes: the beta-CASP family", Nucleic Acids Research, 
vol. 30, no. 16, pp. 3592-3601.  
Callebaut I, Malivert L, Fischer A, Mornon JP, Revy P, de Villartay JP. 2006, "Cernunnos 
interacts with XRCC4xDNA-Ligase IV complex and is homologous to yeast 
nonhomologous end-joining factor Nej1. Journal of Biological Chemistry, vol 281 pp. 
13857-13860. 
Carbone, R., Pearson, M., Minucci, S. & Pelicci, P.G. 2002, "PML NBs associate with the 
HMre11 complex and p53 at sites of irradiation induced DNA damage", Oncogene, vol. 21, 
no. 11, pp. 1633.  
Chen, B., Zhou, X., Taghizadeh, K., Chen, J., Stubbe, J. & Dedon, P.C. 2007, "GC/MS methods 
to quantify the 2-deoxypentos-4-ulose and 3'-phosphoglycolate pathways of 4' oxidation of 
2-deoxyribose in DNA: application to DNA damage produced by γ-radiation and 
bleomycin", Chemical Research in Toxicology, vol. 20, pp. 1701-1708.  
Chen, B.P., Chan, D.W., Kobayashi, J., Burma, S., Asaithamby, A., Morotomi-Yano, K., 
Botvinick, E., Qin, J. & Chen, D.J. 2005, "Cell cycle dependence of DNA-dependent protein 
kinase phosphorylation in response to DNA double strand breaks", The Journal of 
Biological Chemistry, vol. 280, no. 15, pp. 14709-14715.  
Chen, F., Nastasi, A., Shen, Z., Brenneman, M., Crissman, H. & Chen, D.J. 1997, "Cell cycle-
dependent protein expression of mammalian homologs of yeast DNA double-strand break 
repair genes Rad51 and Rad52", Mutation Research/DNA Repair, vol. 384, no. 3, pp. 205-
211.  
Chen, L., Morio, T., Minegishi, Y., Nakada, S., Nagasawa, M., Komatsu, K., Chessa, L., Villa, 
A., Lecis, D., Delia, D. & Mizutani, S. 2005, "Ataxia-telangiectasia-mutated dependent 
phosphorylation of Artemis in response to DNA damage", Cancer Sci., vol. 96, pp. 134-141.  
Chen, L., Nievera, C.J., Lee, A.Y. & Wu, X. 2008, "Cell cycle-dependent complex formation of 
BRCA1.CtIP.MRN is important for DNA double-strand break repair", The Journal of 
Biological Chemistry, vol. 283, no. 12, pp. 7713-7720.  
133 
 
Chen, L., Trujillo, K., Sung, P. & Tomkinson, A.E. 2000, "Interactions of the DNA ligase IV-
XRCC4 complex with DNA ends and the DNA-dependent protein kinase", Journal of 
Biological Chemistry, vol. 275, pp. 26196-26205.  
Critchlow, S.E., Bowater, R.F., Jackson, S.F. 1997, "Mammalian double-strand break repair 
protein XRCC4 interacts with DNA-ligase IV. Current Biology, vol. 7, pp. 588-598. 
Datta, K., Purkayastha, S., Neumann, R.D., Pastwa, E. & Winters, T.A. 2011, "Base damage 
immediately upstream from double-strand break ends is a more severe impediment to 
nonhomologous end joining than blocked 3'-termini", Radiation Research, vol. 175, no. 1, 
pp. 97-112.  
De Bont, R. & van Larebeke, N. 2004, "Endogenous DNA damage in humans: a review of 
quantitative data", Mutagenesis, vol. 19, no. 3, pp. 169-185.  
De Haro, L.P., Wray, J., Williamson, E.A., Durant, S.T., Corwin, L., Gentry, A.C., Osheroff, N., 
Lee, S.H., Hromas, R. & Nickoloff, J.A. 2010, "Metnase promotes restart and repair of 
stalled and collapsed replication forks", Nucleic Acids Research, vol. 38, no. 17, pp. 5681-
5691.  
de Villartay, J.P., Shimazaki, N., Charbonnier, J.B., Fischer, A., Mornon, J.P., Lieber, M.R. & 
Callebaut, I. 2009, "A histidine in the beta-CASP domain of Artemis is critical for its full in 
vitro and in vivo functions", DNA Repair, vol. 8, no. 2, pp. 202-208.  
Dedon, P.C. & Goldberg, I.H. 1992, "Free-radical mechanisms involved in the formation of 
sequence- dependent bistranded DNA lesions by the antitumor antibiotics bleomycin, 
neocarzinostatin, and calicheamicin", Chemical Research in Toxicology, vol. 5, pp. 311-332.  
Dedon, P.C. & Goldberg, I.H. 1990, "Sequence-specific double-strand breakage of DNA by 
neocarzinostatin involves different chemical mechanisms with a staggered cleavage site", 
Journal of Biological Chemistry, vol. 265, pp. 14713-14716.  
Dellaire, G. & Bazett-Jones, D.P. 2004, "PML nuclear bodies: dynamic sensors of DNA damage 
and cellular stress", BioEssays : News and Reviews in Molecular, Cellular and 
Developmental Biology, vol. 26, no. 9, pp. 963-977.  
Dellaire, G., Ching, R.W., Ahmed, K., Jalali, F., Tse, K.C., Bristow, R.G. & Bazett-Jones, D.P. 
2006, "Promyelocytic leukemia nuclear bodies behave as DNA damage sensors whose 
response to DNA double-strand breaks is regulated by NBS1 and the kinases ATM, Chk2, 
and ATR", The Journal of Cell Biology, vol. 175, no. 1, pp. 55-66.  
Demple, B. & Harrison, L. 1994a, "Repair of oxidative damage to DNA: Enzymology and 
biology", Ann.Rev.Biochem., vol. 63, pp. 915-948.  
Demple, B. & Harrison, L. 1994b, "Repair of oxidative damage to DNA: enzymology and 
biology", Annual Review of Biochemistry, vol. 63, pp. 915-948.  
134 
 
Desai-Mehta, A., Cerosaletti, K.M. & Concannon, P. 2001, "Distinct functional domains of 
nibrin mediate Mre11 binding, focus formation, and nuclear localization", Molecular and 
Cellular Biology, vol. 21, no. 6, pp. 2184-2191.  
Deshpande, R.A. & Wilson, T.E. 2007, "Modes of interaction among yeast Nej1, Lif1 and Dnl4 
proteins and comparison to human XLF, XRCC4 and Lig4", DNA Repair, vol. 6, no. 10, pp. 
1507-1516.  
Dever, S.M., Golding, S.E., Rosenberg, E., Adams, B.R., Idowu, M.O., Quillin, J.M., Valerie, 
N., Xu, B., Povirk, L.F. & Valerie, K. 2011, "Mutations in the BRCT binding site of 
BRCA1 result in hyper-recombination", Aging, vol. 3, no. 5, pp. 515-532.  
Dexheimer, T.S., Antony, S., Marchand, C. & Pommier, Y. 2008, "Tyrosyl-DNA 
Phosphodiesterase as a Target for Anticancer Therap", Anticancer Agents Med.Chem., vol. 
8, pp. 381-389.  
Dobbs, T.A., Palmer, P., Maniou, Z., Lomax, M.E. & O'Neill, P. 2008, "Interplay of two major 
repair pathways in the processing of complex double-strand DNA breaks", DNA Repair, vol. 
7, no. 8, pp. 1372-1383.  
Dronkert, M.L., Beverloo, H.B., Johnson, R.D., Hoeijmakers, J.H., Jasin, M. & Kanaar, R. 2000, 
"Mouse RAD54 affects DNA double-strand break repair and sister chromatid exchange", 
Molecular and Cellular Biology, vol. 20, no. 9, pp. 3147-3156.  
Drouet, J., Frit, P., Delteil, C., de Villartay, J.P., Salles, B. & Calsou, P. 2006, "Interplay 
between Ku, artemis and DNA-PKcs at DNA ends", Journal of Biological Chemistry, vol. 
281, pp. 27784-27793.  
Durocher, D. & Jackson, S.P. 2001, "DNA-PK, ATM and ATR as sensors of DNA damage: 
variations on a theme?", Current Opinion in Cell Biology, vol. 13, pp. 225-231.  
Elliott, B., Richardson, C. & Jasin, M. 2005, "Chromosomal translocation mechanisms at 
intronic alu elements in mammalian cells", Molecular Cell, vol. 17, pp. 885-894.  
Falck, J., Coates, J. & Jackson, S.P. 2005, "Conserved modes of recruitment of ATM, ATR and 
DNA-PKcs to sites of DNA damage", Nature, vol. 434, no. 7033, pp. 605-611.  
Fernandez-Capetillo, O. & Nussenzweig, A. 2008, "ATM breaks into heterochromatin", 
Molecular Cell, vol. 31, no. 3, pp. 303-304.  
Fnu, S., Williamson, E.A., De Haro, L.P., Brenneman, M., Wray, J., Shaheen, M., 
Radhakrishnan, K., Lee, S.H., Nickoloff, J.A. & Hromas, R. 2011, "Methylation of histone 
H3 lysine 36 enhances DNA repair by nonhomologous end-joining", Proceedings of the 
National Academy of Sciences of the United States of America, vol. 108, no. 2, pp. 540-545.  
 
135 
 
Fouladi, B., Waldren, C.A., Rydberg, B. Cooper, P.K., "Comparision of repair of identical 
sequences in primary human fibroblasts and immortal hamster-humna hybrid cells harboring 
a single copy of human chromosome 11, Radiation Research, vol. 153, pp. 795-804. 
Franklin, R.E. & Gosling, R.G. 2003, "Molecular configuration in sodium thymonucleate. 1953", 
Nature, vol. 421, no. 6921, pp. 400-1; discussion 396.  
Geng, L., Zhang, X., Zheng, S. & Legerski, R.J. 2007, "Artemis links ATM to G2/M checkpoint 
recovery via regulation of Cdk1-cyclin B", Molecular and Cellular Biology, vol. 27, pp. 
2625-2635.  
Goodarzi, A.A., Noon, A.T., Deckbar, D., Ziv, Y., Shiloh, Y., Löbrich, M. & Jeggo, P.A. 2008, 
"ATM signaling facilitates repair of DNA double-strand breaks associated with 
heterochromatin", Molecular Cell, vol. 31, pp. 167-177.  
Goodarzi, A.A., Yu, Y., Riballo, E., Douglas, P., Walker, S.A., Ye, R., Harer, C., Marchetti, C., 
Morrice, N., Jeggo, P.A. & Lees-Miller, S.P. 2006, "DNA-PK autophosphorylation 
facilitates Artemis endonuclease activity", The EMBO Journal, vol. 25, pp. 3880-3889.  
Goodwin, K.D., He, H., Imasaki, T., Lee, S.H. & Georgiadis, M.M. 2010, "Crystal structure of 
the human Hsmar1-derived transposase domain in the DNA repair enzyme Metnase", 
Biochemistry, vol. 49, no. 27, pp. 5705-5713.  
Gottlieb, T.M. & Jackson, S.P. 1993, "The DNA-dependent protein kinase: requirement for DNA 
ends and association with Ku antigen", Cell, vol. 72, pp. 131-142.  
Grawunder, U., Wilm, M., Wu, X., Kulesza, P., Wilson, T.E., Mann, M. & Lieber, M.R. 1997, 
"Activity of DNA ligase IV stimulated by complex formation with XRCC4 protein in 
mammalian cells", Nature, vol. 388, pp. 492-495.  
Gu, J., Lu, H., Tsai, A.G., Schwarz, K. & Lieber, M.R. 2007, "Single-stranded DNA ligation and 
XLF-stimulated incompatible DNA end ligation by the XRCC4-DNA ligase IV complex: 
influence of terminal DNA sequence", Nucleic Acids Research, vol. 35, pp. 5755-5762.  
Gu, J., Li, S., Zhang, X., Wang, L., Niewolik, D., Schwarz, K., Legerski, R.J., Zandi, E. & 
Lieber, M.R. 2010, "DNA-PKcs regulates a single-stranded DNA endonuclease activity of 
Artemis", DNA Repair, vol. 9, no. 4, pp. 429-437.  
Guiochon-Mantel, A., Savouret, J.F., Quignon, F., Delabre, K., Milgrom, E. & De The, H. 1995, 
"Effect of PML and PML-RAR on the transactivation properties and subcellular distribution 
of steroid hormone receptors", Molecular Endocrinology (Baltimore, Md.), vol. 9, no. 12, 
pp. 1791-1803.  
Hammarsten, O. & Chu, G. 1998, "DNA-dependent protein kinase: DNA binding and activation 
in the absence of Ku", Proceedings of the National Academy of Sciences of the United States 
of America, vol. 95, pp. 525-530.  
136 
 
Hammarsten, O., DeFazio, L.G. & Chu, G. 2000, "Activation of DNA-dependent protein kinase 
by single-stranded DNA ends", Journal of Biological Chemistry, vol. 275, pp. 1541-1550.  
Haring, M., Rudiger, H., Demple, B., Boiteux, S. & Epe, B. 1994, "Recognition of oxidized 
abasic sites by repair endonucleases", Nucleic Acids Research, vol. 22, pp. 2010-2015.  
Hartley, K.O., Gell, D., Smith, G.C.M., Zhang, H., Divecha, N., Connelly, M.A., Admon, A., 
Less-Miller, S.P., Anderson, C.W. & Jackson, S.P. 1995, "DNA-dependent protein kinase 
catalytic subunit: A relative of phosphatidylinositol 3-kinase and the ataxia telangiectasisa 
gene product", Cell, vol. 82, pp. 849-856.  
Helleday, T., Lo, J., van Gent, D.C. & Engelward, B.P. 2007, "DNA double-strand break repair: 
from mechanistic understanding to cancer treatment", DNA Repair, vol. 6, pp. 923-935.  
Helleday, T., Petermann, E., Lundin, C., Hodgson, B. & Sharma, R.A. 2008, "DNA repair 
pathways as targets for cancer therapy", Nature Reviews.Cancer, vol. 8, no. 3, pp. 193-204.  
Henner, W.D., Rodriguez, L.O., Hecht, S.M. & Haseltine, W.A. 1983, "gamma-Ray induced 
deoxyribonucleic acid strand breaks. 3' glycolate termini", Journal of Biological Chemistry, 
vol. 258, pp. 711-713.  
Hopfner, K.P., Craig, L., Moncalian, G., Zinkel, R.A., Usui, T., Owen, B.A., Karcher, A., 
Henderson, B., Bodmer, J.L., McMurray, C.T., Carney, J.P., Petrini, J.H. & Tainer, J.A. 
2002, "The Rad50 zinc-hook is a structure joining Mre11 complexes in DNA recombination 
and repair", Nature, vol. 418, no. 6897, pp. 562-566.  
Hopfner, K.P., Karcher, A., Shin, D.S., Craig, L., Arthur, L.M., Carney, J.P. & Tainer, J.A. 2000, 
"Structural biology of Rad50 ATPase: ATP-driven conformational control in DNA double-
strand break repair and the ABC-ATPase superfamily", Cell, vol. 101, no. 7, pp. 789-800.  
Hromas, R., Williamson, E.A., Fnu, S., Lee, Y.J., Park, S.J., Beck, B.D., You, J.S., Laitao, A., 
Nickoloff, J.A. & Lee, S.H. 2012, "Chk1 phosphorylation of Metnase enhances DNA repair 
but inhibits replication fork restart", Oncogene, .  
Hromas, R., Wray, J., Lee, S.H., Martinez, L., Farrington, J., Corwin, L.K., Ramsey, H., 
Nickoloff, J.A. & Williamson, E.A. 2008, "The human set and transposase domain protein 
Metnase interacts with DNA Ligase IV and enhances the efficiency and accuracy of non-
homologous end-joining", DNA Repair, vol. 7, no. 12, pp. 1927-1937.  
Hsu, H.-., Yannone, S.M. & Chen, D.J. 2001, "Defining the interactions between DNA-PK and 
ligase IV/XRCC4", DNA Repair, vol. 1, pp. 225-235.  
Hutchinson, F. 1966, "The Molecular Basis for Radiation Effects on Cells", Cancer Research, 
vol. 26, no. 9 Part 1, pp. 2045-2052.  
137 
 
Iacovoni, J.S., Caron, P., Lassadi, I., Nicolas, E., Massip, L., Trouche, D. & Legube, G. 2010, 
"High-resolution profiling of gammaH2AX around DNA double strand breaks in the 
mammalian genome", The EMBO Journal, vol. 29, no. 8, pp. 1446-1457.  
Ibañez, I.L., Bracalente, C., Molinari, B.L., Palmieri, M.A., Policastro, L., Kreiner, A.J., Burlon, 
A.A., Valda, A., Navalesi, D., Davidson, J., Davidson, M., Vazquez, M., Ozafran, M. & 
Duran, H. 2009, "Induction and rejoining of DNA double strand breaks assessed by H2AX 
phosphorylation in melanoma cells irradiated with proton and lithium beams", International 
Journal of Radiation Oncology, Biology, Physics, vol. 74, no. 4, pp. 1226-1235.  
Inamdar, K.V., Pouliot, J.J., Zhou, T., Lees-Miller, S.P., Rasouli-Nia, A. & Povirk, L.F. 2002, 
"Conversion of phosphoglycolate to phosphate termini on 3' overhangs of DNA double-
strand breaks by the human tyrosyl-DNA phosphodiesterase hTdp1", Journal of Biological 
Chemistry, vol. 276, pp. 24323-24330.  
Ira, G., Pellicioli, A., Balijja, A., Wang, X., Fiorani, S., Carotenuto, W., Liberi, G., Bressan, D., 
Wan, L., Hollingsworth, N.M., Haber, J.E. & Foiani, M. 2004, "DNA end resection, 
homologous recombination and DNA damage checkpoint activation require CDK1", 
Nature, vol. 431, no. 7011, pp. 1011-1017.  
Jackson, S.P. 2002, "Sensing and repairing DNA double-strand breaks", Carcinogenesis, vol. 23, 
pp. 687-696.  
Jasin, M. 2000, "Chromosome breaks and genomic instability", Cancer Investigation, vol. 18, 
pp. 78-86.  
Jilani, A., Ramotar, D., Slack, C., Ong, C., Yang, X.M., Scherer, S.W. & Lasko, D.D. 1999, 
"Molecular cloning of the human gene, PNKP, encoding a polynucleotide kinase 3'-
phosphatase and evidence for its role in repair of DNA strand breaks caused by oxidative 
damage", Journal of Biological Chemistry, vol. 274, pp. 24176-24186.  
Johzuka, K. & Ogawa, H. 1995, "Interaction of Mre11 and Rad50: two proteins required for 
DNA repair and meiosis-specific double-strand break formation in Saccharomyces 
cerevisiae", Genetics, vol. 139, no. 4, pp. 1521-1532.  
Jovanovic, M. & Dynan, W.S. 2006, "Terminal DNA structure and ATP influence binding 
parameters of the DNA-dependent protein kinase at an early step prior to DNA synapsis", 
Nucleic Acids Research, vol. 34, no. 4, pp. 1112-1120.  
Kanikarla-Marie, P., Ronald, S. & De Benedetti, A. 2011, "Nucleosome resection at a double-
strand break during Non-Homologous Ends Joining in mammalian cells - implications from 
repressive chromatin organization and the role of ARTEMIS", BMC Research Notes, vol. 4, 
pp. 13.  
Karran, P. 2000, "DNA double strand break repair in mammalian cells", Current Opinion in 
Genetics & Development, vol. 10, pp. 144-150.  
138 
 
Kinner, A., Wu, W., Staudt, C. & Iliakis, G. 2008, "Gamma-H2AX in recognition and signaling 
of DNA double-strand breaks in the context of chromatin", Nucleic Acids Research, vol. 36, 
no. 17, pp. 5678-5694.  
Kobayashi, N., Agematsu, K., Sugita, K., Sako, M., Nonoyama, S., Yachie, A., Kumaki, S., 
Tsuchiya, S., Ochs, H.D., Sugita, K., Fukushima, Y. & Komiyama, A. 2003, "Novel 
Artemis gene mutations of radiosensitive severe combined immunodeficiency in Japanese 
families", Human Genetics, vol. 112, no. 4, pp. 348-352.  
Kool, E.T. 2001, "Hydrogen bonding, base stacking, and steric effects in dna replication", 
Annual Review of Biophysics and Biomolecular Structure, vol. 30, pp. 1-22.  
Krempler, A., Deckbar, D., Jeggo, P.A. & Löbrich, M. 2007, "An imperfect G2M checkpoint 
contributes to chromosome instability following irradiation of S and G2 phase cells", Cell 
Cycle (Georgetown, Tex.), vol. 6, no. 14, pp. 1682-1686.  
Lallemand-Breitenbach, V. & de Thé, H. 2010, "PML Nuclear Bodies", Cold Spring Harbor 
Perspectives in Biology, vol. 2, no. 5.  
Lamarche, B.J., Orazio, N.I. & Weitzman, M.D. 2010, "The MRN complex in double-strand 
break repair and telomere maintenance", FEBS Letters, vol. 584, no. 17, pp. 3682-3695.  
Leber, R., Wise, T.W., Mizuta, R. & Meek, K. 1998, "The XRCC4 gene product is a target for 
and interacts with the DNA-dependent protein kinase", Journal of Biological Chemistry, 
vol. 273, pp. 1794-1801.  
Lee, J.H., Goodarzi, A.A., Jeggo, P.A. & Paull, T.T. 2010, "53BP1 promotes ATM activity 
through direct interactions with the MRN complex", The EMBO Journal, vol. 29, no. 3, pp. 
574-585.  
Lee, J.W., Yannone, S.M., Chen, D.J. & Povirk, L.F. 2003, "Requirement for XRCC4 and DNA 
ligase IV in alignment-based gap filling for nonhomologous DNA end joining in vitro", 
Cancer Research, vol. 63, pp. 22-24.  
Lee, J. & Paull, T.T. 2004, "Direct Activation of the ATM Protein Kinase by the 
Mre11/Rad50/Nbs1 Complex", Science, vol. 304, no. 5667, pp. 93-96.  
Lee, K.J., Huang, J., Takeda, Y. & Dynan, W.S. 2000, "DNA ligase IV and XRCC4 form a 
stable mixed tetramer that functions synergistically with other repair factors in a cell- free 
end-joining system", Journal of Biological Chemistry, vol. 275, pp. 34787-34796.  
Lee, S.H., Oshige, M., Durant, S.T., Rasila, K.K., Williamson, E.A., Ramsey, H., Kwan, L., 
Nickoloff, J.A. & Hromas, R. 2005a, "The SET domain protein Metnase mediates foreign 
DNA integration and links integration to nonhomologous end-joining repair", Proceedings 
of the National Academy of Sciences of the United States of America, vol. 102, pp. 18075-
18080.  
139 
 
Lee, S.H., Oshige, M., Durant, S.T., Rasila, K.K., Williamson, E.A., Ramsey, H., Kwan, L., 
Nickoloff, J.A. & Hromas, R. 2005b, "The SET domain protein Metnase mediates foreign 
DNA integration and links integration to nonhomologous end-joining repair", Proceedings 
of the National Academy of Sciences of the United States of America, vol. 102, no. 50, pp. 
18075-18080.  
Lees-Miller, S.P., Chen, Y.R. & Anderson, C.W. 1990, "Human cells contain a DNA-activated 
protein kinase that phosphorylates simian virus 40 T antigen, mouse p53, and the human Ku 
autoantigen", Molecular and Cellular Biology, vol. 10, pp. 6472-6481.  
Leuther, K.K., Hammarsten, O., Kornberg, R.D. & Chu, G. 1999, "Structure of DNA-dependent 
protein kinase: implications for its regulation by DNA", The EMBO Journal, vol. 18, pp. 
1114-1123.  
Li, L., Salido, E., Zhou, Y., Bhattacharyya, S., Yannone, S.M., Dunn, E., Meneses, J., Feeney, 
A.J. & Cowan, M.J. 2005, "Targeted disruption of the Artemis murine counterpart results in 
SCID and defective V(D)J recombination that is partially corrected with bone marrow 
transplantation", Journal of immunology (Baltimore, Md.: 1950), vol. 174, pp. 2420-2428.  
Li, Z., Otevrel, T., Gao, Y., Cheng, H.L., Seed, B., Stamato, T.D., Taccioli, G.E. & Alt, F.W. 
1995, "The XRCC4 gene encodes a novel protein involved in DNA double- strand break 
repair and V(D)J recombination", Cell, vol. 83, pp. 1079-1089.  
Lieber, M.R. 2008, "The mechanism of human nonhomologous DNA end joining", The Journal 
of Biological Chemistry, vol. 283, no. 1, pp. 1-5.  
Lightfoot, J., Testori, S., Barroso, C. & Martinez-Perez, E. 2011, "Loading of meiotic cohesin by 
SCC-2 is required for early processing of DSBs and for the DNA damage checkpoint", 
Current Biology : CB, vol. 21, no. 17, pp. 1421-1430.  
Liu, H., Sun, X., Zhang, S., Ge, W., Zhu, Y., Zhang, J. & Zheng, S. 2011, "The dominant 
negative mutant Artemis enhances tumor cell radiosensitivity", Radiotherapy and Oncology 
: Journal of the European Society for Therapeutic Radiology and Oncology, vol. 101, no. 1, 
pp. 66-72.  
Llorca, O. & Pearl, L.H. 2004, "Electron microscopy studies on DNA recognition by DNA-PK", 
Micron (Oxford, England : 1993), vol. 35, no. 8, pp. 625-633.  
Lloyd, J., Chapman, J.R., Clapperton, J.A., Haire, L.F., Hartsuiker, E., Li, J., Carr, A.M., 
Jackson, S.P. & Smerdon, S.J. 2009, "A supramodular FHA/BRCT-repeat architecture 
mediates Nbs1 adaptor function in response to DNA damage", Cell, vol. 139, no. 1, pp. 100-
111.  
Ma, Y., Lu, H., Tippin, B., Goodman, M.F., Shimazaki, N., Koiwai, O., Hsieh, C.L., Schwarz, K. 
& Lieber, M.R. 2004, "A biochemically defined system for mammalian nonhomologous 
DNA end joining", Molecular Cell, vol. 16, pp. 701-713.  
140 
 
Ma, Y., Pannicke, U., Schwarz, K. & Lieber, M.R. 2002, "Hairpin opening and overhang 
processing by an Artemis/DNA- dependent protein kinase complex in nonhomologous end 
joining and V(D)J recombination", Cell, vol. 108, pp. 781-794.  
Ma, Y., Schwarz, K. & Lieber, M.R. 2005, "The Artemis:DNA-PKcs endonuclease cleaves DNA 
loops, flaps, and gaps", DNA Repair, vol. 4, pp. 845-851.  
Mancebo, E., Recio, M.J., Martinez-Busto, E., Gonzalez-Granado, L.I., Rojo, P., Fernandez-
Diaz, E., Ruiz-Contreras, J., Paz-Artal, E. & Allende, L.M. 2011, "Possible role of Artemis 
c.512C>G polymorphic variant in Omenn syndrome", DNA Repair, vol. 10, no. 1, pp. 3-4.  
Meek, K., Dang, V. & Lees-Miller, S.P. 2008, "DNA-PK: the means to justify the ends?", 
Advances in Immunology, vol. 99, pp. 33-58.  
Mimori, T. & Hardin, J.A. 1986, "Mechanism of interaction between Ku protein and DNA", 
Journal of Biological Chemistry, vol. 261, pp. 10375-10379.  
Mohapatra, S., Kawahara, M., Khan, I.S., Yannone, S.M. & Povirk, L.F. 2011, "Restoration of 
G1 chemo/radioresistance and double-strand-break repair proficiency by wild-type but not 
endonuclease-deficient Artemis", Nucleic Acids Research, vol. 39, no. 15, pp. 6500-6510.  
Moshous, D., Callebaut, I., de Chasseval, R., Corneo, B., Cavazzana-Calvo, M., Le Deist, F., 
Tezcan, I., Sanal, O., Bertrand, Y., Philippe, N., Fischer, A. & de Villartay, J.P. 2001, 
"Artemis, a novel DNA double-strand break repair/V(D)J recombination protein, is mutated 
in human severe combined immune deficiency", Cell, vol. 105, pp. 177-186.  
Moynahan, M.E., Chiu, J.W., Koller, B.H. & Jasin, M. 1999, "Brca1 controls homology-directed 
DNA repair", Molecular Cell, vol. 4, no. 4, pp. 511-518.  
Mozumder, A. 1985, "Early production of radicals from charged particle tracks in water", 
Radiation research.Supplement, vol. 8, pp. S33-9.  
Nick McElhinny, S.A., Snowden, C.M., McCarville, J. & Ramsden, D.A. 2000, "Ku recruits the 
XRCC4-ligase IV complex to DNA ends", Molecular and Cellular Biology, vol. 20, pp. 
2996-3003.  
Nikjoo, H., O'Neill, P., Goodhead, D.T. & Terrissol, M. 1997, "Computational modelling of low-
energy electron-induced DNA damage by early physical and chemical events", International 
Journal of Radiation Biology, vol. 71, pp. 467-483.  
Noguti, T. & Kada, T. 1975, "Studies on DNA repair in Bacillus subtilis. I. A cellular factor 
acting on gamma-irradiated DNA and promoting its priming activity for DNA polymerase 
I", Biochimica et Biophysica Acta, vol. 395, no. 3, pp. 284-293.  
Noon, A.T., Shibata, A., Rief, N., Löbrich, M., Stewart, G.S., Jeggo, P.A. & Goodarzi, A.A. 
2010, "53BP1-dependent robust localized KAP-1 phosphorylation is essential for 
141 
 
heterochromatic DNA double-strand break repair", Nature Cell Biology, vol. 12, no. 2, pp. 
177-184.  
Ogawa, H., Johzuka, K., Nakagawa, T., Leem, S.H. & Hagihara, A.H. 1995, "Functions of the 
yeast meiotic recombination genes, MRE11 and MRE2", Advances in Biophysics, vol. 31, 
pp. 67-76.  
Pannicke, U., Honig, M., Schulze, I., Rohr, J., Heinz, G.A., Braun, S., Janz, I., Rump, E.M., 
Seidel, M.G., Matthes-Martin, S., Soerensen, J., Greil, J., Stachel, D.K., Belohradsky, B.H., 
Albert, M.H., Schulz, A., Ehl, S., Friedrich, W. & Schwarz, K. 2010, "The most frequent 
DCLRE1C (ARTEMIS) mutations are based on homologous recombination events", Human 
Mutation, vol. 31, no. 2, pp. 197-207.  
Pannicke, U., Ma, Y., Hopfner, K.P., Niewolik, D., Lieber, M.R. & Schwarz, K. 2004, 
"Functional and biochemical dissection of the structure-specific nuclease ARTEMIS", The 
EMBO Journal, vol. 23, no. 9, pp. 1987-1997.  
Pauling, L. & Corey, R.B. 1951a, "Atomic coordinates and structure factors for two helical 
configurations of polypeptide chains", Proceedings of the National Academy of Sciences of 
the United States of America, vol. 37, no. 5, pp. 235-240.  
Pauling, L. & Corey, R.B. 1951b, "The pleated sheet, a new layer configuration of polypeptide 
chains", Proceedings of the National Academy of Sciences of the United States of America, 
vol. 37, no. 5, pp. 251-256.  
Pauling, L. & Corey, R.B. 1951c, "The polypeptide-chain configuration in hemoglobin and other 
globular proteins", Proceedings of the National Academy of Sciences of the United States of 
America, vol. 37, no. 5, pp. 282-285.  
Pauling, L. & Corey, R.B. 1951d, "The structure of feather rachis keratin", Proceedings of the 
National Academy of Sciences of the United States of America, vol. 37, no. 5, pp. 256-261.  
Pauling, L. & Corey, R.B. 1951e, "The structure of fibrous proteins of the collagen-gelatin 
group", Proceedings of the National Academy of Sciences of the United States of America, 
vol. 37, no. 5, pp. 272-281.  
Pauling, L. & Corey, R.B. 1951f, "The structure of hair, muscle, and related proteins", 
Proceedings of the National Academy of Sciences of the United States of America, vol. 37, 
no. 5, pp. 261-271.  
Pauling, L. & Corey, R.B. 1951g, "The structure of synthetic polypeptides", Proceedings of the 
National Academy of Sciences of the United States of America, vol. 37, no. 5, pp. 241-250.  
Paull, T.T. & Gellert, M. 1998, "The 3' to 5' exonuclease activity of Mre 11 facilitates repair of 
DNA double-strand breaks", Molecular Cell, vol. 1, pp. 969-979.  
142 
 
Pawelczak, K.S. & Turchi, J.J. 2010, "Purification and characterization of exonuclease-free 
Artemis: Implications for DNA-PK-dependent processing of DNA termini in NHEJ-
catalyzed DSB repair", DNA Repair, vol. 9, no. 6, pp. 670-677.  
Pierce, A.J., Hu, P., Han, M., Ellis, N. & Jasin, M. 2001, "Ku DNA end-binding protein 
modulates homologous repair of double-strand breaks in mammalian cells", Genes & 
Development, vol. 15, no. 24, pp. 3237-3242.  
Poinsignon, C., de Chasseval, R., Soubeyrand, S., Moshous, D., Fischer, A., Hache, R.J. & de 
Villartay, J.P. 2004a, "Phosphorylation of Artemis following irradiation-induced DNA 
damage", European Journal of Immunology, vol. 34, no. 11, pp. 3146-3155.  
Poinsignon, C., Moshous, D., Callebaut, I., de Chasseval, R., Villey, I. & de Villartay, J.P. 
2004b, "The metallo-beta-lactamase/beta-CASP domain of Artemis constitutes the catalytic 
core for V(D)J recombination", The Journal of Experimental Medicine, vol. 199, no. 3, pp. 
315-321.  
Povirk, L.F. 1996, "DNA damage and mutagenesis by radiomimetic DNA-cleaving agents: 
bleomycin, neocarzinostatin and other enediynes", Mutation Research, vol. 355, pp. 71-89.  
Povirk, L.F., Zhou, T., Zhou, R., Cowan, M.J. & Yannone, S.M. 2007, "Processing of 3'-
phosphoglycolate-terminated DNA double strand breaks by Artemis nuclease", The Journal 
of Biological Chemistry, vol. 282, no. 6, pp. 3547-3558.  
Ramsden, D.A. & Gellert, M. 1998, "Ku protein stimulates DNA end joining by mammalian 
DNA ligases: a direct role for Ku in repair of DNA double-strand breaks", The EMBO 
Journal, vol. 17, pp. 609-614.  
Reitsema, T.J., Banáth, J.P., MacPhail, S.H. & Olive, P.L. 2004, "Hypertonic saline enhances 
expression of phosphorylated histone H2AX after irradiation", Radiation Research, vol. 
161, no. 4, pp. 402-408.  
Riballo, E., Kuhne, M., Rief, N., Doherty, A., Smith, G.C., Recio, M.J., Reis, C., Dahm, K., 
Fricke, A., Krempler, A., Parker, A.R., Jackson, S.P., Gennery, A., Jeggo, P.A. & Löbrich, 
M.,M. 2004, "A pathway of double-strand break rejoining dependent upon ATM, Artemis, 
and proteins locating to γ-H2AX foci", Molecular Cell, vol. 16, pp. 715-724.  
Rivera-Calzada, A., Maman, J.D., Spagnolo, L., Pearl, L.H. & Llorca, O. 2005, "Three-
dimensional structure and regulation of the DNA-dependent protein kinase catalytic subunit 
(DNA-PKcs)", Structure (London, England : 1993), vol. 13, no. 2, pp. 243-255.  
Roberts, S.A., Strande, N., Burkhalter, M.D., Strom, C., Havener, J.M., Hasty, P. & Ramsden, 
D.A. 2010, "Ku is a 5'-dRP/AP lyase that excises nucleotide damage near broken ends", 
Nature, vol. 464, no. 7292, pp. 1214-1217.  
143 
 
Rogakou, E.P., Pilch, D.R., Orr, A.H., Ivanova, V.S. & Bonner, W.M. 1998, "DNA Double-
stranded Breaks Induce Histone H2AX Phosphorylation on Serine 139", Journal of 
Biological Chemistry, vol. 273, no. 10, pp. 5858-5868.  
Roman, Y., Oshige, M., Lee, Y.J., Goodwin, K., Georgiadis, M.M., Hromas, R.A. & Lee, S.H. 
2007, "Biochemical characterization of a SET and transposase fusion protein, Metnase: its 
DNA binding and DNA cleavage activity", Biochemistry, vol. 46, pp. 11369-11376.  
Rooney, S., Alt, F.W., Lombard, D., Whitlow, S., Eckersdorff, M., Fleming, J., Fugmann, S., 
Ferguson, D.O., Schatz, D.G. & Sekiguchi, J. 2003, "Defective DNA repair and increased 
genomic instability in Artemis-deficient murine cells", The Journal of Experimental 
Medicine, vol. 197, pp. 553-565.  
Roth, D.B., Porter, T.N. & Wilson, J.H. 1985, "Mechanisms of nonhomologous recombination in 
mammalian cells", Molecular and Cellular Biology, vol. 5, pp. 2599-2607.  
Roth, D.B. & Wilson, J.H. 1985, "Relative rates of homologous and nonhomologous 
recombination in transfected DNA", Proceedings of the National Academy of Sciences of 
the United States of America, vol. 82, no. 10, pp. 3355-3359.  
Saberi, A., Hochegger, H., Szuts, D., Lan, L., Yasui, A., Sale, J.E., Taniguchi, Y., Murakawa, Y., 
Zeng, W., Yokomori, K., Helleday, T., Teraoka, H., Arakawa, H., Buerstedde, J. & Takeda, 
S. 2007, "RAD18 and Poly(ADP-Ribose) Polymerase Independently Suppress the Access of 
Nonhomologous End Joining to Double-Strand Breaks and Facilitate Homologous 
Recombination-Mediated Repair", Molecular and Cellular Biology, vol. 27, no. 7, pp. 2562-
2571.  
Sartori, A.A., Lukas, C., Coates, J., Mistrik, M., Fu, S., Bartek, J., Baer, R., Lukas, J. & Jackson, 
S.P. 2007, "Human CtIP promotes DNA end resection", Nature, vol. 450, no. 7169, pp. 509-
514.  
Schultz, L.B., Chehab, N.H., Malikzay, A. & Halazonetis, T.D. 2000, "p53 binding protein 1 
(53BP1) is an early participant in the cellular response to DNA double-strand breaks", The 
Journal of Cell Biology, vol. 151, no. 7, pp. 1381-1390.  
Shaheen, M., Williamson, E., Nickoloff, J., Lee, S.H. & Hromas, R. 2010, "Metnase/SETMAR: 
a domesticated primate transposase that enhances DNA repair, replication, and 
decatenation", Genetica, vol. 138, no. 5, pp. 559-566.  
Sibanda, B.L., Critchlow, S.E., Begun, J., Pei, X.Y., Jackson, S.P., Blundell, T.L. & Pellegrini, 
L. 2001, "Crystal structure of an Xrcc4-DNA ligase IV complex", Nature Structural 
Biology, vol. 8, pp. 1015-1019.  
Smider, V., Rathmell, W.K., Brown, G., Lewis, S. & Chu, G. 1998, "Failure of hairpin-ended 
and nicked DNA To activate DNA-dependent protein kinase: implications for V(D)J 
recombination", Molecular and Cellular Biology, vol. 18, no. 11, pp. 6853-6858.  
144 
 
Smith, G.C. & Jackson, S.P. 1999, "The DNA-dependent protein kinase", Genes & 
Development, vol. 13, pp. 916-934.  
Stewart, G.,S., Wang, ,Bin, Bignell, C.,R., Taylor, A.M.,R. & Elledge, S.,J. "MDC1 is a 
mediator of the mammalian DNA damage checkpoint", Nature, vol. 421, pp. 961-966.  
Suh, D., Wilson III, D.M. & Povirk, L.F. 1997, "3'-Phosphodiesterase activity of human 
apurinic/apyrimidinic endonuclease at DNA double-strand break ends", Nucleic Acids 
Research, vol. 25, pp. 2495-2500.  
Takata, M., Sasaki, M.S., Sonoda, E., Morrison, C., Hashimoto, M., Utsumi, H., Yamaguchi-
Iwai, Y., Shinohara, A. & Takeda, S. 1998, "Homologous recombination and non-
homologous end-joining pathways of DNA double-strand break repair have overlapping 
roles in the maintenance of chromosomal integrity in vertebrate cells", The EMBO Journal, 
vol. 17, pp. 5497-5508.  
Thompson, L.H. & Schild, D. 2001, "Homologous recombinational repair of DNA ensures 
mammalian chromosome stability", Mutation Research, vol. 477, pp. 131-153.  
Thompson, L.H. & Schild, D. 1999, "The contribution of homologous recombination in 
preserving genome integrity in mammalian cells", Biochimie, vol. 81, pp. 87-105.  
Tofilon, P.J. & Camphausen, K. 2009, "Molecular targets for tumor radiosensitization", 
Chemical Reviews, vol. 109, no. 7, pp. 2974-2988.  
Tuteja, N., Tuteja, R., Ochem, A., Taneja, P., Huang, N.W., Simoncsits, A., Susic, S., Rahman, 
K., Marusic, L. & Chen, J. 1994, "Human DNA helicase II: a novel DNA unwinding 
enzyme identified as the Ku autoantigen", The EMBO Journal, vol. 13, pp. 4991-5001.  
Uziel, T., Lerenthal, Y., Moyal, L., Andegeko, Y., Mittelman, L. & Shiloh, Y. 2003, 
"Requirement of the MRN complex for ATM activation by DNA damage", The EMBO 
Journal, vol. 22, no. 20, pp. 5612-5621.  
Valerie, K. & Povirk, L.F. 2003, "Regulation and mechanisms of mammalian double-strand 
break repair", Oncogene, vol. 22, pp. 5792-5812.  
van Vugt, M.A., Gardino, A.K., Linding, R., Ostheimer, G.J., Reinhardt H.C., Ong, S.E., Tan     
       C.S.,    Miao, H., Keezer, S.M., Li, J., Pawson, T., Lewis, T.A., Carr, S.A., Smerdon, S.J.,  
       Brummelkamp, T.R., Yaffe, M.B.,2010, "A mitotic phosphorylation feedback network  
       connects Cdk1, Plk1, 53BP1, and Chk2 to inactivate the G(2)/M DNA damage checkpoint.  
       Plos Biology, vol. 8, pp. 1-20. 
 
Walker, J.R., Corpina, R.A. & Goldberg, J. 2001, "Structure of the Ku heterodimer bound to 
DNA and its implications for double-strand break repair", Nature, vol. 412, pp. 607-614.  
145 
 
Wang, H., Perrault, A.R., Takeda, Y., Qin, W. & Iliakis, G. 2003, "Biochemical evidence for 
Ku-independent backup pathways of NHEJ", Nucleic Acids Research, vol. 31, pp. 5377-
5388.  
Wang, H., Zhang, X., Geng, L., Teng, L. & Legerski, R.J. 2009, "Artemis regulates cell cycle 
recovery from the S phase checkpoint by promoting degradation of cyclin E", The Journal 
of Biological Chemistry, vol. 284, no. 27, pp. 18236-18243.  
Wang, J., Pluth, J.M., Cooper, P.K., Cowan, M.J., Chen, D.J. & Yannone, S.M. 2005, "Artemis 
deficiency confers a DNA double-strand break repair defect and Artemis phosphorylation 
status is altered by DNA damage and cell cycle progression", DNA Repair, vol. 4, pp. 556-
570.  
Wang, M., Wu, W., Wu, W., Rosidi, B., Zhang, L., Wang, H. & Iliakis, G. 2006, "PARP-1 and 
Ku compete for repair of DNA double strand breaks by distinct NHEJ pathways", Nucleic 
Acids Research, vol. 34, no. 21, pp. 6170-6182.  
Wang, S., Guo, M.F., Ouyang, H.F., Li, X., Cordon-Cardo, C., Kurimasa, A., Chen, D.J., Fuks, 
Z., Ling, C.C. & Li, G.C. 2002, "The catalytic subunit of DNA-dependent protein kinase 
selectively regulates p53-dependent apoptosis but not cell-cycle arrest", Proceedings of the 
National Academy of Sciences of the United States of America, vol. 97, pp. 1584-1588.  
Wang, Y., Cortez, D., Yazdi, P., Neff, N., Elledge, S.J. & Qin, J. 2000, "BASC, a super complex 
of BRCA1-associated proteins involved in the recognition and repair of aberrant DNA 
structures", Genes & Development, vol. 14, no. 8, pp. 927-939.  
Ward, J.F. 1990, "The yield of DNA double-strand breaks produced intracellularly by ionizing 
radiation: a review", International Journal of Radiation Biology, vol. 57, no. 6, pp. 1141-
1150.  
WATSON, J.D. & CRICK, F.H. 1953, "Molecular structure of nucleic acids; a structure for 
deoxyribose nucleic acid", Nature, vol. 171, no. 4356, pp. 737-738.  
Weis, K., Rambaud, S., Lavau, C., Jansen, J., Carvalho, T., Carmo-Fonseca, M., Lamond, A. & 
Dejean, A. 1994, "Retinoic acid regulates aberrant nuclear localization of PML-RARα in 
acute promyelocytic leukemia cells", Cell, vol. 76, no. 2, pp. 345-356.  
West, R.B., Yaneva, M. & Lieber, M.R. 1998, "Productive and nonproductive complexes of Ku 
and DNA-dependent protein kinase at DNA termini", Molecular and Cellular Biology, vol. 
18, pp. 5908-5920.  
White, D., Rafalska-Metcalf, I.U., Ivanov, A.V., Corsinotti, A., Peng, H., Lee, S.C., Trono, D., 
Janicki, S.M. & Rauscher, F.J.,3rd 2012, "The ATM Substrate KAP1 Controls DNA Repair 
in Heterochromatin: Regulation by HP1 Proteins and Serine 473/824 Phosphorylation", 
Molecular Cancer Research : MCR, vol. 10, no. 3, pp. 401-414.  
146 
 
Wilkins, M.H., Stokes, A.R. & Wilson, H.R. 1953, "Molecular structure of deoxypentose nucleic 
acids", Nature, vol. 171, no. 4356, pp. 738-740.  
Williams, R.S., Dodson, G.E., Limbo, O., Yamada, Y., Williams, J.S., Guenther, G., Classen, S., 
Glover, J.N., Iwasaki, H., Russell, P. & Tainer, J.A. 2009, "Nbs1 flexibly tethers Ctp1 and 
Mre11-Rad50 to coordinate DNA double-strand break processing and repair", Cell, vol. 
139, no. 1, pp. 87-99.  
Williams, R.S., Williams, J.S. & Tainer, J.A. 2008, "Mre11-Rad50-Nbs1 is a keystone complex 
connecting DNA repair machinery, double-strand break signaling, and the chromatin 
template", Biochemistry and cell biology = Biochimie et Biologie Cellulaire, vol. 85, pp. 
509-520.  
Williamson, E.A., Farrington, J., Martinez, L., Ness, S., O'Rourke, J., Lee, S.H., Nickoloff, J. & 
Hromas, R. 2008a, "Expression levels of the human DNA repair protein metnase influence 
lentiviral genomic integration", Biochimie, vol. 90, no. 9, pp. 1422-1426.  
Williamson, E.A., Rasila, K.K., Corwin, L.K., Wray, J., Beck, B.D., Severns, V., Mobarak, C., 
Lee, S.H., Nickoloff, J.A. & Hromas, R. 2008b, "The SET and transposase domain protein 
Metnase enhances chromosome decatenation: regulation by automethylation", Nucleic Acids 
Research, vol. 36, no. 18, pp. 5822-5831.  
Williamson, E.A., Rasila, K.K., Corwin, L.K., Wray, J., Beck, B.D., Severns, V., Mobarak, C., 
Lee, S.H., Nickoloff, J.A. & Hromas, R. 2008c, "The SET and transposase domain protein 
Metnase enhances chromosome decatenation: regulation by automethylation", Nucleic Acids 
Research, vol. 36, no. 18, pp. 5822-5831.  
Woo, R.A., McLure, K.G., Lees-Miller, S.P., Rancourt, D.E. & Lee, P.W.K. 1998, "DNA-
dependent protein kinase acts upstream of p53 in response to DNA damage", Nature, vol. 
394, pp. 700-704.  
Wray, J., Williamson, E.A., Royce, M., Shaheen, M., Beck, B.D., Lee, S.H., Nickoloff, J.A. & 
Hromas, R. 2009a, "Metnase mediates resistance to topoisomerase II inhibitors in breast 
cancer cells", PloS One, vol. 4, no. 4, pp. e5323.  
Wray, J., Williamson, E.A., Sheema, S., Lee, S.H., Libby, E., Willman, C.L., Nickoloff, J.A. & 
Hromas, R. 2009b, "Metnase mediates chromosome decatenation in acute leukemia cells", 
Blood, vol. 114, no. 9, pp. 1852-1858.  
Wu, X. & Lieber, M.R. 1996, "Protein-protein and protein-DNA interaction regions within the 
DNA end-binding protein Ku70-Ku86", Molecular and Cellular Biology, vol. 16, pp. 5186-
5193.  
Yan, Y., Zhang, X. & Legerski, R.J. 2011, "Artemis interacts with the Cul4A-DDB1DDB2 
ubiquitin E3 ligase and regulates degradation of the CDK inhibitor p27", Cell Cycle 
(Georgetown, Tex.), vol. 10, no. 23, pp. 4098-4109.  
147 
 
Yaneva, M., Kowalewski, T. & Lieber, M.R. 1997, "Interaction of DNA-dependent protein 
kinase with DNA and with Ku: biochemical and atomic-force microscopy studies", The 
EMBO Journal, vol. 16, pp. 5098-5112.  
Yang, S., Kuo, C., Bisi, J.E. & Kim, M.K. 2002, "PML-dependent apoptosis after DNA damage 
is regulated by the checkpoint kinase hCds1/Chk2", Nature Cell Biology, vol. 4, no. 11, pp. 
865.  
Yannone, S.M., Khan, I.S., Zhou, R.-., Zhou, T., Valerie, K. & Povirk, L.F. 2008, "Coordinate 5' 
and 3' endonucleolytic trimming of terminally blocked blunt DNA double-strand break ends 
by Artemis nuclease and DNA-dependent protein kinase", Nucleic Acids Research, vol. 36, 
pp. 3354-3365.  
Yasaei, H. & Slijepcevic, P. 2010, "Defective Artemis causes mild telomere dysfunction", 
Genome Integrity, vol. 1, no. 1, pp. 3.  
Yeung, P.L., Denissova, N.G., Nasello, C., Hakhverdyan, Z., Chen, J.D. & Brenneman, M.A. 
2011, "Promyelocytic leukemia nuclear bodies support a late step in DNA double-strand 
break repair by homologous recombination", Journal of Cellular Biochemistry, .  
Yoo, S. & Dynan, W.S. 1999, "Geometry of a complex formed by double strand break repair 
proteins at a single DNA end: recruitment of DNA-PKcs induces inward translocation of Ku 
protein", Nucleic Acids Research, vol. 27, pp. 4679-4686.  
You, Z., Chahwan, C., Bailis, J., Hunter, T. & Russell, P. 2005, "ATM activation and its 
recruitment to damaged DNA require binding to the C terminus of Nbs1", Molecular and 
Cellular Biology, vol. 25, no. 13, pp. 5363-5379.  
Yuan, J. & Chen, J. 2009, "N terminus of CtIP is critical for homologous recombination-
mediated double-strand break repair", The Journal of Biological Chemistry, vol. 284, no. 46, 
pp. 31746-31752.  
Yun, M.H. & Hiom, K. 2009, "CtIP-BRCA1 modulates the choice of DNA double-strand-break 
repair pathway throughout the cell cycle", Nature, vol. 459, no. 7245, pp. 460-463.  
Zhang, N., Kaur, R., Lu, X., Shen, X., Li, L. & Legerski, R.J. 2005, "The Pso4 mRNA splicing 
and DNA repair complex interacts with WRN for processing of DNA interstrand cross-
links", The Journal of Biological Chemistry, vol. 280, no. 49, pp. 40559-40567.  
Zhang, X., Succi, J., Feng, Z., Prithivirajsingh, S., Story, M.D. & Legerski, R.J. 2004, "Artemis 
is a phosphorylation target of ATM and ATR and is involved in the G2/M DNA damage 
checkpoint response", Molecular and Cellular Biology, vol. 24, pp. 9207-9220.  
Zhang, X., Zhu, Y., Geng, L., Wang, H. & Legerski, R.J. 2009, "Artemis is a negative regulator 
of p53 in response to oxidative stress", Oncogene, vol. 28, no. 22, pp. 2196-2204.  
148 
 
Zhong, S., Salomoni, P., Ronchetti, S., Guo, A., Ruggero, D. & Pandolfi, P.P. 2000, 
"Promyelocytic Leukemia Protein (Pml) and Daxx Participate in a Novel Nuclear Pathway 
for Apoptosis", The Journal of Experimental Medicine, vol. 191, no. 4, pp. 631-640.  
Zhou, R.Z., Blanco, L., Garcia-Diaz, M., Bebenek, K., Kunkel, T.A. & Povirk, L.F. 2008, 
"Tolerance for 8-oxoguanine but not thymine glycol in alignment- based gap filling of 
partially complementary double-strand break ends by DNA polymerase λ in human nuclear 
extracts", Nucleic Acids Research, vol. 36, pp. 2895-2905.  
Zhou, T., Akopiants, K., Mohapatra, S., Lin, P.S., Valerie, K., Ramsden, D.A., Lees-Miller, S.P. 
& Povirk, L.F. 2009, "Tyrosyl-DNA phosphodiesterase and the repair of 3'-
phosphoglycolate-terminated DNA double-strand breaks", DNA Repair, vol. 8, pp. 901-911.  
  
149 
 
 
 
 
VITA 
 
 Susovan Mohapatra was born on November 02, 1982 in Puri, India and is an Indian 
citizen. He graduated from Manipal College of Pharmaceutical Sciences, India, in June 2007 
with a degree of Bachelor in Pharmaceutical Sciences. While at Manipal, he studied the 
prevalence of irrational fixed dose combinations in Indian pharmaceutical market. The study 
was published with him as a co-author in Current Science in 2008. Subsequently, he began 
his graduate studies in August 2007 at Virginia Commonwealth University in Richmond, 
Virginia in the Department of Pharmacology and Toxicology. He joined the laboratory of Dr. 
Lawrence F. Povirk in March 2008, and became a Ph.D. candidate in March 2010. Susovan 
is first author on a manuscript from his graduate work that was published in Nucleic Acids 
Research in 2011. Susovan currently resides in Richmond, Virginia. 
